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ABSTRACT 
 
Small molecules perform many important functions in nature, medicine, and technology. 
However, efforts to discover and optimize new small molecule function are often impeded by limitations 
in synthetic access to this class of compounds. In contrast to peptide and oligonucleotide syntheses, small 
molecule syntheses typically employ strategies and purification methods that are highly customized for 
each target. A broadly applicable automated process for the synthesis of different classes of small 
molecules has thus far remained elusive. To enable the more generalized automation of small molecule 
synthesis, a common building block-based strategy and a common purification process for the preparation 
of many different types of small molecules are needed.  
Towards this goal, we focused on expanding the scope of a building block-based strategy 
involving the iterative coupling of boronate building blocks to include Csp3-rich linear and polycyclic 
small molecules. The first approach undertaken was the discovery of a pinene-derived iminodiacetic acid 
(PIDA) ligand which enabled the stereoselective synthesis of a wide range of new types of Csp3 boronates. 
The utility of these Csp3 boronates was demonstrated in the synthesis of a pharmaceutically relevant 
target using a previously undescribed iterative Csp3-Csp2 coupling. 
In order to access Csp3-rich cyclic and polycyclic molecules via the same building block-based 
iterative coupling process, a linear-to-cyclized strategy inspired by the biosynthesis of polycyclic natural 
products was formulated. Iterative coupling of Csp3 boronates generates linear precursors which can then 
be polycyclized to give the complex topology found in many polycyclic natural products. This strategy 
was utilized in the synthesis of four natural products and natural product-like cores from boronate 
building blocks. 
This building block-based approach to synthesis was successfully automated with the discovery 
of a new type of catch-and-release purification protocol applicable to the boronate intermediates used in 
synthesis. 14 distinct classes of small molecules were constructed from boronate building blocks on a 
small molecule synthesizer using the same iterative coupling process. The synthesis-enabled advances in 
automating small molecule synthesis described in this dissertation now stands to better enable the 
scientific community to bring the substantial power of small molecule synthesis to bear upon many 
important unsolved problems in society. 
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CHAPTER 1 
INTRODUCTION 
 
Junqi Li and Martin D. Burke 
 
1-1 DEVELOPING A PLATFORM FOR AUTOMATING SMALL MOLECULE SYNTHESIS 
Small molecules perform many important functions in nature, medicine, and technology. 
However, efforts to discover and optimize new small molecule function are often impeded by limitations 
in synthetic access to this class of compounds. In contrast, general and automated synthesis platforms 
now exist for peptides1 and oligonucleotides.2 The resulting expanded access to these molecules has 
dramatically accelerated the discovery of their functional potential. Progress in the same direction has 
also been made for oligosaccharide synthesis3 and some organic polymers,4 but a similarly generalized 
synthesis platform does not yet exist for small molecules. Small molecule synthesis has thus far remained 
a time-intensive, complex process that lies solely in the domain of trained chemists. 
However, despite their structural diversity, many small molecules possess inherent modularity 
that would enable systematic building block-based construction. Like peptides, oligonucleotides and 
oligosaccharides, most natural products are biosynthesized via the iterative assembly of a small set of 
building blocks, such as malonyl coenzyme A, isopentenyl pyrophosphate, and pyruvic acid.5 Many 
materials and pharmaceuticals comprise collections of aryl and/or heteroaryl components.6  
 To harness this modularity, our group developed an iterative coupling platform for the synthesis 
of small molecules from boron-containing building blocks. The iterative assembly of these building 
blocks was enabled by the discovery of the N-methyliminodiacetic acid (MIDA) ligand, which can 
attenuate the reactivity of a boronic acid, similar to the way a fluorenylmethoxycarbonyl (Fmoc) group 
protects an amine (Figure 1-1).  
 
Figure 1-1. The iterative coupling platform for small molecule synthesis from MIDA boronate building blocks is 
analogous to peptide synthesis from protected amino acids. D = deprotection, C = coupling 
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 In the iterative coupling platform, making and coupling MIDA boronate building blocks are the 
two key components to synthesis. In this chapter, we summarize the efforts our group and others have 
made in the synthesis and iterative assembly of Csp2 MIDA boronate building blocks, which have enabled 
access to a wide range of linear, Csp2-rich small molecules, especially the polyene natural products. 
 
1-2 SYNTHESIS OF CSP2 MIDA BORONATE BUILDING BLOCKS 
 The benchtop stability of MIDA boronates has enabled more than 200 of these building blocks to 
be made commercially available. In addition, simple MIDA boronate building blocks can also be made 
from the corresponding commercial boronic acids by complexation with the MIDA ligand under various 
conditions. 7  
 Alkenyl boronic esters are commonly prepared by hydroboration of alkynes with catecholborane 
or pinacolborane. Because of the instability of many alkenyl boronic acids, it is desirable to convert the 
boronic ester directly into the corresponding MIDA boronates without hydrolyzing the boronic ester 
under acidic conditions, circumventing the sensitive boronic acid moiety. In the preparation of one MIDA 
boronate building blocks en route to the asymmetric total synthesis of (‒)-peridinin8, we found that the 
pinacol boronic ester obtained by the dicyclohexylborane-catalyzed hydroboration of the corresponding 
alkyne can be converted into MIDA boronate 1.1 simply by treatment with MIDA and DMSO at 65 C 
(Scheme 1-1). The unreacted pinacol boronic ester 1.1 was subjected to another 2 cycles of the reaction to 
give 1.2 in an overall yield of 73%.  The Taylor group found that this hydroboration-transesterification 
sequence is general for the synthesis of alkenyl MIDA boronates from simple alkyne starting materials 
via hydroboration with catecholborane.9  
 
 
Scheme 1-1. Synthesis of an alkenyl MIDA boronate from the alkyne via a hydroboration-transesterification 
reaction.  
 
 The MIDA boronate can also be installed directly onto a commercial starting material without the 
intermediacy of the boronic acid or ester. This is especially useful when the boronic acid or ester is too 
unstable to be isolated. The 2-heterocyclic borane is an archtypical unstable boronic acid containing an 
extremely labile carbon-boron bond. A “hot protocol” was developed for the synthesis of 2-pyridyl MIDA 
boronates. This procedure involved the direct treatment of the 2-pyridyl triisopropylborate salt with 
MIDA in DMSO at 115 °C.10 This procedure works well for a range of 2-heterocyclic, alkynyl, and 
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alkenyl MIDA boronates (Table 1-1). The use of elevated temperatures is necessary for high yields 
because at lower temperatures, the triisopropylborate salt undergoes decomposition faster than 
transesterification to the MIDA boronate, which is stable at 115 °C. 
 
Table 1-1. Synthesis of MIDA boronates using the “hot protocol”.  
 
Ingleson and co-workers developed a Friedel-Crafts type direct electrophilic borylation of arenes 
and heteroarenes using a borenium cation as the electrophile.11 The same trends for site-selectivity is 
observed in this reaction as those for Friedel-Crafts reactions. This finding allows for the preparation of 
aryl and heteroaryl MIDA boronates without pre-functionalizing the arene with a halide. 
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Table 1-2. Preparation of MIDA boronates through direct electrophilic borylation from arenes. 
 
In our early studies, we established that the MIDA boronate motif is compatible with a wide 
variety of reaction conditions involving acids, soft nucleophiles, reductants, oxidants, and electrophiles 
(Figure 1-2).12  
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Figure 1-2. MIDA boronates are compatible with typical oxidation and reduction reactions, protecting group 
manipulations, as well as reactions that involve soft nucleophiles. They are generally incompatible with hard 
nucleophiles. 
 
This general compatibility with a wide variety of common reaction and aqueous work-up 
conditions has allowed simple MIDA boronates that can be made on scale to be elaborated into complex 
MIDA boronates that are not readily accessed by other methods. For example, simple bifunctional 
building blocks (E)- and (Z)-1.5 can be engaged in a host of Pd-catalyzed cross-coupling reactions to 
generate a range of dienyl and enyne MIDA boronates (Figure 1-3).13,14 Importantly, in each of these 
reactions, the stereochemistry of the double bond in 1.5 is faithfully translated into the corresponding 
product. 
 
 
Figure 1-3. Cross-coupling reactions explored with both stereoisomers of simple MIDA boronate building block 1.1 
to yield diene and enyne MIDA boronates. 
 
Ethynyl MIDA boronate 1.2 15  can also undergo a range of reactions to generate aryl and 
heteroaryl MIDA boronates. The Toste group was able to engage the alkyne moiety in Sonogashira 
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couplings to generate arylethynyl MIDA boronates which were then subjected to a gold-catalyzed 
cycloisomerization resulting in 2-benzofuranyl 1.7a or 2-indolyl MIDA boronates 1.7b (Scheme 1-2).16 
This methodology obviates the need to handle these notoriously unstable boranes obtained in a typical 
lithiation and trapping sequence from the parent heterocycles. The Glorius group disclosed a Rh(III)-
catalyzed C-H activation and annulation sequence with ethynyl MIDA boronate, further expanding the 
scope of boron-functionalized heterocycles (1.11 and 1.12) that can be accessed.17 In addition, the alkyne 
handle can undergo cycloaddition reactions to yield various types of heterocycles (1.8, 1.9 and 1.10) from 
1,3 dipolarophiles18,19 and a highly-substituted arene (1.13).14  
 
 
Scheme 1-2. Cycloaddition reactions, and Sonogashira couplings followed by cycloisomerization reactions 
involving ethynyl MIDA boronate 1.6. 
 
1-3 SYNTHESIS VIA SLOW-RELEASE CROSS-COUPLING 
A challenge that arises from using unstable boronic acids as coupling partners arises from the 
problem of rapid decomposition under the reaction conditions. In both Suzuki-Miyaura cross-coupling 
and Rh-catalyzed additions of boronic acids to electrophiles, heat, base and/or the metal catalyst can 
cause the decomposition of boronic acids to become competitive with productive cross-coupling. This 
limits the synthetic utility of boronic acids. We reasoned that the scope of practical reactions involving 
boronic acids can be expanded with the rate-controlled hydrolysis of bench-stable MIDA boronates under 
the cross-coupling conditions, which would allow the ‘slow release’ of unstable boronic acids into the 
reaction mixture. This process, which we term slow-release cross-coupling,20 has been particularly useful 
for coupling unstable and even un-isolable boronic acids.  
Using the slow-release protocol, higher isolated yields of the cross-coupled product are achieved 
with the MIDA boronate than with the corresponding freshly prepared boronic acid (Table 1-3). This 
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difference is especially remarkable for the indole MIDA boronate derivative (entry 6), with almost an 
80% increase in the isolated yield. Importantly, only 1 equivalent of the MIDA boronate is required to 
achieve high yields. Furthermore, the isolated yields obtained with the MIDA boronates were comparable 
to those obtained using syringe-pump additions of the boronic acid. This method has been further 
demonstrated with a number of other unstable aryl, heteroaryl, alkyl, and vinyl MIDA boronates with a 
host of aryl chloride coupling partners.  
 
 
Table 1-3. Cross-coupling efficiency of boronic acids and the corresponding MIDA boronate. a Reaction conditions: 
1.0 equiv. of 1.14 or 1.15 relative to p-t-butoxy chlorobenzene, 5 mol% of Pd(OAc)2, 10 mol% SPhos, 7.5 equiv. of 
K3PO4, 0.07 M in 5:1 Dioxane:H2O, 60 C, 6 hr. b Cross-couplings were run at 100 C. 
 
 
Miller and coworkers utilized a highly regioselective double slow-release cross-coupling strategy 
of a tribromide while making atropisomerically enriched biaryl compounds. 21  As shown in one of 
Miller’s several examples below (Scheme 1-3), the double Suzuki-Miyaura coupling was achieved 
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through the use of functionalized MIDA boronates under slow-release conditions. The low concentration 
of free boronic acid made the system more amenable to distinguish the most reactive of the three 
bromides in the first coupling (often >10:1:1 regioselectivity), and further distinguished between the more 
reactive of the two remaining bromides in the second coupling (often >5:1 regioselectivity) with no 
racemization observed. Interestingly, it was found that the corresponding boronic acids exhibited very 
poor regioselectivity. 
 
 
Scheme 1-3. Synthesis of atropoisomerically enriched polyaryls through Suzuki-Miyaura couplings 
 
The slow-release strategy has been extended beyond Suzuki-Miyaura cross-coupling reactions. In 
diastereoselective Rh-catalyzed additions of organoboranes to chiral sulfinyl imines, Ellman and co-
workers found that the rate-controlled hydrolysis of MIDA boronates in situ led to dramatically increased 
yields to make a host of chiral α-branched amines.22 These conditions were found in most cases to be 
more efficient than with the corresponding trifluoroborate salt and substantially more than the boronic 
acid under conditions optimized for each borane class. Brak and Ellman then applied this method in an 
efficient asymmetric synthesis of (−)-aurantioclavine (Scheme 1-4), a natural alkaloid intermediate in the 
biosynthesis of the communesin family.23 
 
 
Scheme 1-4. Ellman’s synthesis of (‒)-aurantioclavine via a Rh-catalyzed asymmetric addition of a MIDA boronate 
into an N-t-butylsulfinyl imine. 
 
1-4 SYNTHESIS VIA ITERATIVE COUPLING 
The various methods available to synthesize MIDA boronate building blocks with pre-installed 
stereochemistry has enabled us to pursue the building block-based construction of small molecules using 
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the same process. We first demonstrated this with the synthesis of ratanhine, a polyaryl natural product 
from a neolignan family. The building blocks 1.18 – 1.21 are brought together by recursive cycles of 
deprotection and coupling to afford the natural product after a final global deprotection of the MOM 
groups (Scheme 1-5).7a 
 
 
Scheme 1-5. Total synthesis of ratanhine via iterative coupling 
 
The polyene macrolide amphotericin B is a potent, ion-channel forming antifungal agent which 
has been refractory to microbial resistance despite widespread clinical utilization since the 1960s. One 
half of its complex structure consists of 7 contiguous E-alkenyl units. Another potent ion-channel forming 
polyene macrolide, vacidin A, contains an unusual Z,Z motif within the heptaene core (Figure 10). We 
have achieved both the synthesis of the polyene cores of both amphotericin B12 and vacidin A24 via a 
common reaction sequence using the iterative assembly of different stereochemically-defined building 
blocks (Scheme 1-6). Remarkably, all MIDA boronate intermediates were stable despite the extended 
conjugated polyene motifs, which are typically extremely sensitive to light, Lewis, and Bronsted acids. 
These 2 syntheses highlight the utility of pre-installing stereochemistry in the building blocks – the targets 
can be changed without changing the strategy for synthesis.  
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Scheme 1-6. Syntheses of the polyene core of Amphotericin B and vacidin A via iterative cycles of deprotection and 
coupling.  
 
The ability to execute late-stage Suzuki-Miyaura coupling reactions to complete total syntheses of 
natural products is often impeded by the incompatibility of complex boranes with common reaction 
conditions. In addition, the borane reagents used to introduce boron are typically Lewis acidic and can 
lead to decomposition in complex molecule settings. These limitations can preclude the Suzuki-Miyaura 
transform in retrosynthetic analyses of complex molecules. The MIDA boronate platform provides 
solutions to this by enabling the preparation of complex boronate building blocks by allowing the masked 
boronic acid to be carried through multi-step synthesis and facilitates purification of the intermediates. 
The utility of these highly functionalized building blocks is demonstrated with the first stereocontrolled 
synthesis of (‒)-peridinin (Scheme 1-7).8 Three iterations of the deprotect-couple sequence followed by a 
global deprotection complete the total synthesis of the atypical carotenoid natural product. Notably, the 
four constituent MIDA boronate building blocks can be synthesized on decagram scale and stored for 
months without decomposition. 
 
 
Scheme 1-7. First stereocontrolled synthesis of (‒)-peridinin via ICC. 
 
 Building on the progress made in polyene synthesis, our group undertook the challenge of 
developing a general synthesis to polyene motifs found in all polyene natural products. A general 
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retrosynthetic algorithm for systematically deconstructing the polyene motifs into a minimum number of 
MIDA boronate building blocks was devised.25  This analysis led our group to hypothesize that the 
polyene motifs in >75% of all polyene natural products can be constructed with 12 MIDA boronate 
building blocks and one coupling reaction. This hypothesis was tested and confirmed with the 
identification of the 15 polyene motifs found in >75% of the polyene natural products and their 
preparation using only the Suzuki-Miyaura cross-coupling to unite the MIDA boronate building blocks 
(Figure 1-4). This strategy also enabled the total synthesis of 3 polyene natural products using the same 
conditions used to assemble the polyene motifs. 
 
 
Figure 1-4. Synthesis of the polyene motifs found in >75% of polyene natural products from MIDA boronate 
building blocks.  
 
1-5 SUMMARY 
 The capacity of MIDA boronates to serve as stable boronic acid surrogates under multiple 
reaction conditions has allowed the synthesis of more complex MIDA boronate building blocks from 
simple MIDA boronates for small molecule synthesis with the iterative coupling platform. Many 
advances have been made in the synthesis and coupling of aryl, heteroaryl, and alkenyl MIDA boronate 
building blocks, which has allowed the platform to access linear, Csp2-rich molecules. The following 
thesis describes the expansion of the iterative coupling platform to include Csp3-rich and polycyclic small 
molecules via the stereoselective synthesis and coupling of Csp3 boronate building blocks. Together with 
the discovery of a generalized purification strategy for purifying MIDA boronates, the strategic advances 
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made enabled us to automate the synthesis of 14 distinct classes of small molecules. These studies 
illuminate a roadmap towards the more general and automated synthesis of small molecules. 
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CHAPTER 2 
A CHIRAL LIGAND FOR THE STEREOSELECTIVE SYNTHESIS OF CSP3 BORONATES 
 
Junqi Li and Martin D. Burke 
 
 Efficient access to chiral, non-racemic Csp3 boronic acids and their derivatives is critical to 
realizing their potential as valuable building blocks in complex small molecule synthesis This chapter 
details the discovery of a chiral ligand, “pinene-derived iminodiacetic acid” (PIDA), for the highly 
diastereoselective synthesis of oxiranyl Csp3 boronates. The oxiranyl boronates can be readily 
transformed into α-boryl aldehydes via a novel 1,2-migration of the boronate group that proceeds with 
complete maintenance of stereochemical purity. These α-boryl aldehydes can be manipulated into a 
variety of Csp3 boronates that were previously inaccessible. A new type of bifunctional PIDA boronate in 
which both the iodide and boron termini are attached to Csp3 carbons was also synthesized from the α-
boryl aldehyde. We demonstrated the synthetic utility of this building block in the concise and modular 
synthesis of an inhibitor of a glucagon receptor via iterative Csp3 cross-coupling. Portions of this chapter 
were adapted from Li, J.; Burke, M. D. J. Am. Chem. Soc. 2011, 133, 13774. 
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2-1 INTRODUCTION 
The importance of efficient methods for accessing chiral, non-racemic Csp3 boronic acids and 
their derivatives has grown in parallel with recent advances in Csp3 cross-coupling of alkyl boronic acids 
and esters. 1  The toolbox of asymmetric methods for constructing these building blocks is rapidly 
expanding,2 but the synthesis of highly functionalized Csp3 boronates remains a challenge. This is in large 
part due to the instability of the boronic acid or ester functionality and their incompatibility with different 
reaction conditions, thus precluding functionalization of the building blocks after installation of the 
carbon-boron bond. In view of these limitations, the goal was to develop an approach to the 
stereoselective synthesis of shelf-stable functionalized Csp3 boronates. 
N-methyliminodiacetic acid (MIDA) boronates are shelf-stable, crystalline solids that are 
compatible with common reaction conditions,3 enabling simple boron-containing starting materials to be 
transformed into more complex boronate building blocks. 4  The crystal structures of many MIDA 
boronates have revealed that the N-methyl substituent is always closely positioned to the organic group 
appended to boron.3 Variable temperature NMR studies have demonstrated that the iminodiacetic acid 
framework is conformationally rigid in solution. It is also interesting to note that a chiral diol ligand on an 
sp2-hybridized boron were not very effective in promoting a diastereoselective epoxidation reaction with 
the corresponding alkenyl boronic ester in Pietruszka’s studies. 5  Presumably, this is due to weak 
asymmetric induction from the chiral ligand that is held in a distal position from the alkene.  
Collectively, these observations suggested that the enforced proximity between the N-alkyl 
substituent of MIDA and the organic group bound to boron could be leveraged for effective transfer of 
stereochemical information during functionalizations of the corresponding boronates if the N-alkyl group 
were made chiral (Figure 2-1). In view of the versatility of epoxides in the preparation of other chiral 
building blocks, we questioned whether the epoxidation of alkenylboronates can be rendered asymmetric 
via such modifications of the MIDA ligand.  
 
 
Figure 2-1. Leveraging the enforced proximity between the chiral R* group and the organic group bound to boron 
to achieve highly diastereoselective reactions. 
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2-2 IDENTIFYING A CHIRAL LIGAND FOR DIASTEREOSELECTIVE EPOXIDATION 
To test this hypothesis, we first examined the epoxidation of alkenyl boronates under the 
influence of iminodiacetic acid ligands with chiral N-alkyl substituents (Table 2-1). We found that 
pinene-derived iminodiacetic acid ligand (2.1a, PIDA) gave >20:1 d.r. as determined by 1H-NMR of the 
crude reaction mixture in the epoxidation reaction under standard mCPBA conditions. Separating the 
chiral ligand from the nitrogen atom by a methylene spacer resulting in a large decrease in the d.r. (Table 
2-1, entry 2), suggesting that the chiral group must be held in a rigid position proximal to the organic 
group appended to boron for effective transfer of stereochemical information from the chiral group. The 
use of less sterically bulky ligands such as 2.1c and 2.1d did not give satisfactory diastereometic ratios.  
 
 
Table 2-1. Diastereoselective epoxidations of various iminodiacetic acid-based alkenylboronates 
 
Both enantiomers of α-pinene are cheap and readily available on a very large scale, so PIDA has 
the potential to serve as a very practical chiral auxiliary. The PIDA ligand was initially synthesized by 
dialkylation of the chiral amine with chloroacetic acid under basic aqueous conditions, followed by 
treating the diacetate salt with a hot aqueous solution of BaCl2·H2O to form an insoluble barium chelate 
of PIDA. Protonation of this chelate with H2SO4 gives the PIDA ligand as an aqueous solution which is 
then concentrated to give the PIDA ligand as a white solid (Scheme 2-1a). The product generated using 
  
16 
 
this method can be used directly without purification. The procedure requires careful control of the pH 
during the protonation step is critical as lowering the pH below 3 results in formation of the ammonium 
salt of the ligand, which is highly hygroscopic and cannot be isolated. Although this method generated 
sufficient quantities of the ligand for subsequent studies, an improved procedure was needed for the 
practical synthesis of larger quantities of the ligand.  This procedure starts with the dialkylation of the 
chiral with benzyl bromoacetate, followed by hydrogenolysis of the benzyl esters to generate the PIDA 
ligand (Scheme 2-1b). Although a silica gel column is required to purify the intermediate benzyl ester, 
this procedure proved to be more reproducible and more than 9 g of the ligand can be obtained in one run. 
This alkylation-hydrogenolysis sequence was later adapted by Dr. Ian Crouch for the large-scale synthesis 
of 2.3d.6 
 
 
Scheme 2-1. Synthesis routes towards the PIDA ligand 2.1a. 
 
 We next explored the capacity of this ligand to enable the diastereoselective epoxidation of a 
variety of alkenylboronates. Trans 1,2-disubstituted alkenes with both alkyl and electronically different 
aryl substituents work well, giving rise to >20:1 d.r.  (Table 2-2, entries 1-6). Cis 1,2-disubstituted (entry 
7) and trisubstituted alkenes (entry 8) were also effective substrates. Somewhat diminished but still 
synthetically useful diastereoselectivies were observed with 1,1-disubstituted alkenes (entries 9-10), 
which are often challenging substrates for asymmetric functionalization due to the steric similarities 
between the two diastereotopic faces of the alkene. 7  Even the simplest alkenyl boronate 2.2n was 
epoxidized with excellent diastereoselectivity and yield. The stereochemical configuration of the epoxides 
2.3a, 2.3g and 2.3n were unambiguously confirmed by X-ray crystallography. The remaining product 
configurations were assigned by analogy. These oxiranyl PIDA boronates shared many of the 
characteristics of MIDA boronates – they are shelf-stable, crystalline solids that can be purified by silica 
gel chromatography, making them highly desirable chiral building blocks for complex molecule synthesis. 
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Table 2-2. Highly diastereoselective epoxidations of alkenyl PIDA boronates. a Isolated yields after silica gel 
chromatography. b Diastereomeric ratios determined via 1H-NMR analysis of the unpurified reaction mixtures. c 
Conducted on a 15 mmol scale and isolated by crystallization. 
 
2-3 PROPOSED MODEL FOR DIASTEREOSELECTIVITY 
A model to explain the diastereoselectivity of the reaction was developed by first examining the 
crystal structures of 2.2g and 2.3g. Ignoring crystal packing effects, both the crystal structures show that 
the chiral pinane group is positioned in close proximity to the alkene. It is thus reasonable to assume that 
the transition state structure would also have a similar relative spatial position of the two groups. Notably, 
the distance between the methine hydrogen on the carbon attached to nitrogen and the hydrogen on the 
carbon attached to boron decreases by 0.3Å after epoxidation due to rehybridization of the carbon bound 
to boron (Figure 2-2). This implies that the space occupied by the hydrogen is subject to steric 
interactions with the bulky ligand.  
             
Figure 2-2. X-ray structures of 2.2g (left) and 2.3g (right). 
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In this model, the alkenyl PIDA boronate can adopt two different conformations that can 
interconvert by rotation about the carbon-boron bond (Figure 2-3), which leads to two energetically 
different transition states. In both cases, mCPBA can only approach the alkene from the bottom face as 
the top face is blocked by the bulky chiral group. In the transition state, as the sp2 carbon pyramidalizes, 
the carbon-hydrogen bond rotates upwards, resulting in some steric interaction between the hydrogen and 
the ligand (TS1). This steric interaction is however, much larger in the transition state involving the 
alternate conformer (TS2). This results in a large difference in the transition state energies, which in turn 
leads to high diastereoselectivies in the epoxidation of 1,2-substituted alkenes. For 1,1-disubstituted 
alkenes, the steric difference between a methyl group and methylene group in the transition states is 
smaller, thus leading to lower diastereoselectivities observed in the epoxidation reaction. 
 
 
Figure 2-3. Proposed transition states for the epoxidation of 2.2g. 
 
2-4 REARRANGEMENT OF OXIRANYL PIDA BORONATES 
With the oxiranyl PIDA boronates in hand, we turned to exploring the synthetic utility of these 
chiral building blocks. We first attempted the Lewis acid-catalyzed epoxide ring-opening with TMSN3. 
After screening different types of Lewis acids, we found that Mg(ClO4)2 promoted clean conversion of 
the epoxide to a new product as a single diastereomer, but the 1H-NMR of this product was not consistent 
with the target azido-alcohol 2.7. After further characterization, the structure of the product was assigned 
to be an α-boryl aldehyde 2.8, which would be the product of a Meinwald rearrangement8 of the epoxide. 
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Scheme 2-2. Observed product of an attempted Lewis acid-catalyzed epoxide ring-opening reaction. 
 
Carbon-bound boron enolates have been observed spectroscopically 9  and are implicated in 
reactions,10 but are usually not stable enough to be isolated because of rapid 1,3-shift of the boryl group 
from carbon to oxygen to form the more stable oxygen-bound enolate.11 However, α-boryl aldehydes with 
the PIDA ligand are stable solids that can be handled in air. We reasoned that the kinetic stability of the 
-boryl aldehyde arises from an sp3-hybridized boron, which lacks the p-orbital required for interaction 
with the lone pair on the carbonyl oxygen during the 1,3-shift.  
Four possible pathways arising from aryl, hydrogen, or boryl migration (Figure 2-4) exist for the 
Meinwald rearrangement. No ketone or acylboronate products were observed from 1H-NMR analysis of 
the crude reaction mixture, indicating that hydrogen migration was not operative. In addition, the α-boryl 
aldehyde was formed as a single diastereomer. To determine whether aryl- or boryl-migration occurred 
during the rearrangement, the stereochemistry of the resulting products was used as a probe since the two 
pathways would lead to different diastereomers.  
 
Figure 2-4. Four possible pathways of the Meinwald rearrangement of oxiranyl PIDA boronates.  
 
The rearrangement of the epoxide was repeated using Mg(ClO4)2 without TMSN3, giving the 
same -boryl aldehyde 2.8 in 84% yield. The aldehyde was then treated with a diol to form a ketal 2.9 
from which X-ray quality crystals can be grown (Scheme 2-3). The crystal structure of the ketal showed 
that the α-center of the precursor aldehyde is of the R configuration, which is consistent with the 
migration of the boron group. Independent contemporaneous studies by the Yudin group identified the 
same rearrangement using racemic epoxides and the MIDA ligand, and using a deuterium-labeled epoxide 
and BF3·Et2O as the Lewis acid arrived at the same conclusion regarding selective migration of the MIDA 
boronate group (Scheme 2-3).12 
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Scheme 2-3. Determining the migrating group by A) probing the stereochemical outcome of the rearrangement and 
B) deuterium labeling.12 
 
To our knowledge, this type of 1,2-migration of the boryl group has not been previously reported 
in the literature. It is interesting to note that in this case, the boryl group migrates preferentially over the 
phenyl group.  Trans 1,2-disubstituted alkenyl PIDA boronates with an alkyl substituent can also undergo 
the rearrangement using BF3·Et2O with complete maintenance of stereochemical purity, although the 
migrating group has not been unambiguously confirmed in this case.13 
 Gevorgyan and co-workers later utilized this 1,2 boryl migration in their synthesis of borylated 
furans.14  
 
2-5 NEW CSP3 BORONATES FROM α-BORYL ALDEHYDES 
The stability of the α-boryl aldehyde allowed us to synthetically manipulate this versatile 
functional group via reduction to an alcohol followed by a Mitsunobu-type displacement of the alcohol by 
iodide. This reaction sequence thus generated a new type of bifunctional building block in which both the 
halide and the boron termini are attached to Csp3 carbons (Scheme 2-4).  
 
 
Scheme 2-4. Synthesis of bifunctional PIDA boronate 2.13 from α-boryl aldehyde 2.8. 
 
Contemporaneous studies by Yudin and co-workers revealed that α-boryl aldehydes can undergo 
oxidation, carbon-carbon bond formation and nucleophilic addition reactions to give a variety of Csp3 
boronates that are previously inaccessible or difficult to make by other methods (Figure 2-5).15 The group 
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also demonstrated that α-boryl carboxylic acids derived from the corresponding aldehydes can undergo 
Curtius rearrangement with retention of configuration at the migrating carbon.15a  
 
Figure 2-5. Examples of new types of Csp3 boronates that can be derived from α-boryl aldehydes. 
 
 
2-6 CROSS-COUPLING OF CSP3 BORONATES  
The diarylmethine motif is present in more than 2000 natural products and in several marketed 
pharmaceuticals (Figure 2-6). Employing a stereospecific cross-coupling reaction between benzylic Csp3 
boronates and an aryl halide represents an opportunity to gain modular access to the chiral diarylmethine 
motif. Importantly, the stereochemistry is pre-installed in the Csp3 boronate building block which can 
then be coupled using a stereospecific reaction, thus translating the stereochemistry into the final product. 
The Crudden group first demonstrated that secondary benzylic pinacol boronic esters can undergo cross-
coupling efficiently under palladium catalysis with high levels of stereoretention. Interfacing with this 
powerful chemistry provided an opportunity to employ the building blocks generated with the 
aforementioned methodology in a variety of ways.  
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Figure 2-6. Examples of natural products and pharmaceuticals containing the chiral diarylmethine motif. 
 
PIDA boronate 2.13 represents a new type of bifunctional building block that has the potential to 
access important chiral targets such as the glucagon receptor antagonist 2.17 under evaluation via a 
previously undescribed iterative Csp3 cross-coupling approach (Figure 2-7). 2.17 can be retrosynthesized 
into three building blocks with 2.13 as the key building block bearing the stereogenic center that would be 
translated into the final product. 2.13 would first be coupled to an arylzinc reagent in a Csp3-Csp2 Negishi 
reaction, followed by transesterification of the product to a pinacol boronic ester. Applying Crudden’s 
conditions to couple the resulting boronic ester with the aryl halide 2.18 would give the t-butyl ester of 
the final target 2.17.  
 
 
Figure 2-7. Initial retrosynthesis of the glucagon receptor antagonist 2.14. 
 
A model study employing 2.13 and phenylzinc bromide as the coupling partner was used to test 
the feasibility of the proposed Negishi coupling. The conditions optimized for the similar cross-couplings 
of arylzinc halides with alkyl iodides reported by Fu16 or Knochel17 did not give the desired product in 
this system. The major side product observed was the styrene formed by β-hydride elimination after 
oxidative addition, a common problem with the cross-coupling reactions of alkyl iodides. 
In view of the difficulties in getting productive coupling, an alternative route to 2.14 involving 
the polarity reversal of the first two coupling partners was pursued.  We reasoned that the problem of β-
hydride elimination may be alleviated by first transforming 2.13 into an organozinc reagent via zinc 
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insertion and then coupling with an aryl iodide. Using a bulky phosphine ligand on Pd can promote 
reductive elimination after transmetallation,18 thus preventing β-hydride elimination.  
We found that the organozinc reagent 2.17 generated from PIDA boronate 2.13 was stable in 
solution at room temperature.19  Treating 2.17 with p-bromobenzonitrile and diethyl zinc using a Pd 
catalyst and a Buchwald ligand gave the desired products without optimization. This new type of linchpin 
reagent containing a PIDA (or MIDA) boronate and a reactive organozinc moiety was later found to be 
useful for the synthesis of new Csp3 boronates, as will be discussed later in Chapter 3. Having validated 
the feasibility of this approach, we turned to the synthesis of 2.14 via this new type of Csp3-Csp2 iterative 
cross-coupling strategy.  
The presence of the free amide moiety in the aryl iodide 2.18 posed a potential problem of 
competitive proto-demetallation of the organozinc coupling partner. The Knochel group reported the use 
of the Buchwald ligand SPhos and slow addition of the organozinc reagent to enable Negishi couplings 
with unprotected amide functionalities.20 Using this report as the starting point, optimization studies were 
carried out (Figure 2-7) by varying the temperature, Pd, and ligand, and comparing the ratios of the 
desired product 2.19 to the proto-demetallated side product 2.20 in the crude reaction mixture. Pd2dba3 
was a better Pd source than Pd(OAc)2, and a higher temperature promoted productive coupling. The 
trialkylphosphine ligand PCy3 was less effective than the RuPhos ligand. With the best conditions and 
using a slower rate of addition (0.1 mmol in 1 h) of 2.17, an isolated yield of 73% was obtained on a 0.2 
mmol scale. 
 
Figure 2-8. Summary of the optimization studies for the Negishi coupling of 2.17 and 2.18. 
 
Transesterification of the PIDA boronate motif in 2.19 to the corresponding pinacol boronic ester 
2.25 proceeded in 84% yield with complete maintenance of stereochemical purity.  Importantly, the PIDA 
ligand was easily recovered from this reaction in 97% yield. Finally, cross-coupling of this chiral 
secondary boronic ester 2.21 with aryl iodide 2.15 employing the conditions developed by Crudden 
  
24 
 
provided the t-butyl ester of 2.14 with good maintenance of stereochemical purity (94:6 e.r.). 
Deprotection of the t-butyl ester completed a very efficient, modular, and highly stereocontrolled 
synthesis of 2.14 (Scheme 2-5). With the synthesis of 2.14 as the first example of an iterative Csp3-Csp2 
cross-coupling cycle, the scope of the iterative coupling platform has now been expanded to potentially 
include Csp3-rich targets. 
 
Scheme 2-5. Iterative Csp3-Csp2 cross-coupling for the modular synthesis of 2.14. 
 
Attempts were also made to couple other the pinacol boronic ester 2.12 which was synthesized 
from alcohol protection and transesterification to the pinacol boronic ester. NaHCO3 from the original 
protocol for the transesterification reaction was omitted in this reaction to prevent β-elimination of the 
siloxy group. The PIDA ligand was again recovered in good yield in the transesterification reaction 
(Scheme 2-6).  
 
 
Scheme 2-6. Synthesis of pinacol boronic ester 2.23 from 2.12. 
 
The cross-coupling of 2.23 with iodotoluene was examined using Pd(OAc)2 or Pd2dba3 and 
several ligands (PPh3, PtBu3, PCy3 or SPhos) combinations with Ag2O as the base, including the 
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conditions developed by Crudden and co-workers. Under the conditions screened, no productive coupling 
occurred. The two major side products observed in the reaction mixtures were styrene and 
protodeboronated starting material, as well as unreacted iodotoluene (Scheme 2-7).  
 
 
Scheme 2-7. Attempted cross-coupling of 2.23 with iodotoluene under various conditions. 
 
Styrene can be generated under the reaction conditions by two pathways: i) rapid β-elimination 
after complexation of the palladium-hydroxo to the pinacol boronic ester; or ii) “-ate” complexation with 
hydroxide in the presence of adventitious amounts of water followed by β-elimination (Scheme 2-8). The 
cross-coupling of 2.23 was not pursued further after these initial studies, and remains an unsolved 
problem.21,22 
 
Scheme 2-8. Proposed pathways for formation of the styrene side product from 2.23. 
 
 
2-7 DIASTEREOSELECTIVE AZIRIDINATION OF ALKENYL PIDA BORONATES 
Together with Johanna Moratz, we explored the potential of the PIDA ligand to gain 
stereocontrolled access to other types of strained 3-membered cyclic boronates. We first tested the 
aziridination of alkenyl PIDA boronate using an Atkinson-type aziridination23 reaction conditions. Using 
3-amino-2-ethylquinazolin-4(3H)-one (Q-NH2) with PhI(OAc)2,24 we found that the aziridination reaction 
goes with a high d.r.25 of >20:1 as analyzed by 1H-NMR of the crude reaction mixture and an isolated 
yield of 86% (Scheme 2-9). Similar to the oxiranyl PIDA boronates, 2.24 is a stable solid that can be 
purified by silica gel chromatography.26 Notably, the use of N-aminophthalimide in place of Q-NH2 gave 
a lower d.r. of 7:1, suggesting that the steric bulk on the aziridination reagent is important in 
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differentiating between the two enantiotopic faces of the alkene. Thus far, efforts to convert aziridine 2.24 
into other types of Csp3 boronates via ring-opening reactions and removal of the quinazolinone protecting 
group have not been successful due to poor conversion and/or decomposition of the starting material.    
 
 
Scheme 2-9. Diastereoselective aziridination with alkenyl PIDA boronate 2.2a. 
 
 The cyclopropanation of alkenyl PIDA boronate 2.2a and 2.2h were also attempted. Using both 
Simmons-Smith and Pd-catalyzed cyclopropanation conditions, low or no diastereoselectivities were 
obtained (Scheme 2-10). This lack of stereoselectivity may be due to the highly reactive zinc or palladium 
carbenoids involved, leading to early transition states where interactions between the chiral substrate and 
reagent are weak. In non-selective reactions like the cyclopropanation reaction, a practical way of getting 
to the desired stereo-enriched products may be to use the chiral ligand to resolve the diastereomeric 
mixture by chromatography or crystallization, as described below in Section 2-8.   
 
Scheme 2-10. Cyclopropanations of alkenyl PIDA boronates. 
 
2-8 CHIRAL MIDA DERIVATIVES FOR RESOLVING RACEMIC BORONIC ACIDS 
Our group and others have found that the PIDA ligand and 2.1d can serve as chiral reagents for 
resolving racemic boronic acids. Ian Crouch and Pulin Wang used ligand 2.1d (now termed BIDA) to 
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resolve the commercially available s-butyl boronic acid.6 After complexation of the boronic acid with 
BIDA, the resulting two diastereomers can be separated by a silica gel column. This method for obtaining 
diastereomerically pure BIDA boronates is effective for a variety of chiral boronic acids. Lee and Cheon 
used PIDA to resolve racemic 1,1’-bi-2-napthol boronic acids by silica gel chromatography, allowing 
them to gain access to a range of enantiomerically pure 3,3’-disubstituted 1,1’-bi-2-napthol derivatives 
(Scheme 2-11). 27  These examples and the PIDA-promoted diastereoselective epoxidation provide 
practical access to stereochemically pure boronic acids which can otherwise be difficult to access. 
 
 
Scheme 2-11. Diastereomeric resolution of racemic boronic acids using the PIDA and BIDA ligands. 
 
2-9 SUMMARY AND CONCLUSIONS 
Towards the goal of enabling a more general, building block-based approach to small molecule 
synthesis, we have developed the efficient stereoselective synthesis of new types of Csp3 boronate 
building blocks using a pinene-derived chiral ligand PIDA. A serendipitous discovery of a novel type of 
Meinwald rearrangement of oxiranyl PIDA boronates involving migration of the boryl group with 
complete maintenance of stereochemical purity allowed us to gain access to a synthetically versatile α-
boryl aldehyde building block. We also demonstrated the capacity to transform stereochemically pure 
dual Csp3-hybridized halo PIDA boronates into a medicinally important chiral small molecule target via 
highly efficient and flexible iterative Csp3 cross-coupling. The stereoselective functionalization of alkenyl 
boronates bearing a chiral ligand and the diastereomeric resolution of chiral boronates described in this 
chapter now provide rapid access to stereochemically pure boron-containing building blocks for realizing 
their synthetic potential in complex molecule synthesis. 
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CHAPTER 2 
EXPERIMENTAL SECTION 
 
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, Alfa Aesar, TCI 
America, or Frontier Scientific, and were used without further purification unless otherwise noted. 
Pd2dba3, RuPhos, PPh3 and Ag2O were purchased from Sigma-Aldrich. P(o-tol)3 was purchased from  
TCI America. Solvents were purified via passage through packed columns as described by Pangborn and 
coworkers1 (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexane, benzene, and toluene, dry neutral 
alumina and Q5 reactant; DMSO, DMF: activated molecular sieves). All water was deionized prior to use. 
Diisopropylethylamine was freshly distilled under an atmosphere of nitrogen from CaH2.  
 
General Experimental Procedures.  Unless noted, all reactions were performed in flame-dried round-
bottom or modified Schlenk flasks fitted with rubber septa under a positive pressure of argon.  Organic 
solutions were concentrated via rotary evaporation under reduced pressure with a bath temperature of 23 
oC unless otherwise noted. Reactions were monitored by analytical thin layer chromatography (TLC) 
performed using the indicated solvent on E. Merck silica gel 60 F254 plates (0.25mm).  Compounds were 
visualized by exposure to a UV lamp (λ = 254 nm), and/or a solution of KMnO4, followed by brief 
heating using a Varitemp heat gun. Column chromatography was performed using Merck silica gel grade 
9385 60Å (230-400 mesh). 
 
Structural analysis.  1H NMR and 13C NMR spectra were recorded at 20 oC on Varian Unity 500, Varian 
Unity Inova 500NB or Varian Unity 500 instruments.  Chemical shifts (δ) are reported in parts per million 
(ppm) downfield from tetramethylsilane and referenced to residual protium in the NMR solvent (CHCl3, δ 
= 7.26; acetone, δ = 2.05, center line; 1,1,2,2-tetrachloroethane, 5.95) or to added tetramethylsilane (δ = 
0.00).  Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, quint = quintet, sept = septet, m = multiplet, b = broad, app = apparent), coupling constant (J) in 
Hertz (Hz), and integration.  Chemical shifts (δ) for 13C NMR are reported in ppm downfield from 
tetramethylsilane and referenced to carbon resonances in the NMR solvent (CDCl3, δ = 77.0, center line; 
acetone, δ = 39.5, center line). Carbons bearing boron substituents were not observed (quadrupolar 
relaxation). 11B NMR were recorded using a Unity Inova 400 instrument and referenced to an external 
standard of (BF3•Et2O). High resolution mass spectra (HRMS) were performed by Furong Sun and Dr. 
Haijun Yao at the University of Illinois School of Chemical Sciences Mass Spectrometry Laboratory.   
II. Experimental procedures 
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a. Synthesis of 2.1a – 2.1d 
 
General procedure for the synthesis of ligands 2.1a-d: 
To a stirred solution of chloroacetic acid (69 mmol, 2.3 equiv) in H2O (60 ml) at 0 oC was added dropwise 
5N NaOH solution (13.8 ml, 69 mmol, 2.3 equiv), keeping the temperature below 15 oC. The amine (30 
mmol, 1 equiv) in IPA (30 ml) was then added in one portion. The ice bath was then removed and the 
reaction heated at 70 oC (oil bath temperature). After stirring for 2.5 h, the reaction turned clear from an 
initial biphasic mixture. Another 8.1 ml (40.5 mmol, 1.35 equiv) of the 5 N NaOH solution was added, 
and the reaction stirred for a further 14 h at the same temperature. The third portion of the NaOH solution 
(8.1 ml, 40.5 mmol, 1. 35 equiv) was then added and stirred for an additional 2 h at 70 oC. The reaction 
was then heated up to 100 oC. BaCl2.H2O (7.69 g, 31.5 mmol, 1.05 equiv) in H2O (30 ml) was heated until 
the solid dissolved completely. This heated solution was then added dropwise via pipette into the reaction 
mixture. After the addition, the reaction was stirred for an additional 15 min, during which the reaction 
became a thick white suspension. After cooling to room temperature, the white solid was collected by 
filtration and dried in a vacuum oven set at 100 oC. The mass of the Ba chelate was determined. The Ba 
chelate was then suspended in H2O (60 ml) and heated in a 110 oC oil bath until boiling. 5M H2SO4 (1.95 
equiv relative to the Ba chelate) was added dropwise, followed by rinsing with 5 ml H2O. The resulting 
suspension was stirred for another 15 min in the oil bath, then cooled for 5 min and filtered through celite, 
rinsing with 10 ml H2O. The filtrate was concentrated to dryness. The solid obtained was then redissolved 
in Et2O/CH2Cl2 (1:10, 100 ml) and filtered to remove insoluble solids. The CH2Cl2 solution was then 
concentrated in vacuo and the solid obtained was used without further purification. 
 
 
The general procedure was followed using (1R,2R,3R,5S)-(−)-Isopinocampheylamine (Sigma Aldrich, 
4.59 g, 30 mmol),  chloroacetic acid (6.52 g, 69 mmol) and NaOH (30 ml, 150 mmol). 11.33 g of the Ba 
chelate (93%) was obtained. 5.4 ml of 5M H2SO4 was used for the hydrolysis, and the ligand 2.1a was 
obtained as an off-white solid (6.63 g, 82 %). 
 
1H-NMR (500 MHz, DMSO-d6)  
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δ 3.45 (s, 4H), 3.23-3.18 (m, 1H), 2.32-2.23 (m, 1H), 2.19-2.12 (m, 1H), 1.91-1.86 (m, 1H), 1.75-
1.69 (m, 2H), 1.64-1.60 (m, 1H), 1.15 (s, 3H), 1.03 (d, J = 6.5, 3H), 0.92 (s, 3H), 0.79 (d, J = 10 Hz, 1H). 
 
13C-NMR (125 MHz, DMSO-d6) 
δ 173.5, 62.0, 53.8, 47.3, 40.9, 40.3, 38.7, 33.4, 29.6, 27.9, 23.0, 20.9. 
 
HRMS (ESI+) 
Calculated for C14H24NO4: 270.1705 
Found:    270.1703 
 
 
Improved two-step procedure for the synthesis of 2.2a:  
 
 
An oven-dried 500-mL three-necked round-bottom flask equipped with a 3cm egg-shaped PTFE-coated 
magnetic stir bar is cooled under an N2 atmosphere. The vessel is charged with anhydrous K2CO3 (39.80 g, 
288 mmol, 4.86 equiv) and flushed with N2 for another 5 min. MeCN (200 ml) is added to the vessel, 
followed by (1S, 2S, 3S, 5R)-(+)-isopinocampheylamine (10 ml, 59.31 mmol, 1 equiv). With vigorous 
stirring, benzyl bromoacetate (22 ml, 138.9 mmol, 2.3 equiv) is added. The center neck of the vessel is 
sealed with a rubber septum. The reaction is lowered into a pre-heated oil bath and stirred vigorously at 
an internal temperature of 45 °C for 14 h. The reaction is cooled to 23 °C and filtered through Celite into 
a 1-L round-bottomed flask, rinsing the reaction vessel and filter cake with EtOAc (4 × 50 ml). The 
yellow filtrate is concentrated by rotary evaporation (40 °C, 30 mmHg) to give a viscous yellow liquid. 
CH2Cl2 (60 ml) is added, followed by Celite (25 g). The CH2Cl2 is removed via rotary evaporation. The 
celite pad is loaded onto a silica gel column and purified by flash chromatography to afford the product 
2.6 as a clear, colorless oil (23.47 g, 52.20 mmol, 87% yield). 
1H-NMR (500 MHz, CDCl3)  
δ 7.35-7.31 (m, 10H), 5.13 (s, 4H), 3.67 (app s, 4H), 3.27-3.22 (m, 1H), 2.31-2.26 (m, 1H), 2.17-
2.12 (m, 1H), 1.91-1.85 (m, 2H), 1.76-1.69 (m, 2H), 1.18 (s, 3H), 1.06 (d, J = 7.0 Hz, 3H), 0.93 (s, 3H).  
 
13C-NMR (125 MHz, CDCl3) 
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δ 172.1, 135.8, 128.5, 128.3, 128.2, 66.3, 62.7, 53.2, 47.9, 41.6 (2C), 39.0, 34.0, 30.8, 28.0, 23.2, 
21.2. 
 
To a 500-mL single-necked roundbottomed flask containing dibenzyl ester 2.6 (21.00 g, 46.71 mmol, 
1equiv) is added ethanol (300 ml), 10 wt% palladium on carbon (1.74 g, 1.635 mmol, 0.035 equiv) and a 
3 cm PTFE-coated egg-shaped stir bar. The reaction vessel is sealed with a rubber septum and the 
resulting suspension stirred and degassed by bubbling N2 through the suspension for 10 min. Hydrogen 
gas is then bubbled through the solution for 20 min. The vent needle is removed and the reaction stirred 
under a H2 atmosphere for 14 h. The H2-filled balloon is removed, and the reaction is purged of H2 by 
bubbling N2 through the suspension for 30 min. MeOH (100 ml) is added to the suspension. The 
suspension is filtered through Celite into a 1-L filtration flask. The round-bottomed flask and the filter 
cake were washed with MeOH (4 × 50 mL). The slightly yellow filtrate is transferred to a 1-L 
roundbottomed flask and concentrated to a solid via rotary evaporation. Diethyl ether (250 mL) and a 3 
cm egg-shaped stir bar were added. The suspension is stirred for 4 h. The suspension is filtered, washing 
with the white solid with diethyl ether (4 × 50 mL) to afford 2.1a as a white powder (10.88 g, 40.14 
mmol, 85.9%). 
 
 
The general procedure was followed using (−)-cis-myrtanylamine (Sigma Aldrich, 4.59 g, 30 mmol),  
chloroacetic acid (6.52 g, 69 mmol) and NaOH (30 ml, 150 mmol). 11.33 g of the Ba chelate (93%) was 
obtained. 5.4 ml of 5M H2SO4 was used for the hydrolysis, and the ligand 2.1b was obtained as an off-
white solid in about 70-80% purity (1.62 g, 20 %). 
 
1H-NMR (500 MHz, DMSO-d6)  
δ 3.36 (s, 4H), 2.56 (d, J = 7.5 Hz, 2H), 2.30-2.26 (m, 1H), 2.12-2.09 (m, 1H), 1.93-1.91 (m, 1H), 
1.87 – 1.72 (m, 4H), 1.53-1.45 (m, 1H), 1.12 (s, 3H), 0.91 (s, 3H), 0.84 (d, J = 9.5 Hz, 1H). 
 
13C-NMR (125 MHz, DMSO-d6) 
δ 172.4, 59.6, 55.1, 43.5, 40.9, 38.6, 38.2, 32.9, 27.8, 25.8, 22.9, 19.5. 
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HRMS (ESI+) 
Calculated for C14H24NO4: 270.1705 
Found:    270.1700 
 
 
The general procedure was followed using (S)-(+)-1-cyclohexylethylamine (Alfa Aesar, 12.72 g, 100 
mmol), chloroacetic acid (21.74 g, 230 mmol) and NaOH (100 ml, 500 mmol). 27.84 g of the Ba chelate 
(74%) was obtained. 14.4 ml of 5M H2SO4 was used for the hydrolysis, and the ligand 1c was obtained as 
an off-white solid (12.47 g, 51 %). 
 
1H-NMR (500 MHz, DMSO-d6)  
δ 3.37 (d, J = 17.5 Hz, 2H), 3.29 (d, J = 17.5 Hz, 2H), 2.39 (m, 1H), 1.91 (app d, J = 7.5 Hz, 1H), 
1.65-1.51 (m, 4H), 1.24-1.03 (m, 5H), 0.92 (d, J = 6.5 Hz, 3H), 0.89-0.78 (m, 1H). 
 
13C-NMR (125 MHz, DMSO-d6) 
δ 173.4, 62.6, 53.2, 40.8, 30.0, 29.4, 26.1, 25.8, 25.8, 12.6 
 
HRMS (ESI+) 
Calculated for C12H22NO4: 244.1550 
Found:    244.1549 
 
 
The general procedure was followed using (1S, 2S)-(+)-2-benzyloxycyclopentylamine (Alfa Aesar, 5 g, 
26.1 mmol), chloroacetic acid (5.68 g, 60.1 mmol) and NaOH (26.1 ml, 130.5 mmol). 5.87 g of the Ba 
chelate (67%) was obtained. 3.40 ml of 5M H2SO4 was used for the hydrolysis, and the ligand 2.1d was 
obtained as an off-white solid (3.36 g, 42 %). 
 
1H-NMR (500 MHz, DMSO-d6)  
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δ 12.2 (br s, 2H), 7.32-7.24 (m, 5H), 4.42 (d, J = 12 Hz, 1H), 4.36 (d, J = 11.5 Hz, 1H), 3.76-3.74 
(m, 1H), 3.48 (d, J = 17.5 Hz, 2H), 3.43 (d, J = 18 Hz, 2H), 3.24-3.20 (m, 1H), 1.88-1.82 (m, 1H), 1.82-
1.76 (m, 1H), 1.59-1.48 (m, 3H), 1.38-1.30 (m, 1H). 
 
13C-NMR (125 MHz, DMSO-d6) 
δ 173.0, 138.6, 128.1, 127.6, 127.3, 83.0, 70.4, 68.1, 53.6, 29.8, 28.4, 20.9. 
 
HRMS (ESI+) 
Calculated for C16H22NO5: 308.1498 
Found:    308.149 
 
b. Synthesis of 2.2a – 2.2n 
 
 
General procedure for the complexation of chiral ligands 2.1a-d to trans-2-phenylvinylboronic acid: 
To a solution of trans-2-phenylvinylboronic acid (1.5 equiv) in toluene (30 ml) and DMSO (1.5 ml) was 
added the ligand 2.1 (typically 1-5 mmol, 1 equiv). The flask was fitted with a Dean-Stark trap. The 
Dean-Stark trap was fitted with an air-cooled condenser vented to ambient atmosphere. The stirred 
solution was refluxed with azeotropic removal of water for 2 h. The toluene was removed in vacuo, and 
the residue was taken up in 2:1 EtOAc/acetone (60 ml) and washed twice with 1:1 brine/H2O (30 ml). The 
aqueous layer was extracted with 2:1 EtOAc/acetone (30 ml) and the combined organic phase washed 
with brine, dried over MgSO4, filtered and concentrated in vacuo. The crude product was then purified by 
silica gel chromatography, eluting first with Et2O to remove impurities, then with 1:4 (acetone/Et2O). 
 
 
The reaction was carried out on a 20 mmol scale with some modifications from the general procedure and 
purified without the use of silica gel chromatography: To a suspension of trans-2-phenylvinylboronic acid 
(2.96g, 20 mmol) in toluene (200 ml) was added the ligand 2.1a (9.68g, 36 mmol). The flask was fitted 
with a 50 ml Dean-Stark trap and an air-cooled condenser vented to ambient atmosphere. The stirred 
solution was refluxed with azeotropic removal of water for 2 h. After cooling to room temperature, the 
  
36 
 
crude solid product was collected via vacuum filtration. The filtrate was then concentrated to dryness and 
Et2O (50 ml) was added. The resulting white precipitate was collected via vacuum filtration and the 
combined solids were then washed with additional Et2O (50 ml). This solid was then taken up in acetone 
(150 ml) and passed slowly through a pad of silica gel in a 100 ml sintered funnel, eluting with additional 
acetone (50 ml). The filtrate thus obtained was concentrated and dried in vacuo, giving the product 2.2a 
(6.74 g, 88%). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.27, visualized by short wave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.47 (d, J = 7 Hz, 1H), 7.35 (t, J = 7 Hz, 1H), 7.29 (t, J = 7.5 Hz, 1H), 7.07 (d, J = 18 Hz, 1H), 
6.31 (d, J = 18 Hz, 1H), 4.19 (d, J = 17 Hz, 1H), 3.84 (s, 2H), 3.70 (dt, J = 10, 6.5 Hz, 1H), 3.62 (d, J = 
17.5 Hz, 1H), 2.57 – 2.52 (m, 1H), 2.46 – 2.42 (m, 1H), 2.17 (dquint, J = 6.5, 1.5 Hz, 1H), 2.02 (sept, J = 
2.5 Hz, 1H), 1.89 (dt, J = 6, 2 Hz, 1H), 1.74 (ddd, J = 15, 6.5, 2.5 Hz, 1H), 1.27 (d, J = 6.5 Hz, 3H), 1.22 
(s, 3H), 0.92 (d, J = 11 Hz, 1H), 0.88 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 169.5, 166.9, 144.6, 137.6, 128.7, 128.4, 126.7, 68.6, 60.6, 54.4, 49.0, 40.6, 39.1, 38.8, 32.1, 
30.3, 27.0, 23.6, 23.4. 
 
11B-NMR (100 MHz, acetone-d6) 
δ 11.9 
 
HRMS (ESI+) 
Calculated for C22H29BNO4: 382.2190 
Found:    382.2187 
 
 
The general procedure was followed using trans-2-phenylvinylboronic acid (0.22 g, 1.5 mmol), ligand 
2.1b (0.606g, 2.25 mmol) in 20 ml toluene and 1 ml DMSO. A white solid was obtained (0.387 g, 68%). 
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TLC (Hexanes:EtOAc:Et2O 2:2:1) 
Rf = 0.20, visualized by short wave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.50 (app d, J = 7 Hz, 2H), 7.34 (app t, J = 7.5 Hz, 2H), 7.28-7.25 (m, 1H), 6.93, (d, J = 18 Hz, 
1H), 6.33 (d, J = 18 Hz, 1H), 4.17-4.08 (m, 4H), 3.45 (dd, J = 13.5, 6.5 Hz, 1H), 3.34 (dd, J = 13.5, 3 Hz, 
1H), 2.74-2.68 (m, 1H), 2.38-2.26 (m, 2H), 2.16-2.11 (m, 1H), 2.01-1.94 (m, 1H), 1.92-1.76 (m, 3H), 
1.15 (s, 3H), 1.08 (d, J = 10 Hz, 1H), 0.92 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 167.8, 167.4, 144.2, 137.6, 128.6, 128.4, 126.7, 66.8, 58.5, 58.4, 47.3, 40.4, 38.1, 37.4, 31.9, 
27.3, 25.6, 23.3 (2C). 
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.9 
 
HRMS (ESI+) 
 Calculated for C22H29BNO4: 382.2190 
 Found:    382.2187 
 
 
The general procedure was followed using trans-2-phenylvinylboronic acid (0.74 g, 5 mmol), ligand 2.1c 
(1.82 g, 7.5 mmol) in 50 ml toluene and 2.5 ml DMSO. A white solid was obtained (0.311 g, 74%). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.38 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.52 (d, J = 8 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.27 (t, J = 7.5 Hz, 1H), 6.96, (d, J = 18 Hz, 
1H), 6.46 (d, J = 18 Hz, 1H), 4.27 (d, J = 17 Hz, 1H), 4.19 (d, J = 17 Hz, 1H), 4.05 (d, J = 14.5 Hz, 1H), 
4.02 (d, J = 17 Hz, 1H), 3.42-3.38 (m, 1H), 2.05 (m, 1H), 1.86-1.83 (m, 1H), 1.78-1.74 (m, 1H), 1.69-
1.62 (m, 2H), 1.50-1.44 (m, 1H), 1.36-1.27 (m, 6H), 1.18-1.-08 (m, 2H). 
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13C-NMR (125 MHz, CDCl3) 
 δ 168.5, 167.7, 144.3, 128.6, 128.4, 126.7, 67.6, 56.8, 39.2, 32.1, 27.7, 26.4, 25.7, 25.7, 10.5. 
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.9 
 
HRMS (ESI+) 
 Calculated for C20H27BNO5: 356.2033 
 Found:    356.2029 
 
 
Boronate ester 2.2d. The general procedure was followed using trans-2-phenylvinylboronic acid (0.148 
g, 1 mmol), ligand 2.1d (0.461 g, 1.5 mmol) in 15 ml toluene and 0.5 ml DMSO. An off-white solid was 
obtained (0.311 g, 74%). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.38 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.50 (d, J = 8 Hz, 2H), 7.38-7.29 (m, 6H), 7.26-7.22 (m, 1H), 7.18-7.13, (m, 1H), 6.96 (d, J = 
18 Hz, 1H), 6.46 (d, J = 18.5 Hz, 1H), 4.62 (d, J = 11.5 Hz, 1H), 4.55 (d, J = 11 Hz, 1H), 4.41-4.38 (m, 
1H), 4.29 (d, J = 16.5 Hz, 1H), 4.19 (d, J = 17.5 Hz, 1H), 4.14 (d, J = 16.5 Hz, 1H), 4.05 (d, J = 17 Hz, 
1H), 3.70 (q, J = 9 Hz, 1H), 2.30-2.25 (m, 1H), 2.20-2.15 (m, 1H), 1.82-1.6 (m, 4H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 168.8, 167.5, 144.3, 137.5, 136.4, 128.8, 128.6, 128.5, 128.4, 128.3, 126.8, 79.3, 73.4, 72.0, 
60.0, 55.4, 29.6, 26.2, 21.1. 
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.8 
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HRMS (ESI+) 
 Calculated for C24H27BNO5: 420.1978 
 Found:    420.1982 
 
 
 
General procedure for the synthesis of boronates 2.2e-1 and 2.2f-1: 
Preparation of boronic acid solution. A 7 ml vial equipped with a stir bar was charged with the boronic 
acid (2.4 mmol). The vial was taken into the glovebox and THF (6 ml) was added. The mixture was 
stirred rapidly to give 0.4 M solution of the boronic acid. 
 
Preparation of catalyst stock solution. In a glovebox, to a 7 ml vial equipped with a stir bar was added 
P(o-tolyl)3 (170 mg, 0.55 mmol) and Pd2dba3 (128 mg, 0.14 mmol). THF (14 ml) was added to make a 
0.01 M catalyst solution which was stirred at 23 C for 10 min.  
 
The freshly prepared catalyst stock solution was immediately for the preparation of 2.2e-1 and 2.2f-1: 
This reaction was carried out in triplicate. A 7 ml vial (“reaction vial”) equipped with a stir bar was 
charged with (E)-(2-Iodoethenyl)boronate ester2  (0.4 mmol), and Ag2O (1.2 mmol). The vials were taken 
into the glovebox. To each reaction vial was added 0.5 ml THF. 1.5 ml (0.6 mmol) of the boronic acid 
solution was added to the reaction vial, followed by 2 ml of the catalyst stock solution (0.02 mmol 
Pd2dba3, 0.08 mmol P(o-tolyl)3). The reaction was then sealed with a cap, removed from the glovebox and 
placed in a heating block pre-equilibrated at 45 C. The reaction was stirred for 24 h at 45 C, then cooled 
to 23 C. The reaction mixture was filtered through celite, combining the filtrates from the triplicate 
reactions. The celite pad was rinsed with THF (2 ×10 ml). The combined filtrate was concentrated in 
vacuo. The crude product was taken up in CH2Cl2 and loaded onto a silica gel column. The non-polar 
impurities were eluted with Et2O, and the product was eluted with 10-33% Et2O/acetone.  
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The general procedure was followed using a stock solution of 3-methoxycarbonyl-phenylboronic acid 
(432 mg, 2.4 mmol) and (E)-(2-Iodoethenyl)boronate ester (124 mg, 0.4 mmol) and Ag2O (278 mg, 1.2 
mmol)  in each of 3 reaction vials. MIDA boronate 2.2e-1 (340 mg, 89%) was obtained as a white solid 
after silica gel chromatography. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.22, visualized by UV, stained by KMnO4. 
1H-NMR (500 MHz, acetone-d6) 
δ 8.14 (t, J = 1.5 Hz, 1H), 7.90 (dt, J = 7.5, 1.5 Hz, 1H), 7.76 (d, J = 7.5 Hz, 1H), 7.49 (t, J = 8.0 
Hz, 1H), 7.02 (d, J = 18.5 Hz, 1H), 6.47 (d, J = 18.5 Hz, 1H), 4.29 (d, J = 17 Hz, 2H), 4.13 (d, J = 17 Hz, 
2H), 3.89 (s, 3H), 3.09 (s, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
 δ 168.5, 166.5, 141.1, 139.0, 131.4, 130.9, 129.1, 128.8, 127.3, 61.8, 51.8, 46.8. 
 
HRMS (ESI+) 
 Calculated for C15H17BNO6: 318.1149 
 Found:    318.1154 
 
 
The general procedure was followed using a stock solution of 4-fluoro-phenylboronic acid (84 mg, 2.4 
mmol) and (E)-(2-Iodoethenyl)boronate ester (124 mg, 0.4 mmol) and Ag2O (278 mg, 1.2 mmol)  in each 
of 3 reaction vials. MIDA boronate 2.2f-1 (162 mg, 49%) was obtained as a white solid after silica gel 
chromatography. 
 
TLC (Hexanes:acetone 1:1) 
Rf = 0.24, visualized by short wave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.58-7.54 (m, 2H), 7.13-7.09 (m, 2H), 6.93 (d, J = 18.5 Hz, 1H), 6.30 (d, J = 18 Hz, 1H), 4.27 
(d, J = 17 Hz, 1H), 4.09 (d, J = 16.5 Hz, 1H), 3.06 (s, 3H). 
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13C-NMR (125 MHz, acetone-d6) 
 δ 169.1, 163.3 (d, J = 244 Hz), 141.5, 135.7, 129.2 (d, J = 8.8 Hz), 116.0 (d, J = 21.4 Hz), 62.3, 
47.4. 
 
HRMS (ESI+) 
 Calculated for C13H24BNO4F: 278.1000 
 Found:   278.0998 
 
 
In an unoptimized procedure, to a suspension of 2.2e-1 (322 mg, 1.02 mmol) in MeOH (10 ml) in a 20 ml 
vial was added K2CO3 (421 mg, 3.05 mmol) under ambient atmosphere. The vial was capped and placed 
in a heating block pre-heated to 45 C. The reaction was stirred at 45 C for 30 min and then allowed to 
cool to 23 C. The yellow solution of the boronic ester was poured into 20 ml 6N HCl. The solution was 
transferred to a separatory funnel and extracted with Et2O (2 × 25 ml). To the aqueous layer was added 
brine (10 ml) and the aqueous layer was extracted with 1:1 THF/Et2O (25 ml). The organic phase was 
then dried over MgSO4, filtered and concentrated in vacuo to afford boronic acid 2.2e-2.The boronic acid 
was then suspended in toluene (30 ml) and 2.1a was added. The mixture was refluxed with a Dean-Stark 
trap for 2 h. The reaction was cooled to 23 C and concentrated in vacuo. CH2Cl2 (30 ml) was added and 
stirred briefly. The excess ligand 2.1a was removed by filtration. To the filtrate was added celite, and the 
suspension was concentrated in vacuo. The celite pad was loaded onto a silica gel column and the product 
2.2e purified by flash chromatography (100% Et2O – 20% acetone/Et2O) to afford a white solid (298 mg, 
67% over 2 steps). 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.27, visualized by short wave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 8.14 (s, 1H), 7.95 (d, J = 8 Hz, 1H), 7.63 (d, J = 8 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.11 (d, J 
= 18.5 Hz, 1H), 6.38 (d, J = 18 Hz, 1H), 4.21 (d, J = 17.5 Hz, 1H), 3.93 (s, 3H), 3.88 (d, J = 15.5 Hz, 
1H), 3.82 (d, J = 15.5 Hz, 1H), 3.71 (dt, J = 10, 6.5 Hz, 1H), 3.56 (d, J = 17 Hz, 1H), 2.47-2.52 (m, 1H), 
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2.48-2.43 (m, 1H), 2.18-2.16 (m, 1H), 2.03-2.02 (m, 1H), 1.92-1.90 (m, 1H), 1.74 (ddd, J = 13, 6, 2 Hz, 
1H), 1.29 (d, J = 7 Hz, 3H), 1.23 (s, 3H), 0.92 (d, J = 11 Hz, 1H), 0.88 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.5, 166.9 (2H), 143.4, 137.9, 131.2, 130.6, 129.3, 128.7, 127.6, 68.6, 60.6, 54.4, 52.2, 49.0, 
40.5, 39.1, 38.8, 32.0, 30.3, 27.0, 23.6, 23.4 
 
 
HRMS (ESI+) 
 Calculated for C24H31BNO6: 440.2244 
 Found:    440.2250 
 
 
To a solution of 2.2f-1 (139 mg, 0.50 mmol) in THF (5 ml) was added 1N NaOH (1.5 ml, 1.5 mmol) 
under ambient atmosphere and temperature and stirred vigorously for 15 min. The reaction was quenched 
with the addition of sat. NH4Cl solution (5 ml). The mixture was stirred for 3 min, then transferred to a 
separatory funnel, rinsing with Et2O (5 ml). After phase separation, the aqueous phase extracted with 1:2 
THF/Et2O (2 × 7.5 ml). The organic phase was dried over MgSO4, filtered and concentrated in vacuo to 
give the boronic acid 2.2f-2. The solid was suspended up in toluene (20 ml) and 2.1a (20 mg, 0.75 mmol) 
was added. The reaction was heated to reflux with a Dean-Stark trap for 2 h. After cooling to room 
temperature, toluene was removed in vacuo. CH2Cl2 (30 ml) was added and stirred briefly. The excess 
ligand 2.1a was removed by filtration. To the filtrate was added celite, and the suspension was 
concentrated in vacuo. The celite pad was loaded onto a silica gel column and the product purified by 
flash chromatography (100% Et2O – 20% acetone/Et2O) to afford a white solid 2.2f (136 mg, 68% over 2 
steps). 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.30, visualized by short wave UV. 
 
1H-NMR (500 MHz, CDCl3) 
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δ 7.44-7.41, (m, 2H), 7.05-7.01 (m, 3H), 6.20 (d, J = 18 Hz, 1H), 4.19 (d, J = 17.5 Hz, 1H), 3.85 
(s, 2H), 3.69 (dt, J = 10, 6.5 Hz, 1H), 3.63 (d, J = 17.5 Hz, 1H), 2.52 (tt, J = 12, 2.5 Hz, 1H), 2.44 (ddt, J 
= 11, 6, 2 Hz, 1H), 2.19-2.16 (m, 1H), 2.03-2.00 (m, 1H), 1.90 (dt, J = 6, 2 Hz, 1H), 1.73 (ddd, J = 15, 6, 
2.5 Hz, 1H), 1.28 (d, J = 7 Hz, 3H), 1.22 (s, 3H), 0.92 (d, J = 11 Hz, 1H), 0.88 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.5, 166.9, 162.8 (d, J = 247 Hz), 143.3, 133.8, 128.3 (d, J = 7.8 Hz), 115.6 (d, J = 21.4 Hz), 
66.6, 60.6, 54.4, 49.0, 40.5, 39.1, 38.8, 32.1, 30.3, 27.0, 23.6, 23.4. 
 
HRMS (ESI+) 
 Calculated for C22H28BFNO4: 400.2095 
 Found:    400.2101 
 
 
To a solution of 2.2g-13 (197 mg, 1 mmol) in THF (10 ml) was added 1N NaOH (3 ml, 3 mmol) under 
ambient atmosphere and temperature and stirred vigorously for 15 min. The reaction was quenched with 
the addition of sat. NH4Cl solution (10 ml). The mixture was stirred for 3 min, then transferred to a 
separatory funnel, rinsing with Et2O (10 ml). After phase separation, the organic phase was washed with 
another portion of sat. NH4Cl solution (10 ml) and the combined aqueous phase extracted with 1:1 
THF/Et2O (15 ml). The organic phase was dried over MgSO4, filtered and concentrated in vacuo to give 
the boronic acid 2.2g-2 as a white solid. The solid was taken up in toluene (15 ml) and DMSO (0.75 ml) 
and 2.1a (404 mg, 1.5 mmol) was added. The reaction was heated to reflux with a Dean-Stark trap for 1.5 
h. After cooling to room temperature, toluene was removed in vacuo. The residue was taken up in 2:1 
EtOAc/acetone (15 ml) and washed twice with 1:1 H2O/brine (10 ml). The aqueous layers were extracted 
with 2:1 EtOAc/acetone (15 ml). The combined organic phase was dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel chromatography, eluting first with Et2O then 
with 1:4 acetone/Et2O to give 2.2g as a white solid (166 mg, 52% over 2 steps). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.41, stained by KMnO4 
 
  
44 
 
1H-NMR (500 MHz, acetone-d6) 
δ 6.13 (dq, J = 8.5 Hz, 1H), 5.66 (dd, J = 17.5, 1.5 Hz, 1H), 4.19 (d, J = 18 Hz, 1H), 4.18 (d, J = 
16 Hz, 1H), 4.09 (d, J = 15.5 Hz, 1H), 3.94 (d, J = 18 Hz, 1H), 3.87 (dt, J = 10, 3 Hz, 1H), 2.57-2.51 (m, 
1H), 2.49-2.42 (m, 2H), 2.00 (sept, J = 3 Hz, 1H), 1.91 (dt, J = 6, 2 Hz, 1H), 1.79 (dd, J = 6.5, 1.5 Hz, 
3H), 1.61 (ddd, J = 15, 6.5, 1.5 Hz, 1H), 1.33 (d, J = 7 Hz, 3H), 1.25 (s, 3H), 1.04 (d, J = 10.5 Hz, 1H), 
0.98 (s, 3H).  
 
13C-NMR (125 MHz, acetone-d6) 
 δ 170.2, 167.2, 140.8, 67.9, 60.3, 54.5, 49.6, 41.0, 39.0, 38.5, 31.8, 30.3, 26.9, 23.0, 22.9, 20.8. 
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.5 
 
HRMS (ESI+) 
 Calculated for C17H27BNO4: 320.2033 
 Found:    320.2035 
 
 
 
 
In an unoptimized procedure, TBS-protected propargyl alcohol (5.17 g, 30.4 mmol) was weighed into a 
dry 20 ml Ichem vial and the vial was sealed with a septum cap. The vial was flushed with N2 for 20 min, 
then catecholborane (3.4 ml, 31.9 mmol) was added neat in one portion. The reaction was stirred at 60 C 
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in a heating block for 15 h. After cooling to room temperature, 4.36 g (approx. 15 mmol) of this crude 
product was diluted in THF (150 ml) and 1N NaOH (45 ml, 45 mmol) was added. After vigorous stirring 
for 10 min, the mixture was transferred to a separatory funnel and the phases separated. The organic layer 
was washed with 1N NaOH (60 ml), then H2O (60 ml) and 1:1 H2O/brine (60 ml). The organic phase was 
then dried over MgSO4, filtered and concentrated to give a yellow oil as the boronic acid 2.2i-1 (1.48 g, 
6.85 mmol). The boronic acid 2.2i-1 was then dissolved in toluene (60 ml) and DMSO (3 ml). 2.1a was 
then added, and the mixture was heated to reflux with a Dean-Stark trap for 2h. The reaction was then 
cooled to room temperature. Toluene was then removed in vacuo. Et2O was added to the residue and the 
precipitate, which is the crude product, was obtained by vacuum filtration. Purification by silica gel 
chromatography (30-100% EtOAc/hexane) gave a white solid 2.2i (405 mg, ~30% from boronic acid). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.51 visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.22 (dt, J = 17.5, 4Hz, 1H), 5.94 (dt, J = 17.5, 2 Hz, 1H), 4.26-4.25 (m, 2H), 4.23 (d, J = 18 
Hz, 1H), 4.18 (d, J = 15.5 Hz, 1H), 4.12 (d, J = 15 Hz, 1H), 3.98 (d, J = 18 Hz, 1H), 3.86 (dt, J = 10.5, 6 
Hz, 1H), 2.59-2.53 (m, 1H), 2.49-2.41 (m, 2H), 1.99 (sept, J = 3 Hz, 1H), 1.92 (dt, J = 6, 2 Hz, 1H), 1.66 
(ddd, J = 15, 6.5,  Hz, 1H), 1.34 (d, J = 7 Hz, 3H), 1.25 (s, 3H), 1.07 (d, J = 10.5 Hz, 1H), 0.99 (s, 3H), 
0.9 (s, 9H), 0.1 (s, 6H).  
 
13C-NMR (125 MHz, CDCl3) 
δ 169.7, 167.0, 146.2, 68.4, 64.3, 60.3, 54.2, 49.0, 40.6, 38.9, 38.8, 32.0, 30.8, 30.2, 27.0, 25.9, 
23.5 (2C), 15.2, -5.4.  
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.8 
 
HRMS (ESI+) 
 Calculated for C23H41BNO5Si: 450.2847 
 Found:    450.2845 
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The boronate ester 2.2i (1.52 g, 3.38 mmol) was dissolved in CH2Cl2 (68 ml) and cooled to 0 C. H2O 
(0.34 ml) followed by TFA (6.80 ml) was then added. The reaction was stirred at 0 C for 30 min. the 
reaction was washed briefly with H2O (30 ml), then twice with sat. aqueous NaHCO3 (30 ml). The 
combined aqueous layer was washed with CH2Cl2 (30 ml). The organic phase was then dried over MgSO4, 
filtered and concentrated. Following purification by silica gel chromatography (4080% EtOAc/hexane), 
a white solid 2.2h was obtained. (737 mg, 65%). 
 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.20, visualized by KMnO4 
 
1H-NMR (500 MHz, acetone-d6) 
δ 6.26 (dt, J = 18, 4 Hz, 1H), 5.89 (app d, J = 17.5 Hz, 1H), 4.12 (d, J = 15 Hz, 1H), 4.12 (m, 
2H), 3.89 (dt, J = 10, 6.5 Hz, 1H), 2.56 (m, 1H), 2.48-2.2 (m, 2H), 1.99 (sept, J = 3 Hz, 1H), 1.91 (dt, J = 
6, 2.5 Hz, 1H), 1.63 (ddd, J = 15, 6.5, 5 Hz, 1H), 1.35 (d, J = 7 Hz, 3H), 1.25 (s, 3H), 1.06 (d, J = 10.5 
Hz, 1H), 0.97 (s, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
 δ 170.8, 167.9, 146.5, 68.5, 64.5, 60.9, 55.2, 50.2, 41.6, 39.6, 39.1, 32.3, 30.9, 27.5, 23.6, 23.6. 
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.8 
 
HRMS (ESI+) 
 Calculated for C17H27BNO5: 336.1982 
 Found:    336.1979 
 
 
To a solution of 2.2j-14 (117 mg, 0.45 mmol) in THF (5 ml) was added 1N NaOH (1.4 ml, 1.4 mmol) 
under ambient atmosphere and temperature and stirred vigorously for 15 min. The reaction was diluted 
with Et2O and quenched with the addition of sat. NH4Cl solution (10 ml). The mixture was stirred for 3 
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min, then transferred to a separatory funnel. After phase separation, the organic phase was washed with 
another portion of sat. NH4Cl solution (10 ml) and the combined aqueous phase extracted with 3:2 
THF/Et2O (10 ml then 5 ml). The combined organic phase was dried over MgSO4, filtered and 
concentrated in vacuo to give the boronic acid 2.2j-2 as a white solid. The solid was taken up in benzene 
(30 ml) and 2.1a (182 mg, 0.675 mmol) was added. The reaction was heated to reflux with a Dean-Stark 
trap for 2 h. After cooling to room temperature, benzene was removed in vacuo. CH2Cl2 (30 ml) was 
added and stirred briefly. The excess ligand 2.1a was removed by filtration. To the filtrate was added 
celite, and the suspension was concentrated in vacuo. The celite pad was loaded onto a silica gel column 
and the product purified by flash chromatography (100% Et2O – 20% acetone/Et2O) to afford a white 
solid (100 mg, 58% over 2 steps) as the pure cis-isomer. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.52, visualized by short wave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.37 – 7.27 (m, 5H), 5.92 (d, J = 15 Hz, 1H), 4.04 (d, J = 17.5 Hz, 1H), 3.69 (dt, J = 10.5, 6.5 
Hz, 1H), 3.29 (d, J = 14.5 Hz, 1H), 3.27 (d, J = 18 Hz, 1H), 2.54 (d, J = 15 Hz, 1H), 2.53-2.48 (m, 1H), 
2.43 – 2.39 (m, 1H), 2.00 – 1.98 (m, 1H), 1.97 – 1.94 (m, 1H), 1.85 (dt, J = 6, 2.5 Hz, 1H), 1.50 (ddd, J = 
15, 6.5, 2.5 Hz, 1H), 1.25 (s, 3H), 1.02 (s, 3H), 0.99 (d, J = 7 Hz, 3H), 0.82 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 169.4, 166.7, 144.8, 139.6, 128.6, 128.0, 127.6, 67.8, 61.5, 55.0, 49.0, 40.7, 38.8, 38.7, 32.1, 
30.4, 27.1, 23.3, 23.0. 
 
HRMS (ESI+) 
 Calculated for C22H29BNO4: 382.2190 
 Found:    382.2198 
 
 
 
To an oven-dried 300-mL 3-neck round-bottomed flask equipped with a magnetic stir bar, two rubber 
septa (side and center arm) and a thermometer with an adapter (side arm) was added THF (75 mL) and 
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trimethyl borate (6 mL, 53.6 mmol, 1.1 equiv) under an atmosphere of N2. The solution was cooled to -70 
C (internal temperature) in a dry ice/acetone bath. The Grignard reagent (97.5 mL, 48.75 mmol, 0.50 M 
in THF) was cannulated directly into the reaction vessel over 30 min. The reaction vessel was removed 
from the bath after 5 min and allowed to warm to ambient temperature over the course of 3 h resulting in 
a white slurry. While the slurry of the “ate” complex was warming to ambient temperature, an oven-dried 
200-mL 3-neck round-bottomed flask equipped with a magnetic stir bar, a thermometer, a rubber septum 
and a distillation train (center arm) was charged with MIDA (15.78 g, 107.3 mmol, 2.2 equiv) and DMSO 
(75 mL). Using a heating mantle and variac, the suspension was brought to an internal temp of 150 C. 
The suspension of the “ate” complex was added directly into the DMSO solution of MIDA over the 
course of 1 h via cannula transfer (Teflon cannula) under a positive pressure of N2 at a rate such that the 
internal temperature remained between 120–150 C. After the addition was completed the reaction vessel 
was washed with THF (20 mL) and the washes added via cannula transfer to the reaction vessel 
containing the MIDA solution. The remaining THF and MeOH were allowed to distill off (~15 min). The 
reaction vessel was allowed to cool to ambient temperature. The reaction mixture was then transferred to 
a 1 L separatory funnel. To this was added 100 ml of de-ionized water, 100 ml of brine, 150 ml of ethyl 
acetate, and 100 ml of acetone. After mixing, the organic layer was separated, and the aqueous layer was 
extracted thrice with 50 mL of 3:2 ethyl acetate: acetone solution. TLC showed no product in the aqueous 
layer. The combined organic fractions were then washed with 100 mL of brine (3×), and dried by stirring 
with MgSO4 and Darco. The organic fractions were then concentrated to form a orange-brown oil, which 
was taken up in 50 ml acetone. Et2O (400 ml) was slowly added to the acetone solution. 2 phases formed. 
After vacuum filtration to trap the oil, crystals formed which were recovered by another filtration. The 
filtrate was concentrated, and the residue taken up in 20 ml of acetone.  100 ml of Et2O and 100 ml of 
hexane was added sequentially, and the mixture allowed to crystallize overnight. After filtration, the 
filtrate was concentrated, the residue taken up in ~ 10 ml acetone, and Et2O (100 ml) was layered on top 
and the solution was allowed to stand and crystallize. The crystals were collected by vacuum filtration 
and the filtrate discarded. An off-white solid was obtained as an inseparable mixture of 2 MIDA 
boronates (4.43 g, 43%). This mixture was used without further purification for the synthesis of 2.2k. 
 
 
In an unoptimized procedure, to a solution of the crude product containing 2.2k-1 (1.69 g, 8.01 mmol) in 
THF (80 ml) was added 1N NaOH (24 ml, 24 mmol) under ambient atmosphere and temperature and 
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stirred vigorously for 15 min. The reaction was diluted with Et2O (40 ml) and quenched with the addition 
of sat. NH4Cl solution (50 ml). The mixture was stirred for 3 min, then transferred to a separatory funnel. 
After phase separation, the aqueous phase extracted with 2:1 THF/Et2O (2 × 30 ml). The combined 
organic phase was dried over MgSO4, filtered and concentrated in vacuo to give the boronic acid 2.2k-2. 
The solid was taken up in toluene (60 ml) and 2.1a (3.23 g, 12.0 mmol) was added. The reaction was 
heated to reflux with a Dean-Stark trap for 2 h. After cooling to room temperature, toluene was removed 
in vacuo. CH2Cl2 (50 ml) was added and stirred briefly. The excess ligand 2.1a was removed by filtration. 
To the filtrate was added celite, and the suspension was concentrated in vacuo. The celite pad was loaded 
onto a silica gel column and the product purified by flash chromatography (Et2O – 20% acetone/Et2O) to 
afford a white solid (710 mg, 27% over 2 steps) as the pure product 2.2k. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.30, visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.12 (s, 1H), 4.10 (d, J = 17 Hz, 1H), 3.76 (d, J = 15.5 Hz, 1H), 3.76 (d, J = 15.5 Hz, 1H), 3.72 
(dt, J = 10.5, 6 Hz, 1H), 3.46 (d, J = 17.5 Hz, 1H), 2.47-2.41 (m, 2H), 2.15-2.12 (m, 1H), 1.99-1.98 (m, 
1H), 1.91 (dt, J = 6, 2 Hz, 1H), 1.87 (s, 3H), 1.85 (s, 3H), 1.58 (ddd, J = 15, 6, 2 Hz, 1H), 1.30 (d, J = 6.5 
Hz, 3H), 1.25 (s, 3H), 0.95 (s, 3H), 0.89 (d, J = 10.5 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.6, 166.8, 151.2, 68.5, 61.0, 54.1, 49.1, 40.6, 39.1, 38.9, 32.1, 30.2, 29.7, 27.1, 23.6, 23.3, 
21.4. 
 
HRMS (ESI+) 
 Calculated for C18H29BNO4: 334.2190 
 Found:    334.2191 
 
 
To a solution of 1-phenylvinylboronic acid (296 mg, 2 mmol) was added 1a (808 mg, 3 mmol). The 
mixture was refluxed with a Dean-Stark trap for 2 h. The reaction was then cooled to 23 C and 
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concentrated in vacuo. The residue was taken up in CH2Cl2 and absorbed onto celite. The celite pad was 
loaded onto a silica gel column and the product purified by flash chromatography (Et2O – 20% 
acetone/Et2O) to give a slightly yellow solid. The solid was triturated with acetone (2 ml) and filtered to 
obtain a white solid 2.2l (374 mg, 49%). 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.34, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.37-7.32 (m, 4H), 7.29-7.26 (m, 1H), 5.96 (d, J = 3 Hz, 1H), 5.75 (d, J = 3 Hz, 1H), 4.18 (d, J 
= 17 Hz, 1H), 3.59 (d, J = 15.5 Hz, 1H), 3.48 (d, J = 17.5 Hz, 1H), 3.48 (m, 1H), 3.25 (d, J = 15.5 Hz, 
1H), 2.50-2.45 (m, 1H), 2.39 (ddt, J = 11, 6, 2 Hz, 1H), 1.98-1.94 (m, 1H), 1.81 (dt, J = 6, 2 Hz, 1H), 
1.56 (ddd, J = 15.5, 6.5, 2.5 Hz, 1H), 1.21 (s, 3H), 0.94 (d, J = 6.5 Hz, 3H), 0.85 (d, J = 10.5 Hz, 1H), 
0.84 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.1, 166.9, 144.1, 129.3, 128.9, 127.2, 126.8, 67.7, 61.7, 55.3, 48.9, 40.5, 39.0, 38.8, 31.9, 
30.0, 27.1, 23.3, 23.1 
 
HRMS (ESI+) 
 Calculated for C22H29BNO4: 382.2190 
 Found:    382.2192 
 
 
To a solution of 2.2m-15 (197 mg, 1 mmol) in THF (10 ml) was added 1N NaOH (3 ml, 3 mmol) under 
ambient atmosphere and temperature and stirred vigorously for 15 min. The reaction was quenched with 
the addition of sat. NH4Cl solution (10 ml). The mixture was stirred for 3 min, then transferred to a 
separatory funnel, rinsing with Et2O (10 ml). After phase separation, the organic phase was washed with 
another portion of sat. NH4Cl solution (10 ml) and the combined aqueous phase extracted with 1:1 
THF/Et2O (15 ml). The organic phase was dried over MgSO4, filtered and concentrated in vacuo to give 
the boronic acid 2.2m-2 as a white solid. (Note: the boronic acid is unstable, should not be dried 
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completely and must be used immediately.) The boronic acid 2.2m-2 was taken up in toluene (15 ml) and 
DMSO (0.75 ml) and 2.1a (404 mg, 1.5 mmol) was added. The reaction was heated to reflux with a Dean-
Stark trap for 1.5 h. After cooling to room temperature, toluene was removed in vacuo. The residue was 
taken up in 2:1 EtOAc/acetone (15 ml) and washed twice with 1:1 H2O/brine (10 ml). The aqueous layers 
were extracted with 2:1 EtOAc/acetone (15 ml). The combined organic phase was dried over MgSO4, 
filtered and concentrated. The crude product was purified by silica gel chromatography, eluting first with 
Et2O then with 1:4 acetone/Et2O to give a white solid as the pure product 2.2m (153 mg, 48% over 2 
steps). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.44, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.57 (br s, 1H), 5.47 (br s, 1H), 4.20, (d, J = 17.5 Hz, 1H), 3.89 (d, J = 16 Hz, 1H), 3.86 (d, J = 
16 Hz, 1H), 3.72 (dt, J = 10.5, 6.5 Hz, 1H), 3.62 (d, J = 17.5 Hz, 1H), 2.53 – 2.48 (m, 1H), 2.43 – 2.39 
(m, 1H), 2.18 – 2.15 (m, 1H), 1.97 – 1.96 (m, 1H), 1.89 (dt, J = 6, 2 Hz, 1H), 1.86 (s, 3H),  1.56 (ddd, J = 
15, 6, 2.5 Hz, 1H), 1.30 (d, J = 7 Hz, 3H), 1.23 (s, 3H), 0.92 (s, 3H), 0.89 (d, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.6, 166.9, 126.0, 68.8, 61.4, 55.2, 49.0, 40.5, 39.1, 38.8, 31.9, 30.3, 27.0, 23.8, 23.4, 22.0. 
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.6 
 
HRMS (ESI+) 
 Calculated for C17H27BNO4: 320.2033 
 Found:    320.2034 
 
 
To a solution of 2.2n-16 (183 mg, 1 mmol) in THF (10 ml) was added 1N NaOH (3 ml, 3 mmol) under 
ambient atmosphere and temperature and stirred vigorously for 15 min. The reaction was quenched with 
the addition of sat. NH4Cl solution (10 ml). The mixture was stirred for 3 min, then transferred to a 
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separatory funnel, rinsing with Et2O (10 ml). After phase separation, the organic phase was washed with 
another portion of sat. NH4Cl solution (10 ml) and the combined aqueous phase extracted with 1:1 
THF/Et2O (15 ml). The organic phase was dried over MgSO4, filtered and concentrated in vacuo to give 
the boronic acid as a white solid. The solid was taken up in toluene (15 ml) and DMSO (0.75 ml) and 
2.1a (404 mg, 1.5 mmol) was added. The reaction was heated to reflux with a Dean-Stark trap for 1.5 h. 
After cooling to room temperature, toluene was removed in vacuo. The residue was taken up in 2:1 
EtOAc/acetone (15 ml) and washed twice with 1:1 H2O/brine (10 ml). The aqueous layers were extracted 
with 2:1 EtOAc/acetone (15 ml). The combined organic phase was dried over MgSO4, filtered and 
concentrated. The crude product was purified by silica gel chromatography, eluting first with Et2O then 
with 1:4 acetone/Et2O to give a white solid as the pure product 2.2n (153 mg, 55% over 2 steps). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.39, visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.04 (dd, J = 19.5, 14 Hz, 1H), 5.11 (dd, J = 13.5, 3.5 Hz, 1H), 5.84 (dd, J = 19, 3.5 Hz, 1H), 
4.15 (d, J = 17.5 Hz, 1H), 3.78 (d, J = 15.5 Hz, 1H), 3.73 (d, J = 15.5 Hz, 1H), 3.67 (dt, J = 13, 6.5 Hz, 
1H), 3.46 (d, J = 17.5 Hz, 1H), 2.52 – 2.43 (m, 2H), 2.14 (dquint, J = 7, 2 Hz, 1H), 2.02 (sept, J = 3 Hz, 
1H), 1.92 (dt, J = 6, 2 Hz, 1H), 1.67 (ddd, J = 15, 6, 2.5 Hz, 1H), 1.30 (d, J = 7 Hz, 3H), 1.26 (s, 3H), 
0.95 (s, 3H), 0.90 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
 δ 170.2, 167.8, 130.1, 68.6, 61.0, 55.2, 50.2, 41.6, 39.6, 39.2, 32.3, 31.0, 27.4, 23.6. 
 
11B-NMR (100 MHz, acetone-d6) 
 δ 11.3 
 
HRMS (ESI+) 
 Calculated for C16H25BNO4:  306.1877 
 Found:   306.1872 
 
c. Synthesis of 2.3a – 2.3n 
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General procedure for the epoxidation of boronate esters 2.2a-d (Table 1): 
To a solution of the boronate ester 2.2 (0.1 mmol) in CH2Cl2 at 0 C was added mCPBA (max 77%, 43 
mg, 0.19 mmol) portionwise over 3 min under ambient atmosphere. The reaction was stirred for 12 h, 
gradually raising the temperature to rt. The reaction was then concentrated in vacuo at 20 C, and 1H-
NMR analysis was carried out. Conversions for all 4 substrates (2.2a-d) are >95%. The peaks from the 
protons on the epoxide were used to determine the d.r. Note that except for 2.3a for which all stereogenic 
centers have been assigned, the stereochemistry of the epoxide shows only the relative i.e. trans 
configuration of the epoxide substituents.  
 
 
The general procedure was followed using boronate ester 2.2a (38 mg, 0.1 mmol) and mCPBA (43 mg, 
0.19 mmol). d.r. >20:1 
 
 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.46, visualized by KMnO4 
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1H-NMR (500 MHz, CDCl3) 
δ 7.40-7.35 (m, 4H), 7.33-7.30 (m, 1H), 4.40 (dt, J = 10.5, 3.5 Hz, 1H), 4.36 (d, J = 18 Hz, 1H), 
4.22 (d, J = 15 Hz, 1H), 4.14 (d, J = 17.5 Hz, 1H), 4.12 (d, J = 17.5 Hz, 1H), 3.83 (d, J = 2.5 Hz, 1H), 
2.92-2.86 (m, 1H), 2.62-2.57 (m, 1H),  2.57 (d, J = 2.5 Hz, 1H), 2.53-2.47 (m, 1H), 2.11-2.08 (m, 1H), 
2.00 (dt, J = 5.5, 2 Hz, 1H), 1.85 (ddd, J = 14.5, 4, 2.5 Hz, 1H), 1.45 (d, J = 6.5 Hz, 3H), 1.31 (s, 3H), 
1.14 (d, J = 11 Hz, 1H), 1.10 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 169.1, 166.4, 137.9, 128.5, 128.1, 125.5, 68.1, 61.8, 56.7, 54.7, 49.0, 40.6,. 39.2, 39.0, 32.1, 
30.6, 27.1, 23.5, 23.5 
 
11B-NMR (128 MHz, CDCl3) 
 δ 10.5 
 
HRMS (ESI+) 
 Calculated for C22H29BNO5: 398.2139 
 Found:    398.2135 
 
 
The general procedure was followed using boronate ester 2.2b (38 mg, 0.1 mmol) and mCPBA (43 mg, 
0.19 mmol). d.r. = 1.86:1 
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The general procedure was followed using boronate ester 2.2c (36 mg, 0.1 mmol) and mCPBA (43 mg, 
0.19 mmol). d.r. = 2.7:1 
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The general procedure was followed using boronate ester 2.2d (42 mg, 0.1 mmol) and mCPBA (43 mg, 
0.19 mmol). d.r. = 1.56:1 
 
 
 
 
 
General procedure for the epoxidation of boronate esters 3a, 3e-n (Table 2): 
To a solution of the PIDA boronate 2.2 (0.25 mmol) in CH2Cl2 at 0 C was added mCPBA (max 77%, 
106 mg, 0.475 mmol) portionwise over 3 min under ambient atmosphere. The reaction was stirred for 2.5-
12 h, gradually raising the temperature to rt in the ice/water bath. The reaction was then concentrated in 
vacuo at 20 C, and 1H-NMR analysis of the crude reaction mixture was performed to determine the d.r. 
The crude product was then purified by chromatography on a silica gel or florisil column.  
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The epoxidation of 2.2a was carried out on a 15 mmol scale as follows: A solution of boronate ester 2.2a 
(5.72 g, 15 mmol) in CH2Cl2 (300 ml) was cooled to 0 C. mCPBA (max 77%, 4.47 g, 20 mmol) was 
added portionwise under ambient atmosphere over 10 min. The reaction was stirred for 8 h, maintaining 
the bath temperature at 0-10 C. The reaction was then concentrated to approximately 50 ml of CH2Cl2, 
and Et2O was added (150 ml). The solution was stirred vigorously for 5 min, and the white solid (crude 
product) formed was obtained by vacuum filtration. The filtrate was concentrated to approximately 20 ml 
of CH2Cl2 and Et2O (100 ml) and hexane (50 ml) was added. The white solid formed was collected by 
vacuum filtration. The filtrate, containing mostly mCPBA, m-chlorobenzoic acid and other non-polar 
impurities, was discarded. The combined white solid was dissolved in a minimum amount of CH2Cl2 in a 
250 ml Erlenmeyer flask and layered with hexane (CH2Cl2:hexane 1:2). The flask was then cooled to -20 
C in a freezer. This recrystallized product was then collected by vacuum filtration and washed with 
CH2Cl2/hexane 1:10. The white solid was then dried in vacuo (3.87 g, 65%). Spectral data are identical to 
that obtained in the reaction in Table 1. 
 
X-ray quality crystals were obtained by making a saturated solution of 2.3a in 1 ml of 1,2-dichloroethane 
and layering it with about 2 ml of hexane. The layers were allowed to slowly mix at room temperature, 
giving the desired crystals. 
 
 
 
The general procedure was followed using boronate ester 2.3e (88 mg, 0.2 mmol) and mCPBA (69 mg, 
0.4 mmol). The crude product was then taken up in a minimum amount of CH2Cl2, absorbed onto celite 
and loaded onto a silica gel column equilibrated with 50% Et2O/hexane. The non-polar impurities were 
eluted with 50% Et2O/hexane. The product was then eluted with 30% EtOAc/hexanes. After 
concentration at room temperature, the solid was washed with Et2O:hexanes 1:1 (5 ml) to remove residual 
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mCPBA and vacuum filtered. The epoxide was then dried in vacuo, giving the product as a white solid 
(65 mg, 71%). d.r. >20:1. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.33, visualized by UV/vis or KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.98-7.97 (m, 2H), 7.50-7.49 (m, 1H), 7.44-7.41 (m, 1H), 4.39 (dt, J = 10, 6.5 Hz, 1H), 4.25 (d, 
J = 17.5 Hz, 1H), 4.06 (d, J = 15 Hz, 1H), 4.01 (d, J = 2.5 Hz, 1H), 3.92 (s, 3H), 3.74 (d, J = 15.5 Hz, 
1H), 3.49 (d, J = 17 Hz, 1H), 2.76 -2.71 (m, 1H), 2.53-2.45 (m, 1H), 2.49 (d, J = 2.5 Hz, 1H), 2.22-2.20 
(m, 1H), 2.08-2.07 (m, 1H), 1.99-1.97 (m, 1H), 1.84 (ddd, J = 15, 5.5, 2.5 Hz, 1H), 1.39 (d, J = 6.5 Hz, 
3H), 1.30 (s, 3H), 1.11 (s, 3H), 0.95 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.2, 166.8, 166.5, 138.6, 130.5, 130.1, 129.9, 128.6, 126.6, 68.3, 61.7, 56.3, 54.7, 52.2, 49.1, 
40.6, 39.2, 38.9, 32.1, 30.6, 27.0, 23.6, 23.5. 
 
HRMS (ESI+) 
 Calculated for C24H31BNO7: 456.2194 
 Found:    456.2196 
 
 
The general procedure was followed using boronate ester 2.2f (80 mg, 0.2 mmol) and mCPBA (69 mg, 
0.4 mmol). The crude product was then taken up in a minimum amount of CH2Cl2, absorbed onto celite 
and loaded onto a silica gel column equilibrated with 50% Et2O/hexane. The non-polar impurities were 
eluted with 50% Et2O/hexane, then with 80% Et2O/hexanes. The product was then eluted with 30% 
EtOAc/hexanes. The epoxide was then dried in vacuo, giving the product 2.3f as a white solid (43 mg, 
52%). d.r. >17:1. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.39, visualized by UV/vis or KMnO4 
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1H-NMR (500 MHz, CDCl3) 
δ 7.27 – 7.25 (m, 2H), 7.05 – 7.01 (m, 2H), 4.38 (dt, J = 10, 6.5 Hz, 1H), 4.24 (d, J = 17.5 Hz, 
1H), 4.05 (d, J = 15 Hz, 1H), 3.94 (d, J = 3 Hz, 1H), 3.72 (d, J = 15 Hz, 1H), 3.48 (d, J = 17.5 Hz, 1H), 
2.74 – 2.69 (m, 1H), 2.50 (ddt, J = 11, 6, 2 Hz, 1H), 2.45 (d, J = 3 Hz, 1H), 2.22 – 2.17 (m, 1H), 2.09-
2.05 (m, 1H), 1.98 (dt, J = 6.5, 2.5 Hz, 1H), 1.84 (ddd, J = 15, 6, 2.5 Hz, 1H), 1.38 (d, J = 6.5 Hz, 3H), 
1.30 (s, 3H), 1.09 (s, 3H), 0.94 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.2, 166.5, 163.9, 133.9, 127.4 (d, J = 7.8 Hz), 115.7 (d, J = 21.4 Hz), 68.4, 62.0, 56.5, 55.0, 
49.3, 40.9, 39.5, 39.2, 32.4, 30.9, 27.3, 23.8, 23.7. 
 
HRMS (ESI+) 
 Calculated for C22H28BNO5F: 416.2045 
 Found:    416.2052 
 
 
The general procedure was followed using boronate ester 2.2g (80 mg, 0.25 mmol) and mCPBA (106 mg, 
0.475 mmol). The crude product was then taken up in a minimum amount of CH2Cl2 and loaded onto a 
silica gel column equilibrated with 30% Et2O/hexane. The non-polar impurities were eluted with 30% 
Et2O/hexane. The product was then eluted with 2:2:6 (acetone/Et2O/hexane). After concentration at room 
temperature, the solid was washed with Et2O (5-10 ml) to remove residual mCPBA and vacuum filtered. 
The epoxide was then dried in vacuo, giving the product as a white solid 2.3g (51 mg, 64%). d.r. >20:1.  
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.46, visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 4.29 (dt, J = 10.5, 6.5 Hz, 1H), 4.20 (d, J = 17 Hz, 1H), 3.98 (d, J = 15 Hz, 1H), 3.65 (d, J = 15 
Hz, 1H), 3.42 (d, J = 17 Hz, 1H), 3.07 (m, 1H), 2.72-2.66 (m, 1H), 2.51-2.45 (m, 1H), 2.17-2.14 (m, 1H), 
2.12 (d, J = 3 Hz, 1H), 2.05 (sept, J = 3 Hz, 1H), 1.94 (dt, J = 6, 2.5 Hz, 1H), 1.81 (ddd, J = 15, 6. 2.5 Hz, 
1H), 1.37 (d, J = 5 Hz, 3H), 1.33 (d, J = 7 Hz, 3H), 1.27 (s, 3H), 1.04 (s, 3H), 0.92 (d, J = 10 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
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 δ 169.2, 166.3, 109.7, 67.9, 61.7, 54.6, 53.2, 49.0, 40.6, 39.2, 38.9, 32.1, 30.5, 27.0, 23.6, 23.5. 
 
11B-NMR (128 MHz, CDCl3) 
 δ 10.7 
 
HRMS (ESI+) 
 Calculated for C17H27BNO5: 336.1982 
 Found:    336.1977 
 
X-ray quality crystals were obtained by making a saturated solution of 2.3g in 1 ml of 1,2-dichloroethane 
and layering it with about 2 ml of hexane. The layers were allowed to slowly mix at room temperature, 
giving the desired crystals. 
 
 
 
 
The general procedure was followed using boronate ester 2.2h (84 mg, 0.25 mmol) and mCPBA (106 mg, 
0.475 mmol). The crude product was then taken up in a minimum amount of CH2Cl2 and loaded onto a 
silica gel column equilibrated with 30% Et2O/hexane. The non-polar impurities were eluted with 30% 
Et2O/hexane. The product was then eluted with 2:2:6 (acetone/Et2O/hexane). After concentration at room 
temperature, the solid was washed with Et2O (5-10 ml) to remove residual mCPBA and vacuum filtered. 
The epoxide was then dried in vacuo, giving the product as a white solid 2.3h (68 mg, 77%). d.r. >20:1. 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.22, visualized by KMnO4 
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1H-NMR (500 MHz, acetone-d6) 
δ 4.29 (d, J = 18 Hz, 1H), 4.30-4.26 (m, 1H), 4.13 (d, J = 15.5 Hz, 1H), 4.06 (d, J = 18.5 Hz, 1H), 
3.98 (d, J = 15.5 Hz, 1H), 3.02 (dt, J = 6, 3 Hz, 1H), 2.80-2.74 (m, 1H), 2.57-2.51 (m, 1H), 2.50-2.44 (m, 
1H), 1.97 (dt, J = 6, 2.5 Hz, 1H), 1.79 (ddd, J = 15, 6. 2.5 Hz, 1H), 1.39 (d, J = 7.5 Hz, 3H), 1.28 (s, 3H), 
1.10 (d, J = 10.5 Hz, 1H), 1.05 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 170.7, 167.2, 68.8, 64.1, 61.9, 57.8, 55.4, 50.2, 41.6, 39.7, 39.1, 32.3, 31.2, 27.4, 23.9, 23.7. 
 
11B-NMR (128 MHz, acetone-d6) 
 δ 10.8 
 
HRMS (ESI+) 
 Calculated for C17H27BNO6: 352.1931 
 Found:    352.1925 
 
 
The general procedure was followed using boronate ester 2.3i (45 mg, 0.1 mmol) and mCPBA (106 mg, 
0.475 mmol). The crude product was then taken up in a minimum amount of CH2Cl2 and loaded onto a 
silica gel column equilibrated with 30% Et2O/hexane. The non-polar impurities were eluted with 30% 
Et2O/hexane. The product was then eluted with 2:2:6 (acetone/Et2O/hexane). After concentration at room 
temperature, the solid was washed with Et2O (5-10 ml) to remove residual mCPBA and vacuum filtered. 
The epoxide was then dried in vacuo, giving the product as a white solid (35 mg, 75%). d.r. >20:1. 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.51, visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ  4.31 (dt, J = 10.5, 6 Hz, 1H), 4.21 (d, J = 18 Hz, 1H), 4.01 (dd, J = 12.5, 2.5 Hz, 1H), 3.99 (d, 
J = 15.5 Hz, 1H), 3.64 (d, J = 15 Hz, 1H), 3.63 (dd, J = 12.5, 4.5 Hz, 1H), 3.42 (d, J = 17 Hz, 1H), 3.17 
(quint, J = 3 Hz, 1H), 2.70-2.65 (m, 1H), 2.50-2.46 (m, 1H), 2.39 (d, J = 3 Hz, 1H), 2.16-2.15 (m, 1H), 
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2.05 (sept, J = 3 Hz, 1H), 1.95 (dt, J = 6.5, 2.5 Hz, 1H), 1.81 (ddd, J = 15, 6, 3 Hz, 1H), 1.33 (d, J = 6.5 
Hz, 3H), 1.27 (s, 3H), 1.02 (s, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 169.2, 166.3, 67.9, 63.2, 61.7, 57.2, 54.6, 49.0, 40.6, 39.2, 38.9, 32.0, 30.5, 27.0, 25.9, 23.5, 
23.5, 18.3, -5.3, -5.4. 
 
11B-NMR (128 MHz, CDCl3) 
 δ 11.3 
 
HRMS (ESI+) 
 Calculated for C23H41BNO6Si: 466.2796 
 Found:   466.2798 
 
 
The general procedure was followed using PIDA boronate 2.2j (38 mg, 0.1 mmol) and mCPBA (35 mg, 
0.2 mmol) with a reaction time of 11 h. The crude product was purified with a florisil column (80% 
Et2O/hexane, then 20% - 40% EtOAc/hexane), giving the product as a white solid (38 mg, 96%). d.r. = 
17:1. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.4, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.36-7.28 (m, 5H), 4.42 (dt, J = 10, 7 Hz, 1H), 4.33 (d, J = 5 Hz, 1H), 4.10 (d, J = 17.5 Hz, 1H), 
3.66 (d, J = 15 Hz, 1H), 3.54 (d, J = 15 Hz, 1H), 3.30 (d, J = 17 Hz, 1H), 2.77 – 2.71 (m, 1H), 2.72 (d, J 
= 5.5 Hz, 1H), 2.47 (ddt, J = 11, 6, 2 Hz, 1H), 2.13 – 2.10 (m, 1H), 2.08 – 2.05 (m, 1H), 1.95 (dt, J = 6, 2 
Hz, 1H), 1.80 (ddd, J = 14.5, 6, 2.5 Hz, 1H), 1.34 (d, J = 7 Hz, 3H), 1.29 (s, 3H), 1.10 (s, 3H), 0.89 (d, J 
= 7 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
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 δ 169.1, 165.2, 136.6, 128.2, 127.5, 125.7, 67.8, 61.3, 57.9, 54.5, 49.0, 40.6, 39.1, 39.0, 32.1, 30.5, 
27.1, 23.5, 23.4. 
 
HRMS (ESI+) 
 Calculated for C22H29BNO5: 398.2139 
 Found:    398.2141 
 
 
The general procedure was followed using boronate ester 2.2k (83 mg, 0.25 mmol) and mCPBA (86 mg, 
0.5 mmol). The reaction was stopped after 2.5 h. The crude product was then taken up in 15 ml of CH2Cl2, 
absorbed onto celite, concentrated in vacuo and loaded onto a silica gel column. The product was purified 
by silica gel chromatography (50% Et2O/hexanes to 80% Et2O/hexanes to 30% EtOAc/hexanes). The 
product 2.3k was obtained as a white solid (43 mg, 49%). d.r. >20:1. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.42, visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 4.28 (dt, J = 10.5, 6 Hz, 1H), 4.18 (d, J = 17.5 Hz, 1H), 3.90 (d, J = 15 Hz, 1H), 3.72 (d, J = 15 
Hz, 1H), 3.48 (d, J = 17.5 Hz, 1H), 2.65 – 2.60 (m, 1H), 2.48 – 2.44 (m, 1H), 2.18 (s, 1H), 2.18-2.15 (m, 
1H), 2.06 – 2.03 (m, 1H), 1.93 (dt, J = 5.5, 1.5 Hz, 1H), 1.78 (ddd, J = 15, 6.5, 3 Hz, 1H), 1.41 (s, 3H), 
1.39 (s, 3H), 1.32 (d, J = 6.5 Hz, 3H), 1.26 (s, 3H), 1.02 (s, 3H), 0.94 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.4, 166.2, 67.7, 61.4, 60.1, 54.4, 49.0, 40.7, 39.2, 38.9, 31.9, 30.5, 27.2, 27.0, 23.5 (2C), 
20.4 
 
HRMS (ESI+) 
 Calculated for C18H29BNO5: 350.2139 
 Found:    350.2138 
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The general procedure was followed using boronate ester 2.2l (95 mg, 0.25 mmol) and mCPBA (86 mg, 
0.5 mmol). The crude product was then taken up in 10 ml of CH2Cl2, absorbed onto celite, concentrated in 
vacuo and loaded onto a silica gel column. The product was purified by silica gel chromatography (50% 
Et2O/hexanes to 30% EtOAc/hexanes to 35% EtOAc/hexanes). The product 2.3l was obtained as a white 
solid (74 mg, 75%). d.r. (isolated product) 14:1, d.r. (crude product) = 11:1. Note: d.r. was increased 
slightly after column purification. 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.47, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.54 (d, J = 7 Hz, 2H), 7.31 – 7.27 (m, 2H), 7.22 (dt, J = 7.5, 2 Hz, 1H), 4.24 (d, J = 14.5 Hz, 
1H), 4.09 (d, J = 17 Hz, 1H), 4.02 (dt, J = 10.5, 6 Hz, 1H), 3.68 (d, J = 14.5 Hz, 1H), 3.49 (d, J = 17 Hz, 
1H), 3.27 (d, J = 7 Hz, 1H), 2.51 (d, J = 6.5 Hz, 1H), 2.29 (ddt, J = 11, 6, 2 Hz, 1H), 2.09 – 2.03 (m, 1H), 
1.82 (dt, J = 5.5, 2 Hz, 1H), 1.56 (sept, J = 3.5 Hz, 1H), 1.33 (d, J = 6.5 Hz, 3H), 1.11 (s, 3H), 1.08 (dd, J 
= 6, 2.5 Hz, 1H), 1.00 – 0.95 (m, 1H), 0.77 (d, J = 11 Hz, 1H), 0.72 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.7, 166.9, 141.4, 128.8, 127.2, 125.2, 67.6, 61.3, 57.7, 55.3, 49.1, 41.0, 39.7, 39.0, 32.0, 29.4, 
27.1, 24.0, 23.9. 
 
HRMS (ESI+) 
 Calculated for C22H29BNO5: 398.2139 
 Found:    398.2141 
 
 
Epoxide 3h. The general procedure was followed using boronate ester 2.2h (80 mg, 0.25 mmol) and 
mCPBA (106 mg, 0.475 mmol). The crude product was then taken up in a minimum amount of CH2Cl2 
and loaded onto a silica gel column equilibrated with 30% Et2O/hexane. The non-polar impurities were 
eluted with 30% Et2O/hexane. The product was then eluted with 2:2:6 (acetone/Et2O/hexane). After 
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concentration at room temperature, the solid was washed with Et2O (5-10 ml) to remove residual mCPBA 
and vacuum filtered. The epoxide was then dried in vacuo, giving the product as a white solid (49 mg, 
49%). d.r. 10:1. 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.40, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 4.54 (dt, J = 10.5, 6.5 Hz, 1H), 4.22 (d, J = 17.5 Hz, 1H), 3.89 (d, J = 15 Hz, 1H), 3.64 (d, J = 
15 Hz, 1H), 3.40 (d, J = 17 Hz, 1H), 2.85 (d, J = 5.5 Hz, 1H), 2.71 (m, 1H), 2.58 (d, J = 5 Hz, 1H), 2.49-
2.45 (m, 1H), 2.13 (m, 1H), 2.07 (sept, J = 3 Hz, 1H), 1.94 (dt, J = 6, 2 Hz, 1H), 1.74 (ddd, J = 15, 6. 2.5 
Hz, 1H), 1.39 (s, 3H), 1.32 (d, J = 7 Hz, 3H), 1.27 (s, 3H), 1.04 (s, 3H), 0.93 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.3, 166.3, 67.3, 61.4, 55.3, 54.9, 49.0, 40.7, 39.3, 39.0, 32.0, 30.6, 27.0, 23.5, 23.4, 21.2 
 
11B-NMR (96 MHz, CDCl3) 
 δ 10.8 
 
HRMS (ESI+) 
 Calculated for C17H27BNO5: 336.1982 
 Found:    336.1976 
 
 
Epoxide 3n. The general procedure was followed using boronate ester 2.2h (76 mg, 0.25 mmol) and 
mCPBA (106 mg, 0.475 mmol). The crude product was then taken up in a minimum amount of CH2Cl2 
and loaded onto a silica gel column equilibrated with 30% Et2O/hexane. The non-polar impurities were 
eluted with 30% Et2O/hexane. The product was then eluted with 2:2:6 (acetone/Et2O/hexane). After 
concentration at room temperature, the solid was washed with Et2O (5-10 ml) to remove residual mCPBA 
and vacuum filtered. The epoxide was then dried in vacuo, giving the product as a white solid (66 mg, 
82%). d.r. >20:1.  
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TLC (Hexanes:acetone 3:2) 
Rf = 0.43, visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 4.29 (dt, J = 10.5, 6.5 Hz, 1H), 4.22 (d, J = 17.5 Hz, 1H), 3.98 (d, J = 15 Hz, 1H), 3.68 (d, J = 
15 Hz, 1H), 3.48 (d, J = 17 Hz, 1H), 2.87 (dd, J = 6, 5 Hz, 1H), 2.78 (dd, J = 6, 3.5 Hz, 1H), 2.72-2.66 
(m, 1H), 2.51-2.45 (m, 1H), 2.39 (dd, J = 5, 3.5 Hz, 1H), 2.18-2.17 (m, 1H), 2.06 (sept, J = 3 Hz, 1H), 
1.95 (dt, J = 6, 2 Hz, 1H), 1.83 (ddd, J = 15, 6. 2.5 Hz, 1H), 1.34 (d, J = 7 Hz, 3H), 1.27 (s, 3H), 1.03 (s, 
3H), 0.92 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.5, 166.6, 68.1, 61.6, 54.7, 49.0, 45.5, 40.6, 39.2, 38.9, 32.0, 30.5, 27.0, 23.5, 23.5. 
 
11B-NMR (128 MHz, CDCl3) 
 δ 11.0 
 
HRMS (ESI+) 
 Calculated for C16H25BNO5: 322.1826 
 Found:    322.1824 
 
X-ray quality crystals were obtained by making a saturated solution of 2.3h in 1 ml of 1,2-dichloroethane 
and layering it with about 2 ml of hexane. The layers were allowed to slowly mix at room temperature, 
giving the desired crystals. 
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A dry Schlenk flask was charged with 2.3a (795 mg, 2 mmol) and dry CH2Cl2 (40 ml) under a nitrogen 
atmosphere. The flask was flushed with nitrogen and cooled to 0 C. Mg(ClO4)2 (2 mmol) was then added 
in one portion, and the reaction was stirred in the ice/water bath for 2 h. The reaction was then warmed up 
to room temperature and filtered through celite, washing with additional CH2Cl2 (20 ml). The filtrate was 
then concentrated in vacuo at room temperature to afford an off-white solid 2.8. No purification of this 
product was necessary for subsequent reactions. Note: the stereogenic α-carbon of the aldehyde 
epimerizes on silica gel. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 9.88 (d, J = 2.5 Hz, 1H), 7.45 (dd, J = 7, 1.5 Hz, 2H), 7.39 (t, J = 7.5 Hz, 2H), 7.32 (tt, J = 7.5, 
1.5 Hz, 1H), 4.29 (d, J = 18 Hz, 1H), 4.07 (d, J = 18 Hz, 1H), 4.04 (d, J = 15.5 Hz, 1H), 3.93 (br s, 1H), 
3.66 (d, J = 10.5, 6 Hz, 1H), 2.98-2.92 (m, 1H), 2.86 (d, J = 15.5 Hz, 1H), 2.45 (ddt, J = 11, 6, 2 Hz, 1H), 
2.38 (ddt, J = 13, 6.5, 2 Hz, 1H), 2.11 (sept, J = 3 Hz, 1H), 1.88-1.86 (m, 1H), 1.85-1.83 (m, 1H), 1.26 (s, 
3H), 1.08 (d, J = 11 Hz, 1H), 0.99 (s, 3H), 0.93 (d, J = 7 Hz, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 199.9, 168.5, 166.1, 134.4, 129.4, 128.7, 127.4, 67.0, 61.6, 55.3, 48.8, 40.6, 38.8, 38.6, 31.6, 
30.3, 27.0, 23.1, 23.0. 
 
HRMS (ESI+) 
 Calculated for C22H29BNO5: 398.2139 
 Found:    398.2140 
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Acetal 6. A 40ml vial equipped with a stir bar was charged with aldehyde 2.8 (397 mg, 1 mmol), (S,S)-
hydrobenzoin (643 mg, 3 mmol) and MgSO4 (1 g). CH2Cl2 (20 ml) was added, followed by pTsOH•H2O 
(3.8 mg, 0.02 mmol). The vial was flushed briefly with nitrogen and placed in a heat block. The reaction 
was stirred at 35 C for 3 h. After cooling to room temperature, the suspension was filtered through celite 
and the filtrate was concentrated in vacuo. The crude product was purified by silica gel chromatography 
(acetone/Et2O/hexane 1:4:15 1:2:7 1:1:3) to afford 6 (394 mg, 66%) as a white solid.  
 
TLC (Hexanes:EtOAc:Et2O 2:2:1) 
Rf = 0.69, visualized by short wave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.61, (app d, J = 6.5 Hz, 2H), 7.38 (app t, J = 7.5 Hz, 2H), 7.32-7.25 (m, 7H), 7.19-7.17 (m, 
2H), 7.15-7.13 (m, 2H), 6.04 (d, J = 2.5 Hz, 1H), 4.75 (d, J = 8 Hz, 1H), 4.31 (d, J = 8 Hz, 1H), 4.17 (d, 
J = 17.5 Hz, 1H), 3.79 (dt, J = 10, 6 Hz, 1H), 3.44 (d, J = 15 Hz, 1H), 3.42 (d, J = 17 Hz, 1H), 3.00 (d J 
= 2.5 Hz, 1H), 2.92 (d, J = 15 Hz, 1H), 2.77-2.72 (m, 1H), 2.44-2.42 (m, 1H), 2.07 (m, 1H), 1.96 (m, 1H), 
1.85-1.81 (m, 2H), 1.26 (s, 3H), 0.96 (s, 3H), 0.91-0.89 (m, 4H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 168.9, 166.5, 138.7, 137.7, 136.5, 130.8, 128.6, 128.4, 128.3, 128.2, 127.9, 127.2, 126.9, 126.4, 
106.1, 87.4, 84.9, 66.4, 61.6, 55.3, 48.8, 40.6, 38.9, 38.8, 31.7, 30.9, 30.3, 27.0, 23.2, 23.1.  
 
HRMS (ESI+) 
 Calculated for C36H41BNO6: 594.3027 
 Found:    594.3028 
 
X-ray quality crystals were obtained by layering a solution of 2.9 in 1 ml of 1,2-dichloroethane and 
layering it with about 2 ml of hexane. The layers were allowed to slowly mix at room temperature, giving 
the desired crystals. 
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A dry 100 ml Schlenk flask was charged with aldehyde 2.8 (2.19 mg, 5.51 mmol) under an atmosphere of 
nitrogen. CH2Cl2 (60 ml) was added and the solution was cooled to -5 oC in an ice/salt bath.  AcOH (15 
ml) was added slowly. NaBH(OAc)3 (1.75 g, 8.27 mmol) was then added portionwise to the solution over 
3 min. The reaction was stirred at 0 oC for 2 h, then a second portion of NaBH(OAc)3 (584 mg, 2.76 
mmol) was added over 3 min. A third portion of NaBH(OAc)3 (584 mg, 2.76 mmol) was added over 3 
min after another 2 h. The reaction was stirred for another 4 h, then quenched with H2O (20 ml). The 
mixture was stirred for 5 min until the organic layer became clear and effervescence ceased. The mixture 
was then transferred to a separatory funnel. After phase separation, the organic layer was washed H2O (30 
ml), then with phosphate buffer (pH = 7, 0.5 M, 25 ml × 2). The combined aqueous layer was extracted 
with DCM (30 ml). The organic phase was dried over MgSO4, filtered and concentrated.  The crude 
product was purified by silica gel chromatography (30-45% EtOAc/hexane). A white solid 2.12 was 
obtained (1.56 g, 71%).  
 
TLC (Hexanes:acetone) 
Rf = 0.32, visualized by KMnO4 
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1H-NMR (500 MHz, acetone-d6) 
δ 7.39 (app d, J = 7.5 Hz, 2H), 7.33 (app t, J = 7.5 Hz, 2H), 7.24 (app t, J = 7 Hz, 1H), 4.29 (d, J 
= 18 Hz, 1H), 4.07 (d, J = 18 Hz, 1H), 4.04 (d, J = 15.5 Hz, 1H), 3.66 (d, J = 10.5, 6 Hz, 1H), 2.82 (d, J 
= 15 Hz, 1H), 2.82-2.77 (m, 1H),  2.61 (dd, J = 6, 4 Hz, 1H), 2.44 (ddt, J = 11, 6, 2 Hz, 1H), 2.33 (ddt, J 
= 13, 6.5, 2 Hz, 1H), 2.08 (m, 2H), 1.86 (dt, J = 5.5, 2 Hz, 1H), 1.76 (ddd, J = 14.5, 6, 2.5 Hz, 1H), 1.27 
(s, 3H), 1.05 (d, J = 11 Hz, 1H), 1.01 (s, 3H), 0.93 (d, J = 7 Hz, 3H).  
 
13C-NMR (125 MHz, CDCl3) 
δ 168.9, 166.5, 140.8, 129.4, 128.4, 126.9, 66.6, 65.5, 61.8, 55.2, 48.8, 40.6, 38.8, 38.7, 31.7, 30.2, 
27.0, 23.1, 23.0. 
 
HRMS (ESI+) 
 Calculated for C22H31BNO5: 400.2295 
 Found:    400.2297 
 
 
To a dry 25 ml Shclenk flask was added PPh3 (346 mg, 1.32 mmol), imidazole (112 mg, 1.65 mmol) and 
a solution of the alcohol 2.12 (438 mg, 1.10 mmol) in DCM (15 ml) under a positive pressure of N2. I2 
(335 mg, 1.32 mmol) was then added in one portion. The reaction was stirred for 2 h, then transferred to a 
separatory funnel and washed with 10 ml H2O. The aqueous layer was extracted with 10 ml DCM. The 
combined organic layer was dried over MgSO4, filtered and concentrated. The crude product was purified 
by silica gel chromatography (40 to 60% EtOAc/hexanes). The off-white solid was then dissolved in 
DCM (approx. 25 ml) and passed through a pad of activated charcoal. The colorless filtrate was then 
concentrated in vacuo to give a white solid (235 mg, 42%). 
 
TLC (Hexanes:EtOAc 1:1) 
Rf = 0.42, visualized by short wave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.38 – 7.26 (m, 5H), 4.15 (d, J = 17 Hz, 1H), 4.01 (dd, J = 10, 3.5 Hz, 1H), 3.69 (dt, J = 10.5, 6 
Hz, 1H), 3.55 (dd, J = 12.5, 10 Hz, 1H), 3.40 (d, J = 17.5 Hz, 1H), 3.39 (d, J = 15 Hz, 1H), 2.73 (d, J = 
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15 Hz, 1H), 2.69 – 2.63 (m, 2H), 2.45 (ddt, J = 11.5, 6, 1 Hz, 1H), 2.08 (sept, J = 3 Hz, 1H), 1.96 – 1.91 
(m, 1H), 1.85 (dt, J = 6, 2 Hz, 1H), 1.76 (ddd, J = 15, 6, 2.5 Hz, 1H), 1.26 (s, 3H), 0.97 (s, 3H), 0.88 (d, 
1H), 0.85 (d, J = 7 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 168.3, 166.1, 142.1 (2C), 129.3, 127.4 (3C), 66.6, 61.7, 55.5, 48.8, 40.6, 38.8 (2C), 31.7, 30.3, 
27.0, 23.1, 22.9. 
 
HRMS (ESI+) 
 Calculated for C22H30BNO4I: 510.1313 
 Found:    510.1309 
 
 
In a glovebox, Zn dust (172 mg, 2.63 mmol) was weighed into a flame-dried 7 ml vial equipped with a 
stir bar. Another 7 ml vial was charged with a THF solution (1.2 ml) of the iodide 2.13 (446 mg, 0.876 
mmol). Both vials, together with another empty 7 ml vial, were sealed with septum cap and removed from 
the glovebox. The vial containing Zn dust was placed under argon, and 3 drops of TMSCl followed by 3 
drops of 1,2-dibromoethane were added. The THF solution of iodide 7 was then added to the Zn dust in 
one portion via syringe under argon. The reaction vial was then placed in a heating block and stirred at 45 
C for 1.5 h. The vial was then removed from the block and 3.2 ml of THF was added to form a 0.2 M 
solution of the organozinc 2.17. 
 
 
Preparation of catalyst stock solution. A dry 7 ml vial equipped with a star bar was charged with RuPhos7 
(9.5 mg, 0.02 mmol). The vial was brought into the glovebox, and Pd2dba3 (4.6 mg, 0.005 mmol) was 
added. THF (1.5 ml) was added, and the mixture stirred at rt for 3 min. 
 
The freshly prepared catalyst stock solution was immediately for the preparation of 2.19: 
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A dry 7 ml vial equipped with a stir bar was charged with iodide 2.18 (75 mg, 0.2 mmol) and brought into 
the glovebox. To this was added NMP (1.2 ml) followed by 1.2 ml (0.004 mmol Pd2dba3, 0.016 mmol 
RuPhos) of the catalyst solution. The vial was sealed with a septum cap, stirred briefly and then brought 
out of the glovebox. The vial was placed in a heating block pre-equilibrated to 60 C, and the solution of 
the organozinc reagent 2.17 (1.5 ml, approx. 0.3 mmol) was added over 3 h with the aid of a syringe 
pump. After the addition was complete, the reaction was stirred for another 2 h at 60 C, then cooled to rt. 
The reaction was diluted with Et2O (10 ml) and washed with sat. NH4Cl (2 × 5 ml) and H2O (2 × 5 ml). 
The combined aqueous layers were extracted with Et2O (10 ml). The organic phase was then dried over 
MgSO4, filtered and concentrated. The residue was taken up in DCM (5 ml), absorbed onto celite and 
loaded onto a silica gel column. The product 2.19 was obtained as a white solid after column 
chromatography (92 mg, 73%). 
 
TLC (Hexanes:EtOAc 3:2) 
Rf = 0.36, visualized by short wave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.49 (d, J = 8.5 Hz, 2H), 7.30-7.13 (m, 4H), 7.14 (app t, J = 7.5 Hz, 1H), 6.96 (d, J = 8 Hz, 2H), 
6.72 (t, J = 6 Hz, 1H), 4.16 (d, J = 17.5 Hz, 1H), 3.64 – 3.57 (m, 3H), 3.45 (d, J = 15.5 Hz, 2H), 3.39 (dd, 
J = 14, 3 Hz, 1H), 3.04 (app t, J = 14 Hz, 1H), 2.66 – 2.61 (m, 1H), 2.51 (t, J = 5.5 Hz, 1H), 2.44 – 2.41 
(m, 2H), 2.06 – 2.05 (m, 1H), 1.95 – 1.92 (m, 1H), 1.83 -1.78 (m, 2H), 1.44 (s, 9H), 1.23 (s, 3H), 0.89 (d, 
J = 7.5 Hz, 1H), 0.87 (s, 3H), 0.81 (d, J = 7 Hz, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 172.2, 168.9, 167.3, 166.7, 145.9, 142.1, 131.7, 128.9, 126.5, 126.4, 81.1, 66.4, 62.0, 55.7, 48.8, 
40.6, 38.8 (2C), 38.7, 35.3, 35.1, 31.7, 30.3, 28.1, 27.0, 23.0, 22.9. 
 
HRMS (ESI+) 
 Calculated for C36H48BN2O7: 631.3555 
 Found:    631.3560 
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PIDA boronate 2.19 (91.3 mg, 0.145 mmol) was dissolved in DCM (1.5 ml) in a 7 ml vial under ambient 
atmosphere. Pinacol (18 mg, 0.152 mmol) was added, followed by MeOH (1.5 ml). The vial was capped 
and placed in a heating block and stirred at 40 C for 3.5 h. The reaction was concentrated in vacuo. The 
residue was azeotroped 5 times with benzene until a white solid was obtained. Benzene (5 ml) was then 
added and the suspension filtered, rinsing with additional benzene. The filtrate was concentrated in vacuo 
to give a white solid tainted with a light brown color. The crude product was then purified on a florisil 
column (20 – 30% EtOAc/hexanes), giving 2.21 as a colorless oil that slowly crystallized over time (58.5 
mg, 84%). The white solid obtained by filtration (PIDA) was dissolved in MeOH, and concentrated in 
vacuo, azeotroping with benzene to remove residual MeOH. PIDA was recovered in 96% yield (37.6 mg). 
 
TLC (EtOAc:hexanes 3:2) 
Rf = 0.59, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.61 (d, J = 8 Hz, 2H), 7.26 – 7.19 (m, 4H), 7.21 (d, J = 8 Hz, 2H), 7.15 – 7.12 (m, 1H), 6.81 (t, 
J = 6 Hz, 1H), 3.66 (q, J = 6 Hz, 1H), 3.19 (dd, J = 13.5, 9 Hz, 1H), 2.98 (dd, J = 13.5, 7.5 Hz, 1H), 2.65 
(dd, J = 9.5, 7.5 Hz, 1H), 2.54 (t, J = 6.5 Hz, 2H), 1.45 (s, 9H), 1.12 (s, 6H), 1.11 (s, 6H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 172.2, 167.2, 145.6, 142.0, 131.9, 129.0, 128.3, 126.6 (2C), 125.5, 83.5, 81.1, 38.6, 35.4, 35.1, 
28.1, 24.5. 
 
HRMS (ESI+) 
 Calculated for C28H39BNO5: 480.2921 
 Found:    480.2924 
 
[α]23D +47.0° (c = 1.0, CHCl3)    
 
The e.r. was determined by chiral HPLC using a ChiraCel OD-H (4.6 × 250 mm) column: 
Conditions: 5% IPA/hexane, flow rate = 0.8 ml/min, temperature = 23 C, detection wavelength = 214 nm 
tr(major) 14.92 min, tr(minor) 13.42 min; e.r. > 95:5 
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A flame-dried 7 ml vial equipped with a stir bar was charged with Ag2O (5.7 mg, 0.249 mmol) and 
brought into the glove box. PPh3 (2.8 mg, 0.0106 mmol) was then added into the vial, followed by a 
solution of the pinacol boronic ester 2.21 (9.9 mg, 0.21 mmol) and iodide 2.15 (6.1 mg, 0.0166 mmol) in 
DME (0.23 ml). To this mixture was added a solution of Pd2dba3 (0.609 mg, 0.00066 mmol) in DME (0.1 
ml). The vial was sealed with a cap, brought out of the glove box and stirred at 60 C for 22.5 h. The 
reaction was then cooled to room temperature, diluted with THF (1.5 ml) and filtered through celite, 
eluting with THF. The filtrate was then concentrated in vacuo. The crude product was purified by silica 
gel chromatography (15 – 20% EtOAc/hexanes) to afford a yellow oil as the product (3.9 mg, 40%).  
 
TLC (Hexanes:EtOAc 3:2) 
Rf = 0.5, visualized by short wave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.58 (d, J = 8 Hz, 2H), 7.48 (dt, J = 6.5, 2 Hz, 2H), 7.34 – 7.37 (m, 1H), 7.26 – 7.18 (m, 3H), 
7.08 (d, J = 8.5 Hz, 1H), 6.78 (t, J = 5.5 Hz, 1H), 4.29 (t, J = 7.5 Hz, H), 3.65 (q, J = 6 Hz, 2H), 3.44 (d, 
J = 8 Hz, 1H), 2.53 (t, J = 6 Hz, 2H), 1.45 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
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δ 172.3, 167.1, 148.6, 144.7, 143.9, 143.7, 139.9, 132.3, 129.3, 129.0, 128.5, 128.5, 128.0, 127.2, 
126.9, 126.8, 126.5, 125.2, 121.2, 81.2, 52.9, 42.0, 35.4, 35.1, 28.1. 
 
HRMS (ESI+) 
 Calculated for C35H35NO4F3: 590.2518 
 Found:    590.2512 
 
[α]23D -13.2° (c = 1.0, CHCl3) 
 
The e.r. was determined by chiral HPLC using a ChiraCel OD-H (4.6 × 250 mm) column: 
Conditions: 20% IPA/hexane, flow rate = 0.7 ml/min, temperature = 23 C, detection wavelength = 214 
nm. 
tr(major) 9.92 min, tr(minor) 8.48 min; e.r. 94: 6 
 
 
 
 
 
To a solution of the t-butyl ester tBu-2.14 in DCM (0.6 ml) in a 2 ml vial was added TFA (0.1 ml) under 
ambient atmosphere. The vial was sealed and the reaction was stirred at room temperature for 2 h. The 
solvent was then removed in vacuo, and TFA removed by co-evaporation with DCM. The crude product 
was then purified by silica gel chromatography (EtOAc – EtOAc + 0.1% AcOH) to afford the product as 
a white solid (3.0 mg, 85%). 
 
TLC (Hexanes:EtOAc 3:7) 
Rf = 0.28, visualized by shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
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δ 7.55 (d, J = 8 Hz, 1H), 7.49 (d, J = 8.5 Hz, 1H), 7.35-7.33 (m, 3H), 7.26 – 7.20 (m, 9 H, 1H), 
7.11 (d, J = 8 Hz, 2H), 6.82 (t, J = 6 Hz, 1H), 4.29 (t, J = 8 Hz, 1H), 3.73 (q, J = 6 Hz, 2H), 3.45 (d, J = 
7.5 Hz, 2H), 2.74 (t, J = 5.5 Hz, 2H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 176.4, 167.6, 148.6, 144.7, 144.3, 143.6, 140.0, 139.9, 131.8, 129.3, 129.0, 128.5 (2C), 127.9, 
127.2, 126.9, 126.5, 125.2, 121.2, 52.9, 41.9, 35.2, 33.7. 
 
HRMS (ESI+) 
 Calculated for C31H27NO4F3: 534.1892 
 Found:    534.1887 
 
The e.r. was determined by chiral HPLC using a ChiraCel OD-H (4.6 × 250 mm) column: 
Conditions: 20% IPA/hexane, flow rate = 0.6 ml/min, temperature = 23 C, detection wavelength = 214 
nm. 
tr(major) 13.11 min, tr(minor) 10.65 min; e.r. 94:6. 
 
 
 
 
 
 
Preparation of catalyst stock solution. A dry 20 ml vial was charged with Pd(OAc)2 (11.2 mg, 0.05 mmol) 
and SPhos8 (41 mg, 0.1 mmol) under ambient atmosphere. The vial was taken into the glovebox. THF 
(12.5 ml) was added and the mixture stirred for 20 min, forming a clear brown solution.  
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The freshly prepared catalyst stock solution was immediately for the preparation of 2.15-1: 
A 20 ml vial equipped with a stir bar was charged with 3-bromophenyl MIDA boronate9 (312 mg, 1 
mmol) and 4-(trifluoromethoxy)phenylboronic acid (309 mg, 1.5 mmol). This was repeated for another 20 
ml vial. Finely ground K3PO4 (637 mg, 3 mmol) was weighed into each of the 2 reaction vials. THF (5 ml) 
was added to each of the reaction vials, followed by 5 ml (0.05 mmol Pd(OAc)2, 0.1 mmol SPhos) of the 
catalyst solution. The reaction vials were sealed with Teflon-lined caps, brought out of the glovebox and 
stirred at 65 C in a heating block for 14 h. The reaction was then cooled to rt, then filtered through celite, 
combining the filtrates from the 2 reactions. The celite pad was washed with additional THF (20 ml). 
Celite was added to the filtrate and the mixture concentrated in vacuo. The celite (containing the absorbed 
crude product) was loaded onto a silica gel column. The column was eluted with Et2O to remove non-
polar impurities, then with 20% acetone/hexanes followed by 30% acetone/hexanes to elute the product. 
The fractions containing the product were concentrated in vacuo, affording the pure product as a white 
solid (586 mg, 75%). 
 
TLC (Hexanes:acetone 1:1) 
Rf = 0.32, visualized by short wave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.84 (app s, 1H), 7.80 (d, J = 9 Hz, 2H), 7.69 (dt, J = 8, 1.5 Hz, 1H), 7.58 (d, J = 7.5 Hz, 1H), 
7.49 (t, J = 15 Hz, 1H), 7.42 (d, J = 8.5 Hz, 2H),  4.38 (d, J = 17 Hz, 2H), 4.21 (d, J = 17 Hz, 2H), 2.82 
(s, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
 δ 169.3, 141.5, 139.8, 132.9, 132.0, 129.6, 129.3, 128.6, 122.2, 62.9, 48.4. 
 
HRMS (ESI+) 
 Calculated for C18H16BNO5F3: 394.1074 
 Found:    394.1078 
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To a solution of MIDA boronate 2.15-1 (763 mg, 1.94 mmol) in THF (20 ml) was added 1N NaOH (6 ml) 
in one portion under ambient atmosphere. The mixture was stirred vigorously for 20 min at rt, then 
diluted with Et2O (20 ml) quenched with sat. NH4Cl (20 ml). The mixture was stirred briefly and 
transferred to a separatory funnel. After shaking and phase separation, the aqueous layer was washed with 
THF/Et2O 1:1 (20 ml). The combined organic phase was dried over MgSO4, filtered and concentrated. 
The residue was dried in vacuo to give the boronic acid 2.15-2 as an off-white solid (540 mg, 98%). The 
solid was transferred to a 40 ml and N-iodosuccinimide (646 mg, 2.87 mmol) was added. The vial was 
sealed with a septum cap and evacuated under high vacuum and back-filled with N2. This cycle was 
repeated twice. MeCN was then added, the vial placed in a heating block and the reaction stirred at 81 C 
for 36 h. The reaction was cooled to rt and concentrated in vacuo to approximately 5 ml of MeCN. After 
dilution with Et2O (30 ml), the organic phase was washed with 1M NaHSO3 (30 ml × 2), then with H2O 
(30 ml). The combined aqueous phase was extracted with Et2O (30 ml). The organic layer was dried over 
MgSO4, filtered and concentrated, giving a brown liquid and a white crystalline solid. This residue was 
taken up in a minimum amount of Et2O and loaded onto a silica gel column. The column was flushed with 
hexanes. The fractions containing product were concentrated in vacuo, giving a yellow oil. This yellow 
oil was further purified by dissolving it in pentane and passing through a short silica gel pad, eluting with 
pentane. A colorless oil was obtained (679 mg, 89%). 
 
TLC (Hexanes) 
Rf = 0.45, visualized by short wave UV 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.91 (t, J = 2 Hz, 1H), 7.70 (ddd, J = 7.5, 1.5, 1 Hz, 1H), 7.55 (dt, J = 8.5, 2 Hz, 2H), 7.51 (ddd, 
J = 8, 1.5, 1 Hz), 7.29 (dd, J = 9, 1 Hz, 1H), 7.18 (t, J = 8 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 149.0, 142.0, 138.3, 136.6, 136.1, 130.5, 128.5, 126.3, 121.5, 121.3, 94.8. 
 
HRMS (EI+) 
 Calculated for C13H8IOF3: 363.95723 
 Found:    363.95628 
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To a suspension of the MIDA boronate 2.2710 (6.37 g, 24.86 g) in DCM (125 ml) at 0 oC was added 
mCPBA (7.29 g, 42.26 mmol) portionwise over 10 min under ambient atmosphere. The reaction was 
stirred for 12 h, gradually rising to RT in the ice/water bath. A white suspension was obtained, which was 
filtered to remove the white solids. The filtrate was concentrated (at 23 oC) to about 5 ml DCM, and the 
white solids were added back into the rbf. With vigorous stirring, 160 ml of Et2O was added and the 
mixture was stirred for 5 min. The white solid (product) was obtained by filtration, rinsing with 40 ml of 
Et2O. The filtrate containing impurities and trace amounts of the product, was discarded. The product was 
then returned to the rbf and stirred with another 100 ml of Et2O. The white solid was obtained after 
filtration, rinsing with 50 ml of Et2O. The solid was then dried in vacuo. White solid (6.28 g, 92%). 
 
TLC (Hexanes:acetone 1:1) 
Rf = 0.38, stained by KMnO4 
 
1H-NMR (400 MHz, acetone-d6) 
δ 7.37 – 7.27 (m, 5H), 4.36 (d, J = 17.2 Hz, 1H), 4.29 (d, J = 16.8 Hz, 1H), 4.18 (d, J = 17.2 Hz, 
1H), 4.04 (d, J = 16.8 Hz, 1H), 3.80 (d, J = 3.2 Hz, 1H), 3.35 (s, 3H), 2.45 (d, J = 2.8 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 169.3, 168.3, 140.1, 129.2, 128.6, 126.4, 63.0, 62.8, 56.5, 47.0. 
 
HRMS (ESI+) 
 Calculated for C13H15NO5: 276.1043 
 Found:    276.1057 
 
 
A flame-dried 300 ml rbf equipped with a stir bar was charged with the MIDA boronate 2.28 (2.59 g, 10 
mmol) and DCM (100 ml) under ambient atmosphere. The mixture was stirred to form slightly cloudy 
solution. Mg(ClO4)2 (2.23 g, 10 mmol) was then added portionwise over 3 min. The rbf was capped with 
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a cap plug and stirred at rt for 2 h 15 min.  The reaction was then filtered through celite, rinsing with 50 
ml DCM. The filtrate (slightly cloudy) was concentrated in vacuo to give a fluffy white solid.  50 ml Et2O 
was added to the solid, and the suspension stirred for 5 min, then vacuum-filtered. The solid was returned 
to the rbf and stirred with another 40 ml Et2O for 5 min. The suspension was filtered, and the white solid 
was dried in vacuo. This crude product 2.29 (2.26 g, 87%) was used without further purification.  
 
TLC (Hexanes:acetone 1:1) 
Rf = 0.34, stained by KMnO4. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 9.82 (d, J = 2.5 Hz, 1H0, 7.37 – 7.25 (m, 4H), 7.26 – 7.23 (m, 1H), 4.28 (d, J = 17 Hz, 1H), 
4.26 (d, J = 17 Hz, 1H), 3.74 (d, J = 17 Hz, 1H), 3.72 (br s, 1H), 3.20 (s, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
 δ 168.2, 137.3, 130.6, 129.3, 127.0, 63.6, 63.3, 47.1. 
 
HRMS (ESI+) 
 Calculated for C13H15BNO5: 276.1043 
 Found:    276.1044    
 
 
To a flame-dried 200 ml 3-neck rbf was added MIDA boronate 2.29 (2.26 g, 8.72 mmol) under positive 
N2 atm. DCM (100 ml) was added, and the mixture stirred at rt until a homogeneous solution was formed. 
The solution was cooled to 0 C in an ice/water bath and AcOH (25 ml) was then added slowly. After 
stirring for another 5 min, NaBH(OAc)3 (2.77 g, 13.1 mmol, 1.5 eq) was added. The reaction was stirred 
at 0 C for 2 h, then another portion of NaBH(OAc)3 (0.92 g, 4.34 mmol, 0.5 eq) was added. After stirring 
at 0 C for another 2.5 h, the third portion of NaBH(OAc)3 (0.92 g, 4.34 mmol, 0.5 eq) was added. The 
reaction was gradually raised to RT, stirring for 11.5 h. 50 ml of H2O was added slowly to quench the 
reaction. The mixture was transferred to a 500 ml sep funnel, rinsing with 50 ml DCM. After phase 
separation, the organic layer was washed with pH 7 phosphate buffer (1 M, 2 × 50 ml). The combined 
aqueous phase was extracted with 50 ml DCM. The organic phase was dried over MgSO4, filtered and 
concentrated in vacuo. The aqueous layer was thus extracted with EtOAc/acetone 2:1 (150 ml). This 
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organic phase was then washed with brine (50 ml), dried over MgSO4, filtered, combined with the rest of 
the product and concentrated. AcOH was present, forming a thick oil with the product. 100 ml Et2O was 
then added to this oil with vigorous stirring. The white suspension was filtered, washing the white solid 
with additional Et2O (50 ml). The solid was dissolved in acetone and transferred into a rbf. The filtrate 
was concentrated, and additional white solid precipitated with 50 ml Et2O. The solid was dissolved in 
acetone, and transferred to the rbf containing the rest of the product dissolved in acetone. An equal 
volume of hexane was added, and the mixture concentrated in vacuo to give a white fluffy solid. Residual 
water was azeotroped with PhMe, followed by hexane. The white solid was then dried in vacuo (1.54 g, 
64%, ~ 80-90% purity). This crude product 2.30 was used without further purification. 
 
TLC (Hexanes:acetone 1:1) 
Rf = 0.14, stained by KMnO4. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.28 – 7.27 (m, 2H), 7.23 – 7.20 (m, 2H), 7.11 (tt, J = 7.5, 1Hz, 1H), 4.19 (d, J = 16 Hz, 1H), 
4.14 (d, J = 15 Hz, 1H), 4.11 (d, J = 14.5 Hz, 1H), 3.94 (t, J = 9 Hz, 1H), 3.79 (d, J = 8.5 Hz, 1H), 3.66 
(d, J = 17 Hz, 1H), 3.15 (s, 3H), 2.56 (t, J = 7.5 Hz, 1H). 
 
13C-NMR (125 MHz, acetone-d6)  
δ 169.0, 168.8, 144.0, 130.0, 128.8, 125.9, 66.1, 63.6, 63.0, 46.7. 
 
HRMS (ESI+) 
 Calculated for C13H15NO5Na: 300.1019 
 Found:    300.1018 
 
 
A flame-dried 100 ml Schlenk flask was charged with PPh3 (1.87 g, 7.12 mmol), imidazole (0.808 g, 
11.86 g) and I2 (1.81 g, 7.12 mmol). DCM (50 ml) was added and the mixture stirred, forming a slightly 
yellow solution with white solid. After stirring for 5 min, the alcohol 2.30 (1.315 g, 4.75 mmol) was 
added as a solid under positive N2 atmosphere. The reaction was then stirred for 2.5 h. Another 0.1 g of I2 
was added. The reaction was stirred for an additional 1 h. 40 ml H2O was then added, and the mixture 
transferred to a separatory funnel. After phase separation, the organic layer was washed with another 30 
  
82 
 
ml H2O. The combined aqueous phase was extracted with 50 ml DCM. The organic extracts were then 
dried over MgSO4, filtered and concentrated to give a white solid. To this solid was added 50 ml Et2O. 
The suspension was stirred for 30 min and filtered, washing with additional Et2O. The white solid was 
taken up in acetone, absorbed onto celite and loaded onto a silica gel column. The product was purified by 
chromatography (100% Et2O to 30% EtOAc/Et2O to 50% acetone/hexane). The fractions containing the 
product were concentrated to give a white solid. To remove residual triphenylphosphine oxide, the solid 
was triturated with acetone (~ 5ml) and Et2O (20 ml). The suspension was filtered, and the white solid 
washed again with 50 ml Et2O. After filtration, the white solid 2.31 was dried in vacuo (736 mg, 40%). 
 
TLC (Hexanes:acetone 3:2) 
Rf = 0.28, stained by KMnO4. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.32 – 7.21 (m, 5H), 4.27 (d, J = 17 Hz, 1H), 4.10 (d, J = 17 Hz, 1H), 4.08 (d, J = 17 Hz, 1H), 
4.00 (dd, J = 10, 3.5 Hz, 1H), 3.53 (dd, J = 13, 10 Hz, 1H), 3.16 (d, J = 16.5 Hz, 1H), 3.02 (s, 3H), 2.66 
(dd, J = 13, 2.5 Hz, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
 δ 168.4, 167.9, 143.8, 129.7, 129.3, 127.0, 63.3, 63.0, 46.5, 15.5. 
 
HRMS (ESI+) 
 Calculated for C13H16NO4I: 388.0217 
 Found:    388.0226 
 
 
 
In a glovebox, Zn dust (78.5 mg, 1.2 mmol) was weighed into a flame-dried 7 ml vial equipped with a stir 
bar. Another 7 ml vial was charged with a THF:NMP 3:1 solution (0.8 ml) of the iodide 2.31 (155 mg, 0.4 
mmol). Both vials were sealed with septum caps and removed from the glovebox. The vial containing Zn 
dust was placed under argon, and 3 drops of TMSCl followed by 3 drops of 1,2-dibromoethane were 
added. The solution of iodide 2.31 was then added to the Zn dust in one portion via syringe under argon. 
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The reaction vial was then placed in a heating block and stirred at 45 C for 1.5 h. The vial was then 
removed from the block and 1.2 ml of THF was added to form a 0.2 M solution of the organozinc 2.32. 
 
 
Preparation of catalyst stock solution. A dry 7 ml vial equipped with a star bar was charged with 
RuPhos11 (9.5 mg, 0.02 mmol). The vial was brought into the glovebox, and Pd2dba3 (4.6 mg, 0.005 mmol) 
was added. THF (1.5 ml) was added, and the mixture stirred at rt for 3 min. 
 
The freshly prepared catalyst stock solution was immediately for the preparation of 2.33: 
A dry 7 ml vial equipped with a stir bar was charged with iodide 2.21 (75 mg, 0.2 mmol) and brought into 
the glovebox. To this was added NMP (0.75 ml) and THF (0.45 ml) followed by 1.2 ml (0.004 mmol 
Pd2dba3, 0.016 mmol RuPhos) of the catalyst solution. The vial was sealed with a septum cap, stirred 
briefly and then brought out of the glovebox. The vial was placed in a heating block pre-equilibrated to 60 
C, and the solution of the organozinc reagent 2.32 (1.5 ml, approx. 0.3 mmol) was added over 3 h with 
the aid of a syringe pump. After the addition was complete, the reaction was stirred for another 2 h at 60 
C, then cooled to rt. The reaction was diluted with Et2O (7 ml) and washed with sat. NH4Cl (2 × 5 ml) 
and H2O (2 × 5 ml). The combined aqueous layers were extracted with THF:Et2O 1:1 (10 ml). The 
organic phase was then dried over MgSO4, filtered and concentrated. The residue was taken up in acetone 
(5 ml), absorbed onto celite and loaded onto a silica gel column. The product 2.33 was obtained as a white 
solid after column chromatography (86 mg, 85%). 
 
TLC (Hexanes:acetone 1:1) 
Rf = 0.28, visualized by short wave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.60 – 7.57 (m, 1H), 7.58 (d, J = 8 Hz, 1H), 7.17 – 7.11 (m, 4H), 7.05 – 7.01 (m, 1H), 7.02 (d, J 
= 8 Hz, 1H), 4.26 (d, J = 17.5 Hz, 1H), 4.11 (d, J = 14 Hz, 1H), 4.07 (d, J = 13.5 Hz, 1H), 3.54 (q, J = 7, 
2H), 3.31 (dd, J = 14, 3 Hz, 1H), 3.15 (d, J = 17 Hz, 1H), 3.02 (s, 3H), 2.93 (dd, J = 13.5, 12.5 Hz, 1H), 
2.59 (dd, J = 12, 3 Hz, 1H), 2.51 (t, J = 7 Hz, 1H), 1.41 (s, 9H). 
 
13C-NMR (100 MHz, acetone-d6) 
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δ 171.7, 168.9, 168.3, 167.2, 146.7, 143.9, 132.8, 130.2, 129.4, 128.9, 127.4, 126.0, 80.6, 63.5, 63.1, 46.3, 
39.3, 36.5, 36.0, 28.2.   
 
 
To a 7 ml vial charged with MIDA boronate 2.21 (58 mg, 0.114 mmol), pinacol (20 mg, 0.171 mmol) and 
NaHCO3 (48 mg, 0.57 mmol) was added MeOH (3 ml) under ambient atmosphere. The vial was capped 
and placed in a heating block and stirred at 45 C for 5 h. The reaction was concentrated in vacuo. The 
residue was azeotroped 5 times with benzene until a white solid was obtained. Benzene (5 ml) was then 
added and the suspension filtered, rinsing with additional benzene. The filtrate was concentrated in vacuo 
to give a colorless oil residue. To this was added hexanes (10 ml), mixed thoroughly. The supernatant 
hexanes solution was then concentrated in vacuo to give the racemic pinacol ester rac-2.21. 1H-NMR data 
matches that of enantioenriched 2.21. 
 
 
A flame-dried 7 ml vial equipped with a stir bar was charged with Ag2O (30.6 mg, 0.132 mmol) and 
brought into the glove box. PPh3 (23.1 mg, 0.088 mmol) was then added into the vial, followed by a 
solution of the racemic pinacol boronic ester rac-2.21 (52 mg, 0.132 mmol) and iodide 2.15 (32 mg, 
0.088 mmol) in DME (1.6 ml). To this mixture was added a solution of Pd2dba3 (4.83 mg, 0.0158 mmol) 
in DME (1 ml). The vial was sealed with a cap, brought out of the glove box and stirred at 85 C for 24 h. 
The reaction was then cooled to room temperature and filtered through celite, eluting with Et2O. The 
filtrate was then concentrated in vacuo. The crude product was purified by silica gel chromatography (15 
– 20% EtOAc/hexanes) to afford a yellow oil as the product (48.5 mg, 93%). 1H-NMR data matches that 
of enantioenriched tBu-2.14. 
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To a 7 ml vial containing racemic rac-tBu-2.14 (24 mg, 0.041 mmol) was added TFA:DCM 1:4 (1 ml). 
The vial was sealed with a septum cap and vented to the atmosphere via a 22-gauge needle. The reaction 
was stirred at room temperature for 2 h. The solvent was then removed in vacuo. Residual TFA was 
removed by azeotroping with DCM (3 × 5 ml) to give a brown/orange oil. The crude product was purified 
by silica gel chromatography (EtOAc:hexanes:AcOH 7:3:0.4). The product was obtained as a white solid 
(16.2 mg, 74%). 1H-NMR data matches that of enantioenriched 2.14. 
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CHAPTER 3 
A LINEAR-TO-CYCLIZED STRATEGY FOR THE BUILDING BLOCK-BASED SYNTHESIS OF 
(POLY)CYCLIC MOLECULES 
 
Junqi Li, Seiko Fujii, Michael J. Schmidt, Andrea M. E. Palazzolo, Jonathan W. Lehmann, and Martin D. 
Burke 
 
 Topologically complex polycyclic natural products containing multiple bridged and/or fused rings 
are challenging targets for building block-based construction. However, Nature often makes these 
molecules from simpler linear precursors which are biosynthesized via the iterative assembly of a small 
set of building blocks. This suggests that an analogous linear-to-cyclized process can be used for the 
construction of these molecules from building blocks. This chapter details the expansion of scope of the 
iterative coupling strategy from Csp2-rich linear molecules to include the total synthesis of five Csp3-rich 
(poly)cyclic natural products and natural product-like cores. Using the same iterative coupling process 
described in chapters 1 and 2, linear precursors to the cyclic targets were prepared from Csp3 and Csp2 
boronate building blocks and then cyclized to generate 5 structurally distinct (poly)cyclic skeletons.  
 
 Dr. Seiko Fujii and Andrea Palazzolo conducted the synthesis of the steroid-like core. The 
synthesis of building block 3.18 was carried out in collaboration with Michael Schmidt, and Jonathan 
Lehmann executed the synthesis of the building block 3.52. Portions of this chapter were adapted from Li, 
J.; Ballmer, S. G.; Gillis, E. P.; Fujii, S.; Schmidt, M. J.; Palazzolo, A. M. E.; Lehmann, J. W.; 
Morehouse, G. F.; Burke, M. D. Science 2015, 347, 1221-1226 
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3-1 INTRODUCTION 
Natural products are diverse in structure (Figure 3-1), which necessitates the continuing 
development of methods to overcome challenges in total synthesis. The traditional approach to total 
synthesis have been to develop a customized synthesis for each target. As a result of this customized 
approach, automating synthesis has been carried out on ad hoc basis. This substantially limits synthetic 
access to small molecules for the study and application of their functional potential. In recent years, 
efforts have been made on developing unified strategies that can be applied to the synthesis of a collection 
of structurally related targets. 1  However, a generalized strategy for the synthesis of many different 
structurally distinct natural products remains a formidable challenge.  
The biosynthetic origin of natural products allows us to think about a hierarchy of structural 
complexity of natural products. Like peptides, oligonucleotides and oligosaccharides, many natural 
products are biosynthesized via the iterative assembly of a small set of building blocks, such as malonyl 
coenzyme A, isopentenyl pyrophosphate, and pyruvic acid. The iterative assembly of building blocks thus 
results in linear molecules (Figure 3-1A). The next level of complexity is installed when linear precursors 
from building block assembly undergo a macrocyclization event, often enzyme-mediated, to form 
macrocyclic natural products (Figure 3-1B). A higher level of complexity is built when multiple bonds are 
formed during the cyclization. Nature uses a repertoire of these cyclizations, such as Diels-Alder 
cycloadditions, cation-π cyclizations, iminium ion-triggered cascades, and epoxide opening cascades 
(Figure 3-1C). In some cases, individual cyclized fragments can further dimerize to generate dimeric or 
pseudo-dimeric natural products (Figure 3-1D).  
 
Figure 3-1. A collection of natural products with progressive levels of structural complexity. 
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 This general approach to the biosynthesis of many of these complex natural products led us to 
hypothesize that an analogous linear-to-cyclized strategy might enable the iterative coupling platform 
described in Chapters 1 and 2 to access many such structures. In this strategy, the same building block 
assembly process is used to generate a linear precursor, which is then (poly)cyclized into the topologically 
complex products. The stereochemical information in the building blocks is first translated into linear 
precursors via stereospecific couplings and then into the targeted products via stereospecific and/or 
stereoselective (poly)cyclization reactions. To enable such cyclizations, the linear precursors must be 
suitably flexible and therefore rich in sp3 hybridized carbons. Building block-based assembly of these 
precursors thus requires Csp3 couplings, which can be challenging. To test this strategy, we elected to 
target the synthesis of 5 structurally distinct cyclic molecules 3.1 – 3.5 (Figure 3-2) that represent natural 
products from different biosynthetic pathways. The main challenge is the stereoselective synthesis and 
coupling of the boronate building blocks.  
 
 
Figure 3-2. Cyclic targets for testing the linear-to-cyclized approach. The targets can be accessed via different 
cyclization reactions. 
 
 
3-2 FORMAL TOTAL SYNTHESIS OF CITEROFURAN 3.1 
We first developed a few guiding principles in planning the synthesis of 3.1 to 3.5. We aimed to 
minimize the number of Csp3 couplings in our disconnections, and only Csp3-Csp2 (vs Csp3-Csp3) 
couplings will be used. In addition, because alkyl iodides are prone to β-hydride elimination after 
oxidative addition, especially if transmetallation is the turnover-limiting step, we opted to make the Csp3 
coupling partner be the boronic acid.2 
Citreofuran is a macrocyclic polyketide-derived lactone that is known to have DNA-cleaving 
properties.3 It contains both Csp3 and atropisomerism stereochemical elements. The macrolactone can be 
derived from the linear precursor seco-acid 3.6, which in turn can in theory be assembled from the 
building blocks 3.7, 3.8 and 3.9 (Figure 3-3).  
 
Figure 3-3. Retrosynthesis of citreofuran 3.1. 
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The synthesis of the building block 3.7 started from the chiral pool material (R)-(+)-3-butyn-2-ol, 
which is subjected to hydroboration with catecholborane after protection of the silyl group. The resulting 
boronic ester is converted into the alkenyl MIDA boronate 3.11. The final Csp3 boronate 3.7 is then 
obtained from the hydrogenation of C=C bond. 3.8 is synthesized from an electrophilic bromination of 
commercially available 2-furanyl MIDA boronate. The capping aryl halide building block is synthesized 
from published procedures. A TMSE group was chosen as a protecting group for the ester so that only 
one step is needed for the deprotection of the linear precursor 3.6.  
 
 
Scheme 3-1. A) Synthesis of building block 3.7. B) Synthesis of building block 3.8. C) Synthesis of building block 
3.9. 
 
The first coupling was a Csp3-Csp2 coupling between the the aryl halide 3.8 and Csp3 boronic 
acid resulting from the basic hydrolysis of boronate 3.7. Our group had discovered anhydrous conditions 
for coupling secondary alkyl boronic acids 4 , but those conditions have not been investigated with 
heteroaryl halides containing a MIDA boronate functionality. Using conditions modified from that study 
(Pd[P(o-tol)3]2 and Ag2O/K2CO3 as the base mixture), we obtained an isolated yield of 46%.  In this 
coupling reaction, 4 equivalents of the boronic acid and 25 mol% was necessary to reach complete 
conversion due to competitive β-hydride elimination leading to decomposition of the boronic acid. The 
Pd-hydride intermediate from β-hydride elimination also resulted in the formation of protodehalogenation 
product arising from reductive elimination (Scheme 3-2). Under the best optimized conditions, a ratio of 
15:1 of desired product: protodehalogenated product was obtained.  
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Scheme 3-2. Proposed mechanism for the formation of the protodehalogenated side product. 
 
Deprotection of the MIDA boronate 3.15 gives a 2-furanyl boronic acid for the next coupling 
reaction. A slow addition protocol5 was used for the coupling of the boronic acid to the aryl bromide 3.9 
as 2-heterocyclic boronic acids are prone to decomposition under the reaction conditions. With the 2nd 
generation Buchwald XPhos palladacycle and K3PO4, an isolated yield of 87% of the fully protected 
linear precursor 3.6 was obtained. Removal of the silyl groups would reveal the seco-acid which is known 
to undergo an atropdiastereoselective Mitsunobu lactonization to form the macrocycle.6 
 
 
Scheme 3-3. Building block assembly via iterative cycles of coupling and deprotection to generate 3.6. D = 
deprotection; C = coupling. 
 
3-3 FORMAL TOTAL SYNTHESIS OF OBLONGOLIDE 3.2 
Oblongolide is a norsesquiterpene γ-lactone natural product containing a 6,6,5-tricyclic core with 
five Csp3 stereogenic centers, one of which is quaternary.7 A lactonization and Diels-Alder disconnection 
reduces the target to a relatively simple linear precursor, which can be further retrosynthesized into three 
building blocks (Figure 3-4).  
 
 
Figure 3-4. Retrosynthesis of oblongolide 3.2. 
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Since the Diels-Alder reaction is a stereospecific reaction in which the configuration of the C=C 
bonds translates to the relative configuration of the stereogenic centers in the cycloaddition product, it is 
important that the C=C configurations is installed in the building blocks with high selectivity and 
maintained in the building block assembly process. The most difficult part of the synthesis was making 
the chiral non-racemic bifunctional MIDA boronate building block 3.18, which involved 2 critical 
elements – setting the stereocenter and stereoselectively forming the E-alkenyl iodide. 
In planning the synthesis of 3.18 we realized that the methodology described in Chapter 2 
involving the Negishi coupling with an organozinc reagent containing a MIDA (or PIDA) boronate and 
an aryl halide would allow us to install the Z-alkenyl iodide with excellent stereoselectivity. The vinyl 
iodide coupling partner would come from a highly regioselective hydrozirconation-iodinolysis sequence 
developed by Negishi and co-workers (Figure 3-5).8  
 
 
Figure 3-5. Retrosynthesis of building block 3.18. 
 
The synthesis of 3.18 commenced with the acylation of Evans’ (S)-4-Benzyl-2-oxazolidinone 
with crotonic acid, followed by methylation at the α-position with a diastereoselectivity of 3.6:1with the 
desired diastereomer as the major product. After separation of the diastereomers, the imide was reduced 
to the alcohol 3.23. The corresponding tosylate 3.24 was subjected to a hydroboration-hydrolysis-MIDA 
complexation sequence to give the MIDA boronate 3.25 as a single regioisomer. A Finkelstein reaction 
with the tosylate installs the iodide. The MIDA boronate 3.26 is then converted into the organozinc 
reagent 3.19 which underwent a Negishi coupling with the vinyl iodide 3.20. Iododesilylation with the 
conditions developed by the Zakarian group9 generated the desired E-alkenyl iodide 3.18 as a single 
stereoisomer. 
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Scheme 3-4. Synthesis of building block 3.18. 
 
Assembly of the building blocks started from the hydrolysis of the commercially available MIDA 
boronate 3.17 to give the boronic acid which would then undergo coupling with the bifunctional building 
block 3.18. Initial attempts at coupling were made using the 2nd generation XPhos Buchwald 
Palladacycle, and K3PO4 as the base, but this resulted in the formation of 3 isomeric products (Scheme 3-
5).  
 
 
Scheme 3-5. Initial attempt at coupling rac-3.18 and 3.28. 
 
We reasoned that 3.30 might be formed from β-hydride elimination followed by re-insertion into 
the β-position before reductive elimination.10 Re-insertion into the position proximal to the protected 
alcohol may have been promoted by coordination of the oxygen to the Pd center (Scheme 3-6).  
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Scheme 3-6. Proposed mechanism for formation of side product 3.30. 
 
After a ligand screen, the 1,1’-bis(diphenylphosphino)ferrocene (dppf) ligand in combination 
with a Ag2O/K2CO3 base mixture was found to be effective in eliminating the cis isomer 3.31.   It was 
found that the Pd source influenced both the conversion and the ratio of the isomers (Table 3-1). 
Pd(OAc)2 was the optimal Pd source, with only one isomer detected in the 1H-NMR of the crude reaction 
mixture. A 47% isolated yield of MIDA boronate 3.29 was obtained with slow addition of the boronic 
acid into the reaction mixture.  
 
 
Table 3-1. A screen of palladium sources for optimizing the coupling of rac-3.18 and 3.28. Ratios were determined 
by 1H-NMR analysis of the crude reaction mixture. 
 
After deprotection of 3.29, the boronic acid was engaged in a Csp3-Csp2 coupling with the vinyl 
bromide 3.19 using the same conditions used for the Csp3-Csp2 coupling in the synthesis of citreofuran 
(Scheme 3-3), giving an isolated yield of 46% of the protected linear precursor 3.31 (Scheme 3-7). 
Removal of the TIPS group and a substrate-controlled endo-equatorial Diels-Alder reaction followed by 
an intramolecular lactonization would generate oblongolide.11 
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Scheme 3-7. Building block assembly via iterative cycles of coupling and deprotection to generate 3.31. 
 
 
3-4 FORMAL SYNTHESIS OF THE HEXAHYDROINDENE CORE 3.3 
 The hexahydroindene core 3.3 can be derived from the linear precursor 3.33 by an intramolecular 
Diels-Alder reaction. Unlike the synthesis of oblongolide, no Csp3 stereocenters are present in the linear 
precursor. In this case, the enantioselectivity can be controlled using a rapidly expanding toolbox of chiral 
catalysts.12 We thus aimed to use the organocatalytic intramolecular Diels-Alder reaction developed by 
MacMillan and co-workers to transform the linear precursor into the desired trans-bicyclic compound.13 
The linear precursor 3.33 can again be retrosynthesized into 3 building blocks. 3.34 is a commercially 
available building block, so the focus of building block synthesis was on the bifunctional building block 
3.35.  
 
Figure 3-6. Retrosynthesis of hexahydroindene core 3.13. 
 
 We reasoned that the most straightforward synthesis of 3.35 was hydrostannylation followed by 
iodinolysis of the bromoalkyne 3.3714, which can be synthesized from a TMS-protected Grignard reagent 
and trimethyl borate. However, hydrostannylation with tributyltin hydride gave an inseparable mixture of 
the vinyl iodies 3.35, 3.36 and 3.37 in the ratio 88:9:3 after iododestannylation.  
 
 
Scheme 3-8. Initial attempt at the stereoselective synthesis of 3.35. 
 
 We thus turned to the approach we took for the synthesis of the building block 3.18 for 
oblongolide. The bifunctional iodo MIDA boronate 3.39 was first synthesized from the commercial 3-
bromopropylboronic acid pinacol ester. Zinc insertion into the carbon-iodine bond generates the 
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organozinc reagent which then undergoes a Negishi coupling with the vinyl iodide. Iodo-desilylation of 
the vinyl silane 3.40 then generated the desired E-vinyl iodide as a single stereoisomer.  
 
Scheme 3-9. Synthesis of building block 3.35 via the Negishi coupling of 3.40. 
 
The capping building block was synthesized starting from allyl alcohol which underwent a 
hydrozirconation-iodinolysis sequence to give the vinyl iodide 3.42. This compound was volatile and 
unstable when concentrated, leading to a low yield. Oxidation to the aldehyde by MnO2 gives the 
aldehyde which was used immediately in the ketalization reaction. The resulting ketal was a stable and 
can be purified by silica gel chromatography. 
 
 
Scheme 3-10. Synthesis of building block 3.36. 
 
 With the building blocks in hand, we began the synthesis of the linear precursor to the 
hexahydroindene core (Scheme 3-11). Hydrolysis of the MIDA boronate 3.34 gives the boronic acid 
which undergoes cross-coupling with the bifunctional vinyl iodide 3.35 without isomerization with 
Pd(OAc)2 and P(o-tol)3.15 It should be noted that the use of the Wittig reaction for diene synthesis resulted 
in a mixture containing 83.3% of the desired E,E-diene due to the stereoselective nature of the Wittig 
reaction.12 Deprotection of the resulting MIDA boronate and coupling with the vinyl iodide 3.36 using the 
same Csp3-Csp2 coupling conditions for the synthesis of citreofuran and oblongolide generates the desired 
protected linear precursor 3.44.  
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Scheme 3-11. Synthesis of the protected linear precursor 3.44. 
 
3-5 FORMAL SYNTHESIS OF THE STEROID-LIKE CORE 3.4 
  The steroid-like core 3.4 contains a 6,6-trans-fused bicycle that can be retrosynthesized into a 
terpene-like linear precursor containing an aryl capping group 3.45 (Figure 3-7).  3.45 can be further 
broken down into 3 building blocks 3.46, 3.47 and 3.48 which can be assembled via iterative Csp3-Csp2 
couplings.  
 
 
Figure 3-7. Retrosynthesis of the steroid-like core 3.4. 
 
The synthesis of 3.45 was carried out by Dr. Seiko Fujii and Andrea Palazzolo using the same 
iterative coupling process that was used for the synthesis of targets 3.1 – 3.3. The first Csp3-Csp2 coupling 
with the vinyl iodide proved to be challenging because of decomposition of the iodide 3.47 under typical 
anhydrous Suzuki-Miyaura cross-coupling conditions, but good yields were obtained using a Negishi 
coupling between 3.45 and 3.46. Deprotection of the intermediate followed by a second Csp3-Csp2 
coupling with the aryl iodide proceeded in good yields, giving the desired linear precursor that could 
undergo a Lewis acid-catalyzed cation-π cyclization to generate the tricyclic core (see Chapter 4).16 
 
 
Scheme 3-12. Synthesis of the linear precursor 3.45. 
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3-6 TOTAL SYNTHESIS OF THE SECODAPHNANE CORE 3.5 
 The daphniphyllum alkaloids are a family of structurally diverse alkaloids consisting of more 
than 200 members characterized to date with at least 16 core structures. 17  Heathcock proposed the 
secodaphnane core to be the primordial alkaloid from which the other daphniphyllum cores are 
derived.18,19 Heathcock and co-workers also proposed the biosynthesis of the secodaphnane core from 
squalene, and executed the biomimetic synthesis of the pentacyclic core from a squalene-like linear 
precursor,20 thus supporting the notion that both the secodaphnane core and cholesterol are biosynthesized 
from the same prenyl building blocks. 
 
Figure 3-8. Common biosynthetic origins of steroids (e.g. cholesterol) and the daphniphyllum alkaloids. 
 
 The common biosynthetic origins of the daphniphyllum alkaloids and the steroids guided us in 
designing the synthesis to the target 3.5, which is contains the secodaphnane core present in the proto-
daphniphllyine. We realized that the monoterpene tail of the linear precursor can be constructed with the 
same building blocks 3.46 and 3.47 as that used in the synthesis of the steroid-like core. To avoid a 
challenging Csp3-Csp3 coupling, we installed a C=C bond in the capping halide building block which 
could be selectively reduced in the presence of the other C=C bond. Installing the appropriate protecting 
groups21 provided the capping building block 3.52 for the iterative assembly of the linear precursor. 
 
Figure 3-9. Retrosynthesis of the secodaphnane core 3.5.  
 
 The synthesis of the capping building block 3.52 can be simplified by introducing the vinyl halide 
as the last step in the synthesis via a halide-selective Negishi coupling. This would also give us an option 
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of installing either an E- or Z-vinyl halide without the need to start the building block synthesis from the 
first step.  
 
 
Scheme 3-13. Synthesis of Z-3.52 and E-3.52 via Negishi coupling with a common intermediate 3.53. 
 
We questioned whether the E-vinyl bromide E-3.52 might be prone to β-hydride elimination to 
generate the undesired alkyne after oxidative addition during the Csp3-Csp2 coupling in the assembly of 
the precursor. We thus opted to first test the coupling of boronic acid 3.54 with the Z-3.52. Using the 
conditions for optimized for the Csp3-Csp2 couplings, we were only able to obtain an isolated yield of 
34% for the desired product Z-3.51 (Scheme 3.14).  
 
Scheme 3-14. Initial attempts at the Suzuki-Miyaura cross-coupling of 3.54 and Z-3.52. 
 
Separation and NMR analysis of each of the side products revealed that there were a number of 
reaction pathways that led to the decomposition of the vinyl halide Z-3.52 during the reaction. After 
transmetallation, β-hydride elimination followed by reductive elimination on the Pd-hydride species leads 
to formation of proto-dehalogenated product 3.55. Unexpectedly, we also observed the formation of side 
products 3.56a and 3.56b resulting from a competing intramolecular Heck reaction. Oxidative addition 
into the carbon-bromine bond, followed by intramolecular migratory insertion into the terminal C=C bond 
forms a cyclopentene which then undergoes β-hydride elimination to form 3.56a as a mixture of E and Z 
isomers and 3.56b. We were unable to increase the selectivity of the Suzuki-Miyaura coupling over the 
Heck reaction after several attempts at optimizing the reaction.22 
  
99 
 
 
Scheme 3-15. Competitive pathways in the coupling of 3.54 and Z-3.52 leading to formation of multiple side 
products. 
 
 We thus synthesized the E-vinyl halide  E-3.52 by changing the dibromide component to test the 
Suzuki-Miyaura coupling. Gratifyingly, we obtained a 53% isolated yield of the desired product 3.51 
(Scheme 3-16), thus allowing us to complete the synthesis of the linear precursor via iterative assembly of 
the building blocks 3.46, 3.47, E-3.52. 
 
Scheme 3-16. Synthesis of the linear precursor 3.51. 
 
With the fully assembled linear target 3.51 in hand, we were in a position to test the synthesis of 
the secodaphnane core 3.5. A conjugate reduction with magnesium turnings in methanol, followed by 
reduction of the ester and removal of the TIPS protecting group furnishes the diol 3.59. Using the one-pot 
reaction sequence optimized by Heathcock and co-workers for the synthesis of proto-daphniphylline19, 
the diol was oxidized to the bis-aldehyde, which was treated with methylamine gas to form the bis-imine. 
Addition of dry acetic acid to the bis-imine at 80 °C initiates two sequential hetero-Diels-Alder reactions 
followed by an aza-Prins cyclization to generate the pentacyclic core 3.5. The structure was 
unambiguously confirmed by X-ray structure analysis of the N-bromoacyl derivative of 3.5.  
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Scheme 3-17. Synthesis of 3.5 from the linear precursor 3.51. 
 
3-7 SUMMARY AND CONCLUSIONS 
 With accelerating advances in method development, the total synthesis of even very complex 
polycyclic natural products can be accomplished. However, a major challenge in synthesis is creating a 
generalized process that can be applied for the synthesis of structurally distinct classes of small molecules. 
Towards this overarching goal, our group developed a building block-based, iterative coupling approach 
that is analogous to peptide synthesis. This approach has been successfully demonstrated on Csp2-rich 
linear targets, especially polyene natural products, but applying the same iterative coupling approach to 
Csp3-rich cyclic molecules now requires an advance in synthetic strategy. In this chapter, we present a 
biosynthesis-inspired linear-to-cyclized approach which enabled us to successfully expand the scope of 
the iterative coupling platform to include 5 (poly)cyclic targets representing natural products from 
different biosynthetic pathways. Building block assembly using both Csp3-Csp2 and Csp2-Csp2 couplings 
generates the linear precursors, which can undergo various cyclization conditions (Mitsunobu 
lactonization, Diels-Alder reactions, cation-π cyclization, and iminium ion-triggered cascade cyclization) 
to give the desired (poly)cyclic structures. The goals achieved in this chapter lay the groundwork for the 
more general synthesis of complex small molecules using the iterative coupling platform in combination 
with the linear-to-cyclized approach. In the next chapter, we demonstrate how the synthesis of the linear 
precursors can be automated to provide expedient access to the synthesis of the corresponding polycyclic 
structures. 
The continued progress towards the more general synthesis of small molecules first requires a 
complete structural analysis of all natural products outlined in the Introduction of this chapter, which will 
certainly require the aid of intelligent computer programs that can recognize structural patterns in small 
molecules. However, analysis of a small section of the entire set of natural products can already define the 
important problems that need to be solved for the synthesis of natural products to become more general – 
i) the identification and construction of building blocks, ii) the development of new methods for the 
iterative assembly of building blocks, iii) the expansion of the catalyst toolbox for cyclization of linear 
molecules, and iv) the development of mild and selective methods for dimerizing natural product-like 
fragments. 
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22 We reasoned that increasing the concentration of the reaction might increase the selectivity for the 
desired product. However, the boronic acid is prone to form boroxine upon concentration, and thus had to 
be used directly in the coupling reaction as a solution in THF after work-up. Concentrating the THF 
solution of the boronic acid beyond 0.1M led to formation of the boroxine, which is detrimental to the 
reaction. See reference 4. 
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CHAPTER 3 
EXPERIMENTAL SECTION 
 
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, Alfa Aesar, TCI 
America, or Frontier Scientific, and were used without further purification unless otherwise noted. Most 
of the building blocks used in these studies are available from commercial sources. The following MIDA 
boronates were purchased from Sigma-Aldrich: 2-furanyl MIDA boronate (701017). XPhos 2nd 
generation palladacycle refers to chloro(2-dicyclohexylphosphino-2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-
(2′-amino-1,1′-biphenyl)]palladium(II) (741825, Sigma-Aldrich). Solvents were purified via passage 
through packed columns as described by Pangborn and coworkers1 (THF, Et2O, CH3CN, CH2Cl2: dry 
neutral alumina; hexane, benzene, and toluene, dry neutral alumina and Q5 reactant; DMSO, DMF: 
activated molecular sieves). All water was deionized prior to use.  
 
General Experimental Procedures.  Unless noted, all reactions were performed in flame-dried round-
bottom or modified Schlenk flasks fitted with rubber septa under a positive pressure of argon.  Organic 
solutions were concentrated via rotary evaporation under reduced pressure with a bath temperature of 23 
oC unless otherwise noted. Reactions were monitored by analytical thin layer chromatography (TLC) 
performed using the indicated solvent on E. Merck silica gel 60 F254 plates (0.25mm).  Compounds were 
visualized by exposure to a UV lamp (λ = 254 nm), and/or a solution of KMnO4, followed by brief 
heating using a Varitemp heat gun. Column chromatography was performed using Merck silica gel grade 
9385 60Å (230-400 mesh). 
 
Structural analysis.  1H NMR and 13C NMR spectra were recorded at 20 oC on Varian Unity 500, Varian 
Unity Inova 500NB or Varian Unity 500 instruments.  Chemical shifts (δ) are reported in parts per million 
(ppm) downfield from tetramethylsilane and referenced to residual protium in the NMR solvent (CHCl3, δ 
= 7.26; acetone, δ = 2.05, center line) or to added tetramethylsilane (δ = 0.00).  Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sept = 
septet, m = multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), and integration.  
Chemical shifts (δ) for 13C NMR are reported in ppm downfield from tetramethylsilane and referenced to 
carbon resonances in the NMR solvent (CDCl3, δ = 77.0, center line; acetone, δ = 39.5, center line). 
Carbons bearing boron substituents were not observed (quadrupolar relaxation). High resolution mass 
spectra (HRMS) were performed by Furong Sun and Dr. Haijun Yao at the University of Illinois School 
of Chemical Sciences Mass Spectrometry Laboratory.   
 
  
104 
 
 
A flame-dried 250 mL Schlenk flask equipped with a stir bar was charged with imidazole (7.28 g, 107.0 
mmol, 1.5 equiv). The flask was sealed with a rubber septum, evacuated and back-filled with N2 (×3). 
DMF (50 mL) was added via syringe, followed by neat (R)-(+)-3-butyn-2-ol (5g, 71.34 mmol, 1.0 equiv). 
The flask was placed in a water bath at RT. Triisopropylsilyl chloride (23 mL, 107.3 mmol, 1.5 equiv) 
was then added neat dropwise over 5 min. The reaction was stirred at rt for 14.5 h, then partitioned 
between H2O (250 mL) and Et2O (200 mL), rinsing with Et2O (50 mL).  The aqueous phase was extracted 
with Et2O (150 mL). The combined organics were washed with H2O (150 mL), brine, dried over MgSO4, 
filtered and concentrated in vacuo. The crude product was purified by SiO2 column chromatography 
(100% pentane-5% Et2O/pentane) to give the pure product 3.10 as a colorless liquid (12.58 g, 78% yield). 
 
TLC (100% hexanes) 
Rf = 0.27, visualized by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 4.59 (dq, J = 6.5, 2.0 Hz, 1H), 2.37 (d, J = 2.0 Hz, 1H), 1.46 (d, J = 6.0 Hz, 3H), 1.15-1.07 (m, 
21H). 
 
13C-NMR (125 MHz, CDCl3):  
δ 86.6, 71.0, 58.8, 25.6, 17.9 (2C), 12.1. 
 
HRMS (ESI+)  
Calculated for C13H26OSi: 226.1753 
Found:    226.1751 
 
[α]23D +40.3° (c = 0.9, CHCl3). 
 
 
The following procedure was carried out in quadruplicate. A flame-dried 40 mL vial was charged with 
alkyne 3.10 (2.63 g, 11.62 mmol, 1.0 equiv) and a stir bar. The vial was flushed with Ar., then sealed with 
a PTFE septum cap. Catecholborane (1.3 mL, 12.2 mmol, 1.05 equiv) was added via syringe and the 
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reaction stirred for 7 h at 70 °C. The reaction mixtures from the 4 vials were combined into an 
Erlenmeyer flask, rinsing with THF (140 mL total). The flask was placed in an ice-water bath and cooled 
to 0 °C. 1N NaOH (100 mL) was added slowly. The mixture was stirred for 15 min at 0 °C, then the ice-
water bath was removed and the reaction stirred for another 15 min. The dark brown mixture was then 
transferred to a separatory funnel and diluted with Et2O (280 mL). After mixing and phase separation, the 
aqueous phase was extracted with Et2O (70 mL). The combined organics were washed with sat. aq. 
Na2CO3 (70 mL × 5), brine (140 mL), dried over MgSO4, filtered and concentrated. The crude boronic 
acid was diluted with benzene (100 mL) and stored at – 20 °C overnight. After warming the frozen 
mixture to rt, benzene was removed in vacuo. The residue was transferred to a 500 mL single neck rbf, 
rinsing with PhMe (250 mL). DMSO (25 mL) was added, followed by MIDA (7.18 g, 48.8 mmol, 1.05 
equiv). The mixture was stirred and heated to reflux with a Dean-Stark trap for 4.5 h, then cooled briefly. 
PhMe was removed in vacuo and the residue was partitioned between EtOAc (250 mL) and H2O (150 
mL). The aqueous layer was extracted with EtOAc (100 mL). The combined organics were washed with 
1:1 H2O/brine (120 mL × 2), brine, dried over MgSO4, filtered and concentrated. The crude product was 
purified by SiO2 column chromatography (100% Et2O-10% -20% acetone/Et2O). The colorless fractions 
containing the product were concentrated to give 3.11 as a white solid (5.79 g, 32% yield). 
 
TLC (40% acetone/hexanes) 
Rf = 0.50, visualized by KMnO4 stain 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.15 (dd, J = 18.0, 5.5 Hz, 1H), 5.68 (dd, J = 18.0, 1.5 Hz, 1H), 4.52-4.47 (m, 1H), 4.21 (d, J = 
17.0 Hz, 1H), 4.21 (d, J = 16.5 Hz, 1H), 4.01 (d, J = 17.0 Hz, 1H), 3.97 (d, J = 17.0 Hz, 1H), 3.00 (s, 3H), 
1.24 (d, J = 6.5 Hz, 3H), 1.12-1.07 (m, 21H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 169.0 (2C), 150.1, 71.5, 62.2 (2C), 47.3, 25.1, 18.5, 18.4, 13.0. 
 
HRMS (ESI+) 
Calculated for C18H35BNO5Si: 384.2378 
Found:    384.2383 
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A 200 mL single neck rbf was charged with MIDA boronate 3.11 (4.59 g, 11.97 mmol, 1.0 equiv), a stir 
bar and 10 wt% Pd/C (255 mg, 0.24 mmol, 0.02 equiv). The rbf was sealed with a rubber septum, 
evacuated and back-filled with N2 (×3). EtOAc (60 mL) was added via syringe and H2 was bubbled 
through the mixture from a balloon for 5 min. The mixture was then stirred under a H2 atmosphere for 15 
min at rt, then at 45 °C for 45 min. The reaction was cooled to rt and purged with N2, then filtered through 
celite, rinsing with CH2Cl2 (100 mL). The filtrate was concentrated in vacuo and the crude product 
purified on a SiO2 column (30%-35%-40% acetone/hexanes) to give a white solid as the pure product 3.7 
(3.81 g, 83% yield). 
 
TLC (40% acetone/hexanes) 
Rf = 0.47, visualized by KMnO4 stain. 
 
1H-NMR (500 MHz, CDCl3) 
δ 4.18 (d, J = 17.0 Hz, 1H), 4.18 (d, J = 17.0 Hz, 1H), 4.02 (d, J = 16.5 Hz, 1H), 4.01 (d, J = 16.5 
Hz, 1H), 3.96 (dq, J = 12.5, 6.5 Hz, 1H), 3.10 (s, 3H), 1.65-1.58 (m, 1H), 1.52-1.45 (m, 1H), 1.17 (d, J = 
6.0 Hz, 3H), 1.08 (m, 21H), 0.71-0.62 (m, 2H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 168.8, 168.7, 71.3, 62.6 (2C), 46.2, 35.2, 23.4, 18.5 (2C), 13.2. 
 
HRMS (ESI+)  
Calculated for C18H37BNO5Si: 386.2534 
Found:    386.2528 
 
 
A flame-dried 250 mL Schlenk flask was charged with 2-furanyl MIDA boronate (Aldrich catalog # 
701017, 2.00 g, 8.97 mmol, 1.0 equiv) and THF (90 mL). The solution was cooled to 0 °C in an ice-water 
bath. N-bromosuccinimide was added as a solid under a positive pressure of N2. The reaction was stirred 
in the cold bath, gradually warming to rt. After 3 h 15 min, the reaction was cooled to 0 °C and another 
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portion of N-bromosuccinimide (239 mg, 1.35 mmol, 0.15 equiv) was added. The reaction was stirred for 
another 4 h, gradually warming to rt. The reaction mixture was then transferred to a separatory funnel and 
diluted with EtOAc (100 mL). The organics were washed with sat. aq. Na2SO3 (100 mL ×2). The aqueous 
phase was extracted with EtOAc (100 mL). The combined organics were washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo. The crude product was purified by silica gel column (20%-
40%-60% EtOAc/Et2O). The fractions containing product were concentrated and taken up in 10 mL 
acetone. 1:1 Et2O/hexanes (100 mL) was layered on top of the acetone solution and the mixture was left 
to stand at RT. The white solid obtained were filtered and dried in vacuo to give the pure product 3.8 (871 
mg, 32% yield). 
 
TLC (50% acetone/hexanes) 
Rf = 0.47, visualized by KMnO4 stain. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 6.72 (d, J = 3.0 Hz, 1H), 6.44 (d, J = 3.5 Hz, 1H), 4.38 (d, J = 17.0 Hz, 2H), 4.18 (d, J = 17.0 
Hz, 2H), 2.92 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
 δ 168.7, 125.3, 121.6, 112.4, 62.5, 47.9. 
 
HRMS (ESI+)  
Calculated for C9H10BNO5Br: 301.9835 
Found:    301.9826 
 
 
A 300 mL single neck rbf equipped with a stir bar was charged with methyl ester 3.122 (6.43 g, 17.75 
mmol, 1.0 equiv) and THF (160 mL) under ambient atmosphere. The solution was cooled to 0 °C in an 
ice-water bath. N-bromosuccinimide (3.22 g, 18.11 mmol, 1.02 equiv) was added as a solid slowly over 2 
min. The reaction was stirred at 0 °C for 15 min, then the ice-water bath was removed and the reaction 
warmed to rt. The reaction was stirred for a total of 2.5 h. The reaction mixture was concentrated in vacuo. 
The residue was taken up in CH2Cl2 and the crude product was adsorbed onto celite in vacuo. The celite 
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pad was loaded onto a SiO2 column for purification (50-70% DCM/hexanes). The fractions containing 
product were concentrated in vacuo to give a white solid, which was dissolved in hot Et2O/hexanes 
(approx. 1:9, 500 mL) and left to cool at RT to allow crystallization overnight. The white solid formed 
was obtained by vacuum filtration, rinsing with hexanes (60 mL) and dried in vacuo, giving the pure 
product 3.13 (4.75 g, 68% yield). 
 
TLC (60% DCM/hexanes) 
Rf = 0.35, visualized by shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.47-7.45 (m, 2H), 7.40-7.32 (m, 8H), 6.58 (d, J = 3.0 Hz, 1H), 6.55 (d, J = 2.5 Hz, 1H), 5.10 (s, 
2H), 5.01 (s, 2H), 3.81 (s, 2H), 3.72 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 170.9, 158.5, 155.9, 136.4, 136.3, 135.9, 128.6, 128.5, 128.1, 127.9, 127.5, 126.9, 109.1, 106.5, 
100.9, 70.8, 70.3, 52.2, 42.0. 
 
HRMS (ESI+) 
Calculated for C23H22O4Br: 441.0701 
Found:    441.0705 
 
 
A 40 mL Ichem vial equipped with a stir bar was charged with methyl ester 3.13 (932 mg, 2.11 mmol, 1.0 
equiv), followed by EtOH (10 mL), H2O (10 mL) and KOH (2.37 g, 42.24 mmol, 20 equiv), forming a 
thick suspension. THF (10 mL) was then added. The vial was sealed and stirred vigorously at 60 °C. The 
solids gradually dissolved to form a clear biphasic mixture. After 2 h 15 min, the reaction was cooled to 
RT and transferred to a 125 mL Erlenmeyer flask, rinsing with H2O. With vigorous stirring, the reaction 
was neutralized to pH 3 with 2N HCl at rt. The mixture was transferred to a separatory funnel, rinsing 
with Et2O and H2O. The organic layer was diluted with EtOAc (50 mL). After mixing and phase 
separation, the aqueous layer was extracted with EtOAc (50 mL). The combined organics were washed 
with brine (50 mL × 2), dried over MgSO4, filtered and concentrated in vacuo to give 3.14 as a white 
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solid that was used directly for the next step without purification. 1H-NMR (500 MHz, CDCl3): δ 7.47-
7.44 (m, 2H), 7.42-7.30 (m, 8H), 6.59 (d, J = 2.5 Hz, 1H), 6.56 (d, J = 2.5 Hz, 1H), 5.10 (s, 2H), 5.00 (s, 
2H), 3.85 (s, 2H). 
 
 
A flame-dried 25 mL Schlenk flask equipped with a stir bar was charged with acid 74-3 obtained above, 
and DMAP (28.2 mg, 0.23 mmol, 0.11 equiv). CH2Cl2 (18 mL) was added, followed by 
trimethylsilylethanol (0.61 mL, 4.26 mmol, 2.0 equiv). EDC.HCl (445 mg, 2.32 mmol, 1.1 equiv) was 
added as a solid. The reaction was stirred for 18 h at RT, then transferred to a separatory funnel. The 
organic layer was washed sequentially with H2O, 1N HCl and sat. NaHCO3, then with brine, dried over 
MgSO4, filtered and concentrated in vacuo. The crude product was purified by SiO2 column 
chromatography (10-20% EtOAc/hexanes) to give a white cloudy liquid 3.9 (1.27 g, 71% yield over 2 
steps) that turned into a white solid after storage in the freezer. 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.59, visualized by UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.54-7.34 (m, 10 H), 6.80 (d, J = 2.5 Hz, 1H), 6.75 (d, J = 2.5 Hz, 1H), 5.22 (s, 3H), 5.11 (s, 
3H), 4.21-4.17 (m, 2H), 3.79 (s, 2H), 1.02-0.98 (m, 2H), 0.04 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 170.6, 158.5, 155.9, 136.4 (2C), 136.2, 128.6, 128.5, 128.1, 127.9, 127.6, 127.0, 109.2, 106.6, 
101.0, 70.9, 70.3, 63.3, 42.4, 17.2, -1.5. 
 
HRMS (ESI+) 
Calculated for C27H32O4SiBr: 527.1253 
Found:    527.1261 
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A mixture of the MIDA boronate 3.7 (963 mg, 2.5 mmol) in THF (23 mL) and 1N NaOH (7.5 mmol, 7.5 
mL) was stirred under ambient atmosphere and temperature for 20 min. The reaction was quenched with 
the addition of saturated aqueous NH4Cl (20 mL). The mixture was transferred to a separatory funnel, 
diluting with Et2O (20 mL). After mixing and phase separation, the aqueous phase was extracted with 
Et2O (10 mL). The combined organics were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo. The residue was transferred into an oven-dried 40 mL vial as a solution in DCM. 
The solution was concentrated and dried on high vac to give a white semi-solid which was used directly 
in the next reaction. 
To the vial containing the boronic acid was added a stir bar, bromide 3.8 (302 mg, 1 mmol), Ag2O (603 
mg, 2.6 mmol), and K2CO3 (719 mg, 5.2 mmol). The vial was taken into the glovebox and Pd[P(o-tol)3]2 
(179 mg, 0.25 mmol) was added into the vial. The vial was then sealed with a septum cap and removed 
from the glovebox. THF (15 mL) was added and the reaction was stirred at 60 °C in a heating block for 
11.5 h. The reaction was cooled to RT, then dilted with EtOAc and filtered through celite. To the solution 
containing the crude product was added celite, and the mixture concentrated in vacuo. The celite pad was 
loaded onto a silica gel column for purification (15 to 20 to 25% acetone/hexanes). The fractions were 
concentrated to give a yellow solid, which was taken p in 40% EtOAc/hexanes and loaded onto a second 
silica gel column (5 cm length). The yellow impurity was removed by eluting with 40% EtOAc/hexanes. 
The product was eluted with 60 to 80% EtOAc/hexanes. A white solid was obtained as the pure product 
3.15 (208 mg, 46%) after concentrating the fractions. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 6.55 (d, J = 4.0 Hz, 1H), 6.04 (d, J = 3.5 Hz, 1H), 4.33 (d, J = 21 Hz, 2H), 4.11-4.07 (m, 3H), 
2.85 (s, 3H), 2.74 (t, J = 9.5 Hz, 2H), 1.86-1.79 (m, 2H), 1.22 (d, J = 7.5 Hz, 3H), 1.07 (m, 21H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.9, 160.3, 119.5, 105.8, 68.7, 62.2, 47.6, 38.8, 24.4, 23.7, 23.7, 18.5 (2C), 13.2.  
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A mixture of the MIDA boronate 3.15 (43 mg, 0.095 mmol) in THF (1 mL) and 1N NaOH (0.3 mmol, 0.3 
mL) was stirred under ambient atmosphere and temperature for 30 min. The reaction was quenched with 
the addition of saturated aqueous NH4Cl (1 mL). The mixture was transferred to a separatory funnel, 
diluting with Et2O (2 mL). After mixing and phase separation, the aqueous phase was extracted with Et2O 
(2 mL). The combined organics were washed with brine, dried over MgSO4, filtered and transferred into 
20 mL vial as a solution in Et2O/THF (8mL). The solution was concentrated to a final volume of 3 mL 
under Ar. A 7 mL vial was charged with a stir bar, bromide 3.9 (23.7 mg, 0.045 mmol), G2-XPhos 
palladacycle (3.5 mg, 0.0045 mmol), and K3PO4 (57.3 mg, 0.27 mmol). The vial was evacuated and filled 
with Ar (×4). 1mL of the boronic acid was transferred into the reaction via syringe under Ar. The 
remaining 2 mL of the solution was added slowly into the reaction mixture with a syringe pump at a rate 
of 1.4 mL/h, with the reaction stirring at 55 °C in a heat block. After the addition, the reaction was stirred 
for another 12 h at the same temperature. The reaction was then cooled to RT, then filtered through celite, 
eluting with Et2O. The filtrate was concentrated in vacuo to a black residue, which was purified by silica 
gel chromatography (35 to 45 to 50% DCM/hexanes). The pure product was obtained as a colorless oil 
(29.2 mg, 87%). 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.50-7.48 (m, 2H), 7.43-7.39 (m, 4H), 7.37-7.32 (m, 3H), 7.31-7.28 (m, 1H), 6.77 (d, J = 2.5 Hz, 
1H), 6.68 (d, J = 2.5 Hz, 1H), 6.37 (d, J = 3.0 Hz, 1H), 6.10 (d, J = 3.0 Hz, 1H), 5.14 (s, 2H), 5.13 (s, 2H), 
4.14-4.08 (m, 3H), 3.64 (d, J = 1.5 Hz, 2H), 2.75 (t, J = 8.0 Hz, 2H), 1.92-1.80 (m, 2H), 1.24 (d, J = 6.5 
Hz, 3H), 1.09-1.08 (m, 21H), 0.98-0.95 (m, 2H), 0.03 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 171.6, 160.2, 158.8, 155.8, 148.1, 138.2, 138.1, 137.1, 129.3, 129.1, 128.7, 128.5, 128.4, 128.0, 
115.4, 112.0, 110.2, 106.6, 100.3, 70.9, 70.6, 68.7, 63.0, 40.9, 38.8, 24.5, 23.8, 18.6, 18.5, 17.9, 13.2, -1.5. 
 
HRMS (ESI+) 
Calculated for C44H63O6Si2 743.4163 
Found:    743.4166 
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In an oven-dried 3-neck 1000 mL RBF, a solution of (S)-4-benzyloxazolidin-2-one (25.35 g, 143.08 
mmol), crotonic acid (24.81 g, 288.2 mmol), and DMAP (2.28 g, 18.67 mmol) in anhydrous CH2Cl2 (500 
mL) was cooled to 4 °C (internal temp) under N2 using an ice-water bath.  To this was added DCC (59.12 
g, 286.55 mmol), causing an exotherm (internal temperature rose to ~10 °C).  After approximately 10 min, 
a precipitate began to form.  After 18 h, TLC showed full consumption of the acid while oxazolidinone 
remained.  Another portion of crotonic acid (6.15 g, 71.42 mmol) and DCC (14.52 g, 70.37 mmol) were 
added at 0 °C and the reaction was stirred and warmed to RT for a further 3 h.  The reaction was filtered 
through a Buchner funnel, rinsing with CH2Cl2 (150 mL).  The filtrate was then washed with sat. 
NaHCO3 (200 mL), 1:1 sat. NaHCO3/water (200 mL), and water (200 mL).  The aqueous layer was then 
extracted with CH2Cl2 (200 mL).  The combined organics were then dried over Na2SO4, filtered, and 
concentrated in vacuo to give a thick orange slurry.  After storage overnight under nitrogen at 0 °C, the 
slurry was taken up in a minimum of CH2Cl2, loaded onto Celite, and purified by column chromatography 
(9 cm × 13 cm height, equilibrated with CH2Cl2, gradient: 100% DCM to 2.5% EtOAc/DCM to 5% 
EtOAc/DCM).  The resulting product was still impure, so was passed through another silica gel column 
(9 cm x 8 cm, CH2Cl2) before recrystallizing from a minimum of hot EtOAc to yield 3.21 (21.37 g , 61% 
yield) as a waxy solid. 1H-NMR matches literature data.3 (46) The solid was further dried by azeotroping 
with toluene (2 × 100mL) and drying under high vacuum (~3 h). 
 
 
An oven-dried 1000 mL RBF was fitted with a stir-bar, a cryogenic thermometer, an addition funnel, and 
an N2/vacuum inlet.  The warm flask was then vac/N2-filled (3 ×) before adding THF (340 mL) and 
iPr2NH (13.5 mL, 96.3 mmol) and cooling to -70 oC.  nBuLi (1.6 M in hexanes, 60.0 mL, 96 mmol) was 
then added to the addition funnel via syringe before adding to the reaction over ~25 min.  After stirring at 
-70 oC for a further 25 min, HMPA (16.7 mL, 96.0 mmol) was added in a dropwise fashion (via the 
addition funnel, over ~10 min).  The solution was allowed to stir at -70 °C for approximately 1 h. A 
separate 500 mL single neck rbf containing imide 3.21 was vac/N2-filled (3 ×).  The white solid was then 
taken up in THF (120 mL) with stirring.  This solution was then added to the addition funnel via syringe 
and added to LDA solution in a slow, dropwise manner (-68 to -70 °C, over ~50 min) giving a translucent 
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orange solution which was stirred for a further 30 minutes at this temperature before adding neat MeI 
(16.5 mL, 265 mmol) in a dropwise manner (over ~35 min) at -70 °C.  The yellow solution was stirred at 
-70 °C for 1 h and then the iPrOH/dry ice bath was replaced with an ice/brine bath, allowing it to stir for 
45 min before warming to room temperature and stirring for another 30 min.  The reaction was then again 
placed in an ice/brine bath and quenched with sat. NH4Cl (300 mL).  The mixture was then transferred to 
a separatory funnel, rinsing with Et2O.  After mixing and phase separation, the aqueous layer was 
extracted with Et2O (3 × 250 mL).  The combined organic layers were washed with brine (200 mL), dried 
over MgSO4, filtered and concentrated in vacuo to give a fluorescent yellow oil.  Crude 1H NMR showed 
with a d.r. of 3.6:1 (desired:undesired diastereomer).  The desired diastereomer was purified by splitting 
the crude material into two batches and running two columns on each batch (for four total columns).  
Gradient: 100% hexanes to 7.5% EtOAc/hexanes, in 2.5% increments.  The columns gave 3.22 (9.67 g, 
43% yield) as a colorless oil with a d.r. of >20:1 by 1H NMR. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.36 – 7.27 (m, 3H), 7.24 – 7.19 (m, 2H), 5.98 (ddd, J = 17.2, 10.3, 7.7 Hz, 1H), 5.20 (dt, J = 17.3, 1.1 
Hz, 1H), 5.14 (dt, J = 10.3, 1.0 Hz, 1H), 4.66 (ddd, J = 10.5, 7.2, 3.7 Hz, 1H), 4.46 (dtd, J = 7.8, 6.9, 5.9 
Hz, 2H), 4.23 – 4.15 (m, 1H), 3.29 (dd, J = 13.4, 3.3 Hz, 1H), 2.78 (dd, J = 13.4, 9.6 Hz, 1H), 1.35 (d, J = 
6.9 Hz, 3H). 
 
 
A solution of imide 3.22 (9.67 g, 37.3 mmol) in Et2O (300 mL) was cooled to ~0 oC in an ice/brine bath, 
stirring for ~15 minutes before adding H2O (1.68 mL, 93.3 mmol) via syringe.  With vigorous stirring, 
LiBH4 (2.04 g, 93.7 mmol) was added in four portions in a slow, cautious manner (a vigorous exotherm 
was noted, with effervescence).  After the addition was complete, the flask was fitted with a rubber 
septum which had already been pierced with a N2 inlet needle and vent needle.  The mixture was stirred in 
the ice/brine bath for 1.5 h before being warmed to room temperature and stirring for 40 min.  TLC 
analysis (20% EtOAc/hexanes) showed no remaining starting material.  The reaction mixture was cooled 
in an ice/water bath for ~5 min before being quenched with sat. Rochelle’s salt (70 mL, added slowly via 
addition funnel).  The biphasic reaction mixture was vigorously stirred for 10 min before being 
transferred to a separatory funnel.  After mixing and phase separation, the organic layer was drained into 
a RBF containing sat. Rochelle’s salt (150 mL) and stirred for 1 hour.  The combined aqueous layers were 
extracted (2 × 100 mL Et2O).  The combined organic layers were then washed with brine  (100 mL), dried 
over Na2SO4, filtered, and concentrated to ~35 mL (house vacuum, room temperature), at which point, 
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oxazolidinone side product had begun crystallizing out.  To this solution was added 150 mL pentane, 
which caused the precipitation of more oxazolidinone.  This mixture was filtered, washing the solids with 
~50 mL of 30% Et2O/pentane.  The resulting cloudy filtrate was loaded directly atop a silica gel column 
(5 cm x 7 cm height) and eluted (gradient: 30% Et2O/pentane to 40% Et2O/pentane to 50% Et2O/pentane).  
The product came off in ~1000 mL of eluent, which was concentrated to give a solution of the product 
alcohol 3.23 (1H NMR calculation: 2.36 g, 74% yield) in Et2O/pentane, which was used directly in the 
next step. A small sample had the solvents fully removed to give enough pure alcohol to obtain an optical 
rotation which is in agreement with the known literature value. 1H-NMR matches literature data.4  
[α]D24: -29.8 (c=1.42, CHCl3). 
 
 
A flask containing a concentrated solution of alcohol 3.23 (2.36 g, 27.4 mmol) in Et2O/pentane was 
charged with a stir bar and CH2Cl2 (70 mL).  The solution was then stirred in an ice/water bath and cooled 
for 15 min, during which DMAP (402.8 mg, 3.3 mmol) and Et3N (11.5 mL, 82.5 mmol) were added.  
After cooling, pTsCl (6.28 g, 32.9 mmol) was added under ambient atmosphere, rinsing the funnel with 
another portion of CH2Cl2 (20 mL).  The flask was then fitted with a rubber septum, purged with N2 for 
~5 minutes, and then allowed to stir under N2 for 15 h, gradually warming to room temperature. TLC 
showed no remaining starting material (20% EtOAc/hexanes).  The reaction was then quenched with 
water (50 mL).  The biphasic mixture was stirred rapidly for 10 min before transferring to a separatory 
funnel.  After mixing and phase separation, the aqueous layer was extracted with CH2Cl2 (2 × 75 mL).  
The combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo to ~20 mL.  To 
this solution was added several scoops of Celite, and the solvent was removed in vacuo to give the crude 
product loaded on Celite.  This was loaded atop a silica gel column equilibrated with 5% Et2O/hexanes.  
Gradient: 5% Et2O/hexanes to 7.5% Et2O/hexanes to 10% Et2O/hexanes.  The fractions containing 
product were concentrated to give 3.24 (5.06 g, 77% yield) as a colorless oil. 
 
TLC (10% EtOAc/hexanes) 
Rf = 0.34, visualized by UV, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.76 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 5.60 (ddd, J = 17.3, 10.4, 7.0 Hz, 1H), 5.05 – 
4.98 (m, 2H), 3.89 (dd, J = 9.4 and 6.4 Hz, 1H), 3.82 (dd, J = 9.4 and 6.8 Hz, 1H), 2.53 – 2.45 (m, 1H), 
2.42 (s, 3H), 0.98 (d, J = 6.8 Hz, 3H). 
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13C-NMR (125 MHz, CDCl3) 
δ 144.8, 138.4, 133.0, 129.9, 127.9, 116.0, 74.0, 37.0, 21.7, 16.0. 
 
HRMS (ESI+) 
Calculated for NaC12H16O3S: 263.0718 
Found:    263.0716 
 
 
Note: this reaction was done in duplicate, and the two vials were combined for workup. An oven-dried 40 
mL vial was charged with tosylate 3.24 (1.01 g, 4.19 mmol), sealed with a septum cap, and then vac/filled 
with N2 (×3).  CH2Cl2 (10.0 mL) was then added via syringe, followed by a solution of HBBr2▪SMe2 (1.0 
M in CH2Cl2, 5.0 mL, 5.0 mmol) at room temperature.  The vial was then placed in a 40 °C heating block 
and allowed to stir for 10 h.  1H NMR of an aliquot of the reaction revealed nearly complete conversion. 
Separately, a rbf flask containing 100 mL Et2O and 50 mL water was cooled to 0 °C in an ice bath.  The 
two vials containing the reaction mixtures were cannulated into this rbf in a dropwise fashion with 
vigorous stirring.  After stirring for ~10 min, the biphasic mixture was transferred to a separatory funnel.  
After mixing and phase separation, the aqueous layer was extracted with Et2O (2 × 100 mL).  The 
combined organics were washed with brine (100 mL), dried over Na2SO4, and vacuum filtered.  The 
solution was then concentrated to ~15 mL of a cloudy mixture and used directly in the next step.  
To the solution of the boronic acid in a rbf was added MIDA (1.53 g, 10.4 mmol), and a PhH:DMSO 
mixture (10:1, 88 mL). The rbf was then fitted with a Dean-Stark trap and a water-cooled condenser.  The 
mixture was stirred and refluxed for 1 h, after which TLC showed complete conversion.  The reaction 
mixture was cooled to room temperature and transferred to a separatory funnel containing 1:1 brine/water 
(100 mL) and EtOAc (100 mL), rinsing with EtOAc.  After mixing and phase separation, the aqueous 
layer was extracted with EtOAc (100 mL).  The combined organics were then washed with 1:1 
brine/water (100 mL), brine (100 mL), and then dried over Na2SO4.  After filtration, the solution was 
concentrated, giving a viscous oil.  This oil was diluted with acetone (~5 mL) before adding hexanes (100 
mL) in a slow, dropwise fashion via addition funnel, causing a white powdery solid to precipitate.  The 
white solid was collected by vacuum filtration and then dried under high vacuum to give 3.25 (2.14 g, 
64% yield). 
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TLC (50% acetone/hexanes) 
Rf = 0.31, visualized by UV, stained by KMnO4. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.81 (d, J = 8.3 Hz, 2H), 7.48 (d, J = 7.9 Hz, 2H), 4.17 (d, J = 16.9 Hz, 2H), 4.00 (d, J = 16.9 
Hz, 2H), 3.96 (dd, J = 9.6, 5.5 Hz, 1H), 3.86 (dd, J = 9.5, 6.5 Hz, 1H), 3.06 (s, 3H), 2.46 (s, 3H), 1.74 (dq, 
J = 12.9, 6.5 Hz, 1H), 1.45 – 1.36 (m, 1H), 1.19 (dddd, J = 13.8, 12.3, 7.5, 4.8 Hz, 1H), 0.88 (d, J = 6.7 
Hz, 3H), 0.61 (dt, J = 13.2, 4.8 Hz, 1H), 0.51 (dt, J = 13.2, 4.9 Hz, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.7, 145.7, 134.5, 130.8, 128.7, 75.8, 62.7, 46.3, 35.9, 28.0, 21.5, 16.6. 
 
HRMS (ESI+) 
Calculated for C17H25BNO7S: 398.1445 
Found:    398.1451 
 
 
A flame-dried 40 mL vial was charged with MIDA boronate 3.25 (761.8 mg, 1.92 mmol) and NaI (444.6 
mg, 2.97 mmol).  Acetone (6.0 mL, HPLC grade) was added via syringe under a positive pressure of N2.  
The reaction was then stirred for 13 h in a 60 °C heating block before TLC showed complete conversion.  
The reaction mixture was then poured into a separatory funnel containing EtOAc (100 mL) and water 
(100 mL), rinsing once with EtOAc.  Upon shaking, a persistent emulsion formed.  After adding brine (30 
mL) and re-shaking, the aqueous layer was extracted with EtOAc (100 mL).  The combined organic 
layers were then washed with sat. Na2S2O3 (2 × 50 mL) and brine (100 mL), dried over Na2SO4, filtered 
and concentrated.  The crude product was then taken up in a minimum of acetone and hexanes (100 mL) 
was added in a slow, dropwise fashion via addition funnel causing the product to precipitate out as a fine 
white powder.  This powder was isolated via vacuum filtration and dried overnight under high vacuum to 
give 3.26 (550 mg, 81% yield).  
 
TLC (50% acetone/hexanes) 
Rf = 0.41, visualized by UV, stained by KMnO4. 
 
1H-NMR (500 MHz, acetone-d6) 
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δ 4.20 (d, J = 16.9 Hz, 2H), 4.04 (dd, J = 16.9 and 1.4 Hz, 2H), 3.39 (dd, J = 9.6 and 4.0 Hz, 1H), 
3.29 (dd, J = 9.6 and 5.7 Hz, 1H), 3.13 (s, 3H), 1.49 – 1.39 (m, 2H), 1.38 – 1.29 (m, 1H), 1.00 (d, J = 6.2 
Hz, 3H), 0.69 – 0.62 (m, 2H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.8, 62.6, 46.3, 37.8, 31.6, 20.7, 18.7. 
 
 
HRMS (ESI+)  
Calculated for C10H18BNO4I: 354.0374 
Found:    354.0372. 
 
 
The following procedure was modified from a known literature procedure.5 An oven-dried 1L 3-neck rbf 
equipped with a thermometer and stir bar was added Cp2ZrCl2 (30.56 g, 104.5 mmol, 1.15 equiv). The 
flask was sealed with rubber septa and evacuated and back-filled with Ar (×3). THF (225 mL) was added 
via cannula. The solution was cooled to an internal temperature of 4 °C in an ice-water bath. DiBAlH 
solution (1 M in THF, 100 mL, 100 mmol, 1.1 equiv) was cannulated into the rbf, keeping the internal 
temperature at 3-4 °C. The addition took 23 min. The reaction was then stirred at 3 °C for 30 min. 
Phenyldimethylsilylethylene (16.1 mL, 91.1 mmol, 1.0 equiv) was added neat via syringe at the same 
temperature over 10 min. The reaction was then allowed to warm to 18 °C over 3 h. The reaction was 
then cooled to -69 °C (internal temperature) in a dry ice/IPA bath. Under air, solid I2 (30.0 g, 118.18 
mmol, 1.3 equiv) was added to a graduated conical flask containing THF (150 mL). The flask was sealed 
with a rubber septum and stirred to dissolve the I2. The solution was then cannulated into the reaction 
flask under Ar, maintain the internal temperature at ≤ -65 °C. The addition took 1 h 15 min. After the 
addition was complete, the reaction was stirred at – 70 °C for 1.5 h. The dry ice bath was removed and the 
reaction quenched with 1N HCl (200 mL). The mixture was stirred vigorously, then transferred to a 2L 
separatory funnel and extracted with Et2O (100 mL). The aqueous layer was extracted with Et2O (100 
mL). The combined organics were washed with sat. aq. Na2S2O3 (200 mL), brine, dried over MgSO4, 
filtered and concentrated in vacuo. During solvent removal, a large amount of solids precipitated. To the 
concentrated residue was added hexanes (150 mL). The suspension was filtered to remove the orange 
solids, rinsing with hexanes (100 mL). The filtrate was concentrated to a yellow oil. The product was 
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purified by a total of 3 SiO2 columns (hexanes) to the pure product as a colorless oil 3.20 (15.66 g, 60% 
yield). 
 
TLC (hexanes) 
Rf = 0.57, visualized by UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.52-7.51 (m, 2H), 7.41-7.38 (m, 3H), 7.20 (d, J = 16.5 Hz, 1H), 6.75 (d, J = 16.0 Hz, 1H), 0.38 
(s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 148.3, 136.5, 133.7, 129.5, 128.0, 91.5, -2.9. 
 
 
Formation of the organozinc reagent:  Iodide 3.26 (1.36 g, 3.85 mmol) was weighed into an oven-dried 40 
mL vial.  This and another empty vial were taken into the glove box.  THF (4.5 mL) and DMF (1.5 mL) 
were added to dissolve the iodide.  The other vial was charged with Zn dust (754.6 mg, 11.54 mmol) and 
a magnetic stir bar before sealing both vials and removing from the glove box.  Under a positive pressure 
of N2, TMSCl and 1,2-dibromoethane were added to the vial containing the Zn dust (three drops each 
from a 25 gauge needle).  This was stirred briefly before transferring the iodide 3.26 solution to this vial 
via syringe.  The vial was then rinsed with another portion of THF (1.4 mL).  The vial was placed into a 
45 oC heating block for 2 h.  At this point, a small aliquot was removed, quenched with sat. NH4Cl, and 
extracted with EtOAc.  1H NMR of the extract showed full conversion.  The reaction vial was then taken 
into the glove box and filtered through an HPLC iso-disc syringe-tip filter into a dry 40 mL vial.  This 
colorless solution was stored in the glove box for approximately 36 h before use in the next step. 
In the glovebox, (E)-(2-iodovinyl)dimethyl(phenyl)silane 3.20 (1.12 g, 3.90 mmol) was weighed into the 
40 mL vial, followed by the addition of THF (8.6 mL) and DMF (2.1 mL).  RuPhos (182 mg, 0.390 mmol) 
and Pd2(dba)3 (90.1 mg, 0.0984 mmol) were then added to the solution in that order.  The vial was then 
sealed and removed from the glove box, along with the vial containing the solution of alkylzinc prepared 
above.  The vial containing the catalyst was placed into a 60 oC heating block and had a N2 inlet needled 
inserted into the septum.  The alkylzinc solution was then slowly added to this vial with the assistance of 
a syringe pump (~75 min).  The reaction stirred for a total of 8 h (from the beginning of the addition). The 
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reaction was then cooled to room temperature and transferred to a separatory funnel containing sat. 
NH4Cl (80 mL) and EtOAc (60 mL).  The vial was rinsed with a further 20 mL EtOAc.  After shaking, a 
persistent emulsion formed which was resolved by adding a small amount (~5 mL) of brine and remixing.  
After phase separation, the aqueous layer was extracted with EtOAc (80 mL).  The combined organic 
layers were then washed with 1:1 water:brine (100 mL) and brine (100 mL).  The organic layers were 
then stirred over MgSO4 and Darco before filtering through Celite.  1H NMR of the crude mixture showed 
product to be the primary component.  The crude mixture was dry loaded onto Celite and then purified by 
column chromatography (silica gel, equilibrated with 20% acetone/hexanes, gradient: 20% to 25% to 30% 
acetone/hexanes) to give 3.27 (1.003 g, 67% yield) as a slightly off-white foam. 
 
TLC (50% acetone/hexanes) 
Rf = 0.53, visualized by UV, stained by KMnO4. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.56 – 7.52 (m, 2H), 7.38 – 7.33 (m, 3H), 6.15 (dt, J = 18.5, 6.8 Hz, 1H), 5.79 (dt, J = 18.5, 1.4 
Hz, 1H), 4.17 (d, J = 16.9 Hz, 2H), 4.00 (dd, J = 16.8, 3.7 Hz, 2H), 3.07 (s, 3H), 2.25 (dddd, J = 13.5, 6.6, 
5.3, and 1.6 Hz, 1H), 2.03 – 1.95 (m, 1H), 1.56 – 1.48 (m, 1H), 1.46 – 1.37 (m, 1H), 1.23 (dddd, J = 13.6, 
12.2, 7.3, 4.8 Hz, 1H), 0.89 (d, J = 6.7 Hz, 3H), 0.72 – 0.56 (m, 1H), 0.31 (s, 6H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.8, 149.2, 139.9, 134.6, 129.7, 129.6, 128.6, 62.7, 46.3, 45.0, 36.0, 31.8, 19.7, -2.2.. 
 
HRMS (ESI+) 
Calculated for C20H31NO4SiB: 388.2115 
Found:    388.2112 
 
 
A vial containing vinyl silane 3.27 (176.9 mg, 0.46 mmol) was charged with a stir bar and HFIPA (2.0 
mL).  The mixture was then sonicated briefly to give a homogenous solution.  The vial was then cooled to 
0 oC in an ice-water bath before adding 2,6-lutidine (40 μL, 0.34 mmol) under ambient atmosphere.  NIS 
(156.4 mg, 0.70 mmol) was then added in three portions over about 2 min, yielding a purple/red mixture.  
The mixture was then stirred in the ice-water bath for 70 min before TLC showed complete conversion. 
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Sat. Na2S2O3 (5 mL) was added at 0 oC and the mixture was stirred for 10 min, after which a faint yellow 
color remained.  The reaction mixture was transferred to a separatory funnel containing EtOAc (10 mL) 
and sat. Na2S2O3 (10 mL).  After shaking and phase separation, the aqueous layer was extracted with 
EtOAc (15 mL).  The combined organic layers were washed with brine (20 mL), dried over Na2SO4, and 
treated with Darco before filtering.  This solution was concentrated to give a colorless sticky residue.  
This residue was taken up into a minimum of acetone (~1 mL) and 50 mL of hexanes was dripped into 
this solution with vigorous stirring in a slow, dropwise manner via addition funnel, precipitating an off-
white powder.  This off-white powder was isolated via vacuum filtration and dried under high vacuum to 
give 3.18 (104.1 mg, 60% yield). 
 
TLC (50% acetone/hexanes) 
Rf = 0.50, visualized by UV, stained by KMnO4. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 6.54 (dt, J = 14.9 and 7.6 Hz, 1H), 6.14 (d, J = 14.3 Hz, 1H), 4.17 (d, J = 16.9 Hz, 2H), 4.01 (dd, 
J = 16.9 and 1.7 Hz, 2H), 3.10 (s, 3H), 2.80 (d, J = 16.9 Hz, 3H), 2.18 – 2.11 (m, 1H), 1.96 – 1.89 (m, 
1H), 1.56 – 1.46 (m, 1H), 1.44 – 1.34 (m, 1H), 1.26 – 1.17 (m, 1H), 0.88 (d, J = 6.7 Hz, 3H), 0.71 – 0.55 
(m, 2H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.8, 146.7, 75.7, 62.6, 46.2, 43.5, 35.7, 31.5, 19.4. 
 
HRMS (ESI+) 
Calculated for C12H20BNO4I: 380.0530 
Found:    380.0527 
 
 
In an unoptimized procedure, to a solution of tert-butylmethacrylate (5 mL, 30.77 mmol, 1.0 equiv) in 
CCl4 (100 mL) was added neat bromine (1.6 mL, 31.38 mmol, 1.02 equiv) slowly over 1 min under 
ambient atm. The rbf was sealed with a rubber septum and the reaction stirred under an N2 atm, warming 
to RT overnight. The reaction was stirred for 17.5 h, then 1M Na2S2O3 (50 mL) was added to quench the 
reaction. The mixture was stirred vigorously until the organic layer turns from red-orange to colorless. 
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The layers were separated and the aqueous phase extracted with CH2Cl2 (50 mL × 2). The combined 
organics were washed with brine, dried over MgSO4, filtered and concentrated to give a colorless liquid, 
which was a mixture of the dibromide and the starting material in a ratio of 8.5:1. This material was 
dissolved in THF and cooled to 0 °C. DBU was added neat via syringe under ambient atm over 3 min. 
The reaction was stirred for 17 h. H2O (100 mL) and Et2O (100 mL) was added and the mixture stirred 
vigorously. The layers were separated and the aqueous layer extracted with Et2O (50 mL). The combined 
organics were washed with brine, dried over MgSO4, filtered and concentrated in vacuo to give an orange 
liquid which was purified by SiO2 column chromatography (20%-30% DCM/hexanes), giving a colorless 
liquid which was a mixture of the desired vinyl bromide and the dibromide in the ratio 12:1. This material 
was resubjected to the reaction using DBU (0.9 mL, 6 mmol) and THF (100 mL) to consume the 
remaining dibromide. The reaction was subjected to the same work-up procedure described above and 
purified by SiO2 column chromatography, giving the pure product 3.19 as a colorless liquid (4.09 g, 60% 
yield over 2 steps).  1H-NMR matches literature data.6 
 
 
A mixture of the MIDA boronate 3.28 (1.00 g, 2.71 mmol) in THF (27 mL) and 1N NaOH (8.2 mmol, 8.2 
mL) was stirred under ambient atmosphere and temperature for 20 min. The reaction was quenched with 
the addition of saturated aqueous NH4Cl (25 mL). After briefly stirring, the mixture was transferred to a 
separatory funnel, rinsing with Et2O (10 mL). After mixing and phase separation, the aqueous phase was 
extracted with Et2O (2 × 25 mL). The combined organics were washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo. The residue was taken up in Et2O (5 mL), causing some white solid to 
precipitate. The some suspension was filtered through celite, eluting with Et2O (10 mL). The filtrate was 
collected in a 40 mL vial. The solution was concentrated in vacuo to give a white foamy solid which was 
used in the coupling reaction. 
A flame-dried 40 mL vial was charged with iodide rac-3.18 (303 mg, 0.8 mmol), Pd(OAc)2 (9.0 mg, 0.04 
mmol), and Ag2O (556 mg, 2.4 mmol). The vial was taken into the glovebox. K2CO3 (663 mg, 4.8 mmol) 
and dppf (42 mg, 0.076 mmol) were added. The boronic acid in the 40 mL was dissolved in THF (16.9 
mL). 5 mL of this soltion was added to the reaction vial. The vials were sealed with septum caps and 
removed from the glovebox, then placed under N2. The reaction vial was stirred at 45 °C in a heating 
block. A 10 mL syringe was charged with 10mL of the boronic acid solution. The solution was then 
slowly added to the reaction vial with the aid of a syringe pump over 2.5 h. The reaction was stirred for a 
total of 12.5 h. The reaction was cooled to RT, then filtered through celite, rinsing with EtOAc. The crude 
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product was adsorbed onto celite in vacuo. The celite pad was loaded onto a silica gel column equilibrated 
with 20% acetone/hexanes. A white solid 3.29 (176 mg, 47%) was obtained after column purification (20 
to 30 to 40% acetone/hexanes).  
 
1H-NMR (500 MHz, acetone-d6) 
δ 6.31-6.26 (m, 1H), 6.11-6.06 (m, 1H), 5.71-5.62 (m, 2H), 4.31 (app d, J = 5 Hz, 2H), 4.17 (d, J 
= 16.5 Hz, 2H), 4.01 (d, J = 16.5 Hz, 1H), 4.01 (d, J = 16.5 Hz, 1H), 3.09 (s, 3H), 2.18-2.13 (m, 1H), 1.91 
(quint, J = 7.5 Hz, 1H), 1.51-1.38 (m, 2H), 1.10-1.07 (m, 21H), 0.86 (d, J = 6.5 Hz, 3H), 0.71-0.57 (m, 
2H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.7, 133.5, 131.9, 131.2, 130.6, 128.4, 64.3, 62.6, 46.2, 40.5, 36.5, 31.8, 19.6, 18.3, 12.7 
 
HRMS (ESI+) 
Calculated for C24H43NO5SiB: 464.3004 
Found:    464.3007 
 
 
A mixture of the MIDA boronate 3.29 (33.1 mg, 0.071 mmol) in THF (0.71 mL) and 1N NaOH (0.22 
mmol, 0.22 mL) was stirred under ambient atmosphere and temperature for 20 min. The reaction was 
quenched with the addition of saturated aqueous NH4Cl (1 mL). After briefly stirring, the mixture was 
transferred to a separatory funnel, rinsing with Et2O (2 mL). After mixing and phase separation, the 
aqueous phase was extracted with Et2O (2 × 2 mL). The combined organics were washed with brine, 
dried over MgSO4, filtered and concentrated in vacuo to give the boronic acid which was used directly for 
the coupling. 
 
 
TLC (40% CH2Cl2/hexanes) 
Rf = 0.25, visualized by UV, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
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δ 6.64 (dt, J = 7.5, 1.5 Hz, 1H), 6.32-6.27 (m, 1H), 6.13-6.08 (m, 1H), 5.72-5.64 (m, 2H), 4.31 
(app d, J = 4.5 Hz, 2H), 2.25-2.10 (m, 3H), 2.01-1.95 (m, 1H), 1.76 (d, J = 1.5 Hz, 3H), 1.57 (sextet, J = 
6.5 Hz, 1H), 1.50-1.43 (m, 10 H), 1.30-1.24 (m, 1H), 1.14-1.06 (m, 21H), 0.92 (d, J = 7.0 Hz, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 167.6, 141.2, 132.3, 131.2, 130.5, 129.7, 129.0, 79.9, 63.7, 40.0, 35.2, 33.0, 28.1, 26.3, 19.4, 
18.0, 12.3, 12.0. 
 
HRMS (ESI+) 
Calculated for C27H50O3SiNa: 473.3427 
Found:    473.3430 
 
 
To a solution of 3-bromopropylboronic acid pinacol ester (1.00 g, 4.02 mmol, 1.0 equiv) in a solution of 
THF (4 mL) and H2O (3 mL) was added solid NaIO4 (4.30 g, 20.08 mmol, 5.0 equiv) at 0 °C under 
ambient atm. 1N HCl (8.1 mL, 8.1 mmol, 2.01 equiv) was then added slowly over 3 min. The reaction 
was stirred in the ice-water bath for 3 h, then transferred to a separatory funnel and diluted with H2O (25 
mL) and Et2O (25 mL). After mixing and phase separation, the aqueous layer was extracted with Et2O (25 
mL × 2). The combined organics were washed with sat. aq. Na2S2O3 (25 mL), brine, dried over MgSO4, 
filtered and concentrated to 5 mL. Benzene (25 mL) was added and the solution was concentrated to 20 
mL. Another portion of benzene (25 mL) was added, followed by DMSO and MIDA (591 mg, 4.02 mmol, 
1.0 equiv). The mixture was heated to reflux with a Dean-Stark trap and a water-cooled condenser for 1 h. 
The reaction was then transferred to a separatory funnel containing H2O (50 mL) and EtOAc (50 mL). 
After mixing and phase separation, the aq. layer was extracted with EtOAc (25 mL × 2). The combined 
organics were washed with H2O, brine, dried over MgSO4, filtered and concentrated to give a white solid. 
The solid was washed with Et2O, filtered and dried in vacuo to give the pure product 3.38 (781 mg, 67% 
yield). 
 
1H-NMR (500 MHz, acetone-d6) 
δ 4.21 (d, J = 17.0 Hz, 2H), 4.06 (d, J = 17.0 Hz, 2H), 3.51 (t, J = 7.0 Hz, 2H), 3.12 (s, 3H), 1.95 
– 1.87 (m, 2H), 0.80 – 0.73 (m, 2H). 
 
13C-NMR (125 MHz, acetone-d6) 
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δ 168.7, 62.7; 46.3, 37.7, 29.1. 
 
HRMS (ESI+) 
Calculated for C8H14NO4BrB: 278.0199 
Found:    278.0195 
 
 
MIDA boronate 3.38 (825 mg, 2.97 mmol, 1.0 equiv) and NaI (1.56 g, 10.39 mmol, 3.5 equiv) were 
added into a 40 mL Ichem vial equipped with a stir bar. Under ambient atm, acetone (20 mL) was added. 
The vial was sealed with a PTFE-lined cap and stirred at 60 °C for 4 h. This reaction was carried out in 
quadruplicate. The reactions were cooled to RT, then combined and filtered through celite, rinsing with 
EtOAc. The filtrate was concentrated in vacuo to give a yellow viscous liquid. EtOAc (100 mL) was 
added and the solution transferred to a separatory funnel containing H2O (100 mL), rinsing with EtOAc 
(100 mL). After mixing and phase separation, the aqueous layer was extracted with EtOAc (60 mL × 2). 
The combined organics were washed with sat. aq. Na2S2O3 (50 mL × 2). The organic phase was washed 
with brine, dried over MgSO4, filtered and concentrated to give a white solid. To the white solid was 
added acetone (approx. 3 mL), Et2O (25 mL) and hexanes (50 mL) sequentially. The mixture was stirred 
for 5 min, then vacuum filtered. The product 3.39 (3.68 g, 95% yield) was obtained as a white solid after 
drying in vacuo. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 4.21 (d, J = 17.0 Hz, 2H), 4.05 (d, J = 17.0 Hz, 2H), 3.31 (t, J = 7.0 Hz, 2H), 3.12 (s, 3H), 1.94 
– 1.85 (m, 2H), 0.79 – 0.71 (m, 2H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.7, 62.6, 46.3, 30.0, 11.6. 
 
HRMS (ESI+) 
Calculated for C8H14NO4IB: 326.0061 
Found:    326.0061 
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A flame-dried 20 mL vial equipped with a stir bar was charged with Zn dust (588 mg, 9 mmol, 3.0 equiv). 
A separate flame-dried 7 mL vial equipped with a stir bar was charged with MIDA boronate 3.39 (975 mg, 
3.0 mmol, 1.0 equiv). DMF (2 mL) and THF (3.5 mL) were added to dissolve 3.39.  Under Ar, 3 drops of 
TMSCl followed by 3 drops of 1,2-dibromoethane were added sequentially to the vial containing Zn dust 
from a syringe with a 25 gauge needle. With stirring, the solution containing 3.39 was transferred to this 
vial via syringe, rinsing with THF (0.5 mL). The reaction was stirred at 45 °C for 1.5 h. The vial was 
taken into the glovebox and stored at RT overnight. In the glovebox, a flame-dried 40 mL vial was 
charged with vinyl iodide 3.20 (1.32 g, 4.13 mmol, 1.5 equiv), RuPhos (128 mg, 0.275 mmol, 0.1 equiv) 
and Pd2dba3 (63 mg, 0.069 mmol, 0.025 equiv), followed by DMF (7 mL). The organozinc solution (5.5 
mL) was added, followed by THF (14 mL). The vial was sealed with a PTFE-lined cap, removed from the 
glovebox and stirred at 60 °C for 7 h. The reaction was cooled to rt and quenched with sat. aq. NH4Cl (25 
mL). The aqueous layer was extracted with EtOAc (25 mL × 2). The combined organics were washed 
with H2O, brine, dried over MgSO4, filtered and concentrated in vacuo. The crude product was purified 
by SiO2 column chromatography (20-30-35% acetone/hexanes). The pure fractions containing product 
were concentrated in vacuo and the resulting solid triturated with acetone/hexanes to give a white solid. 
The supernatant was combined with mixed fractions from the column and re-subjected to SiO2 column 
purification. The solids obtained were combined to give the pure product 3.41 (588 mg, 60% yield). 
 
TLC (50% acetone/hexanes) 
Rf = 0.58, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.56 – 7.51 (m, 2H), 7.37 – 7.30 (m, 3H), 6.18 (dt, J = 18.5, 6.5 Hz, 1H), 5.79 (dt, J = 18.5, 1.5 
Hz, 1H), 4.17 (dt, J = 17.0 Hz, 2H), 4.00 (d, J = 16.9 Hz, 2H), 3.07 (s, 3H), 2.25 – 2.16 (m, 2H), 1.53 – 
1.45 (m, 2H), 0.68 – 0.63 (m, 2H), 0.30 (s, 6H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.8, 150.3, 139.9, 134.5, 129.6, 128.5, 128.0, 62.6, 46.2, 40.7, 24.2, -2.3. 
 
HRMS (ESI+) 
Calculated for C18H27BNO4Si: 360.1802 
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Found:    360.1797 
 
 
A flame-dried 10 mL Schlenk flask equipped with a stir bar was charged with vinyl silane 3.41 (500 mg, 
1.39 mmol, 1.0 equiv). HFIPA (5.6 mL) was added via syringe. The solution was cooled in an ice-brine 
bath. 2,6-lutidine (0.115 mL, 0.97 mmol, 0.7 equiv) was added. After 10 min, N-iodosuccinimide (470 
mg, 2.09 mmol, 1.5 equiv) was added as a solid in one portion. The reaction was stirred at the same 
temperature for 1 h, then quenched with sat. aq. Na2S2O3 (5 mL). The mixture was stirred vigorously for 5 
min, then partitioned between EtOAc (20 mL) and H2O (10 mL). The aqueous layer was extracted with 
EtOAc (20 mL). The combined organics were washed with sat. aq. Na2S2O3 (20 mL), brine (× 2), dried 
over MgSO4, filtered and concentrated in vacuo. The residue was azeotroped once with CH2Cl2. Et2O (30 
mL) was added to the crude product and the mixture stirred for 5 min. The suspension was filtered and the 
solid rinsed with Et2O (10 mL × 2), giving the pure product 3.35 as a white solid (372 mg, 76% yield).  
 
TLC (50% acetone/hexanes) 
Rf = 0.44, visualized by KMnO4 stain. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 6.57 (dt, J = 14.5, 7.0 Hz, 1H), 6.13 (dt, J = 14.5, 1.5 Hz, 1H), 4.18 (d, J = 17.0 Hz, 2H), 4.02 
(d, J = 17.0 Hz, 2H), 3.09 (s, 3H), 2.12 (dq, J = 7.3, 1.5 Hz, 2H), 1.53 – 1.43 (m, 2H), 0.68 – 0.61 (m, 2H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.8, 147.9, 75.1, 62.6, 46.2, 39.5, 24.0 
 
HRMS (ESI+) 
Calculated for C10H16BNO4I: 352.0217 
Found:    352.0229 
 
 
A dry 500 mL Schlenk flask equipped with a stir bar was charged with Cp2Zr2Cl2 (14.86 g, 50.83 mmol, 
1.0 equiv) under Ar. The flask was sealed with a rubber septum. THF (120 mL) was cannulated into the 
flask. The cloudy suspension was cooled to 0 °C. DiBAl-H solution (1M in THF, 50 mL, 50 mmol, 1.1 
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equiv) was added into the reaction over 25 min with the aid of a syringe pump. The reaction mixture was 
stirred at 0 °C for 45 min. Propargyl alcohol (2.7 mL, 46.21 mmol, 1.0 equiv) was added neat dropwise 
into the reaction flask over 15 min. After the addition, the cold bath was removed and the reaction stirred 
at RT for 1.5 h, then cooled to -78 °C. Iodine (15.25 g, 60.07 g, 1.3 equiv) was added to a 100 mL single 
neck rbf. THF (24 mL) was added via syringe under Ar. The mixture was stirred to dissolve the solids. 
The solution was then cannulated into the reaction flask over 30 min, rinsing with THF (5 mL). The 
reaction was then stirred for 45 min at -78 °C. The cold bath was removed and the reaction quenched with 
the addition of 1N HCl (100 mL). The mixture was transferred to a separatory funnel, rinsing with H2O 
(50 mL) and Et2O (50 mL). After mixing, brine (50 mL) was added to aid separation. The aqueous phase 
was extracted with Et2O (100 mL × 2). The combined organics were washed with sat. aq. Na2S2O3 (100 
mL, then 50 mL). The organics were washed with sat. aq. NaHCO3, brine, dried over MgSO4, filtered 
through celite and concentrated to 50 mL. Celite was added and the crude product adsorbed onto celite in 
vacuo for SiO2 column purification. The fractions containing 3.42 were concentrated to a small volume 
(~5 mL) and transferred into a 40 mL vial, rinsing with CH2Cl2. The solution (0.95 g, 11% yield based on 
NMR) was used for the next reaction. 1H-NMR matches literature data.5  
 
 
To the allylic alcohol 3.42 (0.95g, 5.14 mmol, 1.0 equiv) in CH2Cl2 (20 mL) was added MnO2 (activated, 
8.94 g, 102.8 mmol, 20 equiv) in one portion under ambient atmosphere and temperature. The reaction 
was stirred for 1.5 h, then another portion of MnO2 (2.23 g, 25.6 mmol, 5 equiv) was added and the 
reaction stirred for another 15 min. The reaction was filtered through celite, rinsing with additional 
CH2Cl2 (10 mL). To the filtrate was added neopentyl glycol (1.62 g, 15.6 mmol, 3.0 equiv ), followed by 
MgSO4 (3.02 g) and pTsOH.H2O (25.6 mg, 0.135 mmol, 0.026 equiv). The reaction was stirred at 35 °C 
for 1.5 h, then cooled to rt. After filtering to remove MgSO4, the filtrate was concentrated in vacuo. The 
crude product was purified by SiO2 column chromatography to give 3.36 (505 mg, 37% yield over 2 steps) 
as a colorless liquid.  TLC (20% EtOAc in Hexanes): Rf = 0.71, visualized with UV, stained with KMnO4; 
1H-NMR (500 MHz, CDCl3): δ 6.69 (dd, J = 14.5, 1.0 Hz, 1H), 6.60 (dd, J = 15.0, 4.0 Hz, 1H), 4.80 (dd, J 
= 4.0, 1.0 Hz, 1H), 3.64 (dd, J = 10.0, 1.5 Hz, 1H), 3.48 (d, J = 10.5 Hz, 1H), 1.19 (s, 3H), 0.74 (s, 3H); 
13C-NMR (125 MHz, CDCl3): δ 142.0, 100.6, 82.5, 77.2, 30.2, 22.9, 21.8; HRMS (EI+) calculated for 
C8H13O2I [M]+ m/z 267.9960, found 267.9972. 
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A mixture of the MIDA boronate 3.34 (2.09 g, 8.07 mmol) in THF (70 mL) and 1N NaOH (24.2 mmol, 
24.2 mL) was stirred under ambient atmosphere and temperature for 20 min. The reaction was quenched 
with the addition of saturated aqueous NH4Cl (70 mL). After briefly stirring, the mixture was transferred 
to a separatory funnel, rinsing with Et2O (20 mL). After mixing and phase separation, the aqueous phase 
was extracted with Et2O (2 × 50 mL). The combined organics were washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo to give a white solid that was used in the coupling reaction. 
A flame-dried 40 mL vial was charged with iodide 3.35 (198 mg, 0.566 mmol), boronic acid (167 mg, 
1.13 mmol), Pd(OAc)2 (6.4 mg, 0.0283 mmol), and Ag2O (262 mg, 1.13 mmol). Inside the glovebox, P(o-
tol)3 (34.5mg, 0.113 mmol), K2CO3 (469 mg, 3.40 mmol) and THF (10 mL). The vial was sealed, brought 
out of glovebox, and stirred at 55 °C in a heating block for 12 h. The reaction was cooled to RT, then 
filtered through celite, rinsing with EtOAc. The filtrate was concentrated in vacuo to give a yellow 
residue, which was taken up in DCM/acetone and adsorbed onto celite in vacuo. The celite pad was 
loaded onto a silica gel column equilibrated at 30% acetone/hexanes. The non-polar impurities were 
eluted with 30% acetone/hexanes. The product was then eluted with 50% acetone/hexanes. The product 
3.43 was obtained as a white solid (121 mg, 65%). 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.43 (app d, J = 7..5 Hz, 2H), 7.32-7.29 (m, 2H), 7.21-7.18 (m, 1H), 6.86 (dd, J = 15.5, 10.5 Hz, 
1H), 6.48 (d, J = 15.5 Hz, 1H), 6.24 (dd, J = 15.0, 10.5 Hz, 1H), 5.89 (dt, J = 15.0 Hz, 7.5 Hz, 1H), 4.18 
(d, J = 17 Hz, 2H), 4.02 (d, J = 17 Hz, 2H), 3.09 (s, 3H), 2.19 (app q, J = 7 Hz, 2H), 1.54-1.48 (m, 2H), 
0.69-0.66 (m, 2H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.8, 138.6, 136.8, 131.6, 130.6, 130.4, 129.4, 127.9, 126.9, 62.6, 46.2, 36.6, 24.9. 
 
HRMS (ESI+) 
Calculated for C18H23O4BN: 328.1720 
Found:    328.1719 
 
 
A mixture of the MIDA boronate 3.43 (73 mg, 0.22 mmol) in THF (2.2 mL) and 1N NaOH (0.67 mmol, 
0.67 mL) was stirred under ambient atmosphere and temperature for 20 min. The reaction was quenched 
with the addition of saturated aqueous NH4Cl (2.2 mL). After briefly stirring, the mixture was transferred 
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to a separatory funnel, rinsing with Et2O (10 mL). After mixing and phase separation, the aqueous phase 
was extracted with 1:2 THF:Et2O (2 × 5 mL). The combined organics were washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo in a 7 mL vial. The boronic acid was used directly in the 
coupling reaction. 
To the vial containing boronic acid was added Ag2O (51.7 mg, 0.223 mmol) and a stir bar. Inside the 
glovebox, K2CO3 (93.9 mg, 0.68 mmol) and Pd[P(o-tol)3]2 (20.0 mg, 0.028 mmol) into the vial. A 
solution of the iodide 3.36 (31 mg, 0.117 mmol) in THF (2.0 mL) and THF (0.2 mL) was then added. The 
vial was sealed with a Teflon-lined cap, brought out of the glovebox, stirred at 55 °C in a heating block 
for 14.5 h. The reaction was cooled to RT, and filtered through celite, rinsing with Et2O. The filtrate was 
concentrated in vacuo at RT. The crude product was purified on a silica gel column (2 to 5 to 10% 
Et2O/pentane) and then re-purified with a silica gel column (5% Et2O/pentane). A colorless oil was 
obtained as the pure product 3.44. 
 
TLC (80% CH2Cl2/hexanes) 
Rf = 0.35, visualized by UV, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.37 (app d, J = 8 Hz, 2H), 7.30 (app t, J = 7.5 Hz, 2H), 7.19 (t, J = 7.0 Hz, 1H), 6.74 (dd, J = 
15.5, 10.5 Hz, 1H), 6.44 (d, J = 16 Hz, 1H), 6.21 (dd, J = 15, 10.5 Hz, 1H), 5.93 (dt, J = 15.5, 7.0 Hz, 1H), 
5.80 (dt, J = 15.5, 7.0 Hz, 1H), 5.59 (ddt, J = 16.0, 5.5, 1.0 Hz, 1H), 4.85 (d, J = 5.0 Hz, 1H), 3.65 (d, J = 
11.5 Hz, 2H), 3.50 (d, J = 10.5 Hz, 2H), 2.17 (q, J = 7.0 Hz, 2H), 2.12 (q, J = 7.0 Hz, 2H), 1.55 (quint, J 
= 7.5 Hz, 2H), 1.22 (s, 3H), 0.74 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 137.8, 135.6, 135.3, 131.0, 130.3, 129.5, 128.7, 127.3, 127.2, 126.3, 101.4, 77.4, 32.4, 31.7, 
30.2, 28.3, 23.1 22.1. 
 
HRMS (ESI+) 
Calculated for C21H29O2 : 313.2168 
Found:    313.2156 
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A 100 mL flask was charged with potassium tert-butoxide (5.30 g, 47.2 mmol, 1.2 eq.), fitted with a 
septum, and vac-filled with nitrogen before adding THF (55 mL). The mixture was cooled to 0 °C and 
methyl P,P-bis(2,2,2-trifluoroethyl)phosphonoacetate  (8.3 mL, 39.3 mmol, 1.0 eq.) was added dropwise 
over 10 min, giving a clear orange mixture. After 40 min of stirring at 0°C, methyl iodide (12.2 mL, 197 
mmol, 5.0 eq.) was added dropwise over 15 min at 0 °C, giving a cloudy orange/white mixture. The 
reaction was gradually warmed to room temperature and allowed to stir overnight. After 22 h, the reaction 
mixture was cooled to 0 °C, quenched with saturated NH4Cl (25 mL), and transferred to a separatory 
funnel with water (25 mL) and ethyl acetate (25 mL).  After mixing and phase separation, the aqueous 
layer was extracted with ethyl acetate (3 x 50 mL EtOAc).  Combined organic layers were dried over 
Na2SO4, filtered, and concentrated to yield a red oil that contained a mixture of starting material, product, 
and bismethylated byproduct.  The crude material was purified by column chromatography (9 cm 
diameter column, 1L of SiO2, 4:1 hexanes/EtOAc) to afford 3.52-2 as a pure colorless oil (5.32 g, 41% 
yield). 1H-NMR identical to literature.7 
 
 
A dry 1 L two neck round bottom flask was charged with 18-crown-6 (30.34 g, 115 mmol, 5.0 equiv.), 
fitted with a thermometer, sealed with a septum, and vac-filled with N2. THF (450 mL) was added, and 
the resulting clear, colorless solution was cooled to -78 °C.  Phosphonoacetate 3.52-2 (7.31 g, 22.0 mmol, 
1.0 equiv.) was added, using THF (25 mL) for quantitative transfer. KHMDS (1 M in THF, 22 mL, 1.0 
equiv.) was added dropwise to the reaction flask over 10 min, accompanied by a color change to light 
orange / pink.  The resulting solution was stirred at -78 °C for 30 min before adding aldehyde 3.52-1 
(4.28 g, 22.0 mmol, 1.0 equiv.), using 25 mL THF for quantitative transfer.  The resulting reaction 
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mixture was stirred at -78 °C for 2 h 20 min. The reaction was quenched with saturated aqueous NH4Cl 
(100 mL). The resulting biphasic mixture was transferred to a 1 L separatory funnel using 100 mL H2O 
and 300 mL Et2O.  After mixing and phase separation, the aqueous layer was extracted with diethyl ether 
(2 × 200 mL Et2O). The combined organic layers were washed with brine (300 mL), dried over Na2SO4, 
and concentrated in vacuo to afford a crude mixture. The same reaction was repeated (23 mmol scale) and 
crude products were combined for chromatographic purification (10:1 to 8:1 hexanes/EtOAc) to give 
3.52-3 as a clear, colorless oil (6.1 g, 51% yield).  
 
TLC (3:1 hexanes/EtOAc) 
Rf = 0.52, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.26 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 6.03 (dt, J = 7.5 Hz, J = 1.8 Hz, 1H), 4.45 (s, 
2H), 3.81 (s, 3H), 3.72 (s, 3H), 3.52 (t, J = 6.0 Hz, 2H), 2.77 (m, 2H), 1.91 (m, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 168.5, 159.4, 140.1, 130.7, 129.5, 128.5, 114.0, 72.7, 69.4, 55.5, 53.6, 51.5, 30.4, 20.9. 
 
HRMS (ESI+) 
Calculated for C15H21O4: 265.1440 
Found:    265.1436 
 
 
A 1 L two neck round bottom flask was fitted with a thermometer, sealed with a rubber septum, and vac-
filled with N2.  THF (280 mL) and the ester 3.52-3 (6.1 g, 23.1 mmol, 1.0 equiv.) were added to the flask, 
and the mixture was cooled with to -78 °C in a dry ice / acetone bath. DIBAL-H (1.0 M in hexanes, 69 
mL, 3.0 equiv.) was added gradually to the reaction flask over 20 min, and the resulting reaction mixture 
was stirred at -78 °C for 5 minutes before switching to a -15 °C dry ice / brine cooling bath. After 1.5 h, 
MeOH (60 mL) was added to quench the reaction at -15 °C.  Using Et2O, the reaction mixture was 
transferred to a 2 L Erlenmeyer flask, and saturated Rochelle’s salt (280 mL) was added.  After stirring 
overnight to complex aluminum salts, the crude mixture was transferred to a 1 L separatory funnel using 
Et2O (50 mL) and water (50 mL). After mixing and phase separation, the aqueous layer was extracted (3 
× 250 mL EtOAc).  The combined organics were washed with brine (400 mL), concentrated in vacuo to 
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approximately 50 mL, diluted in Et2O, dried with Na2SO4, vacuum filtered, and concentrated to give a 
cloudy oil.  Chromatographic purification (9 cm diameter column, 500 mL SiO2, 2:1 hexanes/EtOAc) 
yielded 3.52-4 (5.3 g, 97% yield). 
 
TLC (2:1 hexanes/EtOAc) 
Rf = 0.26, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.24 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 5.32 (td, J = 8.0 Hz, J = 1.3 Hz, 1H), 4.44 (s, 
2H), 4.01 (s, 2H), 3.80 (s, 3H), 3.43 (t, J = 6.0, 2H), 2.34 (app. q, 2H), 1.82 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 159.4, 138.2, 130.0, 129.6, 124.7, 114.0, 73.0, 69.0, 61.4, 55.4, 28.6, 22.4 
 
HRMS (ESI+) 
Calculated for C14H21O3: 237.1491 
Found:    237.1494 
 
 
A 500 mL 3-neck round bottom flask was charged with imidazole (3.67 g, 54.0 mmol, 2.4 eq), sealed 
with three rubber septa, and vac-filled with N2.  Under N2, CH2Cl2 (200 mL) and allylic alcohol 3.52-4 
(5.31 g, 22.5 mmol, 1.0 eq) were added by cannulation with rinsing for quantitative transfer.  After 
cooling to 0 °C in an ice/water bath, TIPSCl (5.8 mL, 27.0 mmol, 1.2 eq) was added dropwise over 7 min.  
The reaction was allowed to warm to rt with stirring overnight.  After 8 h, the reaction mixture was 
transferred to a 500 mL separatory funnel.  The organic layer was washed (2 × 150 mL water), and 
combined aqueous layers were extracted (250 mL CH2Cl2).  The combined organic layers were washed 
with brine (300 mL), dried with MgSO4, vacuum filtered, and concentrated in vacuo to yield the product 
as an oil. Chromatographic purification (25:3:1 hexanes / DCM / Et2O to 25:4:1) gave the pure product 
3.52-5 (7.26 g, 82% yield). 
 
TLC (10:1 hexanes/EtOAc) 
Rf = 0.46, stained by KMnO4. 
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1H-NMR (500 MHz, CDCl3) 
δ 7.26, (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.20 (dt, J = 7.3 Hz, J = 1.2 Hz, 1H), 4.43 (s, 
2H), 4.23 (s, 2H), 3.80 (s, 3H), 3.41 (t, J = 7.2 Hz, 2H), 2.33 (app q, 2H), 1.78 (d, J = 1.1 Hz, 3H), 1.14-
1.04 (m, 21H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 159.3, 137.5, 130.8, 129.5, 121.8, 114.0, 72.7, 70.1, 62.3, 55.5, 28.5, 21.3, 18.3, 12.2. 
 
HRMS (ESI+) 
Calculated for C23H41O3Si:  393.2825 
Found:    393.2818 
 
 
To a 500 mL round bottom flask were added the PMB-protected alcohol 3.52-5 (7.26 g, 18.5 mmol, 1 eq) 
chloroform (160 mL), and water (8 mL).  The mixture was stirred at room temperature for 10 min before 
adding 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 12.6 g, 55.5 mmol, 3.0 eq) portionwise over 
10 min.  After 1 h, the reaction was quenched with the addition of sat. aq. NaHCO3 (100 mL). The 
mixture was filtered through celite, which was rinsed with EtOAc.  The resulting red filtrate was 
concentrated and then transferred to a 500 mL separatory funnel, rinsing with EtOAc (200 mL) and H2O 
(150 mL).  Brine (60 mL) was added to improve phase separation, and then the aqueous layer was 
extracted with EtOAc (2 × 200 mL). The combined organics were washed with brine (250 mL), dried 
with Na2SO4, vacuum filtered, and concentrated to give a dark red oil. Chromatographic purification (8:1 
to 5:1 to 3:1 hexanes/Et2O) gave the pure product 3.52-6 (4.55 g, 90% yield). 
 
TLC (3:1 hexanes/EtOAc) 
Rf = 0.46, stained by KMnO4. 
 
1H-NMR (400 MHz, CDCl3) 
δ 5.26 (t, J = 7.7 Hz, 1H), 4.23 (s, 2H), 3.61 (t, J = 6.2 Hz, 2H), 2.32 (app. q, 2H), 1.82 (s, 3H), 
1.18-1.04 (m, 21H). 
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13C-NMR (125 MHz, CDCl3) 
138.7, 122.6, 62.20, 62.16, 31.3, 21.9, 18.2, 12.2. 
 
HRMS (ESI+) 
Calculated for C15H33O2Si: 273.2250 
Found:    273.2245 
 
 
A dry 50 mL Schlenk flask was charged with PPh3 (4.12 g, 15.7 mmol, 1.1 eq), sealed with a rubber 
septum, and vac-filled with N2 (×3). CH2Cl2 (35 mL) was added.  The resulting mixture was stirred and 
cooled to 0 °C.  Br2 (2.39 g, 15.7 mmol, 1.1 eq) was gradually added until the yellow color persisted, and 
then several additional crystals of PPh3 were added until the color vanished.  The resulting off-white, 
opaque mixture was treated with a dropwise addition of pyridine (2.26 g, 28.6 mmol, 2.0 eq), followed by 
a dropwise addition of 3.52-6 (3.89 g, 14.29 mmol, 1.0 eq)) as a solution in DCM (5 mL) with rinsing (10 
mL DCM) for quantitative transfer.  After 1.5 hours TLC showed the reaction was almost complete.  The 
crude mixture was transferred to a rbf and concentrated in vacuo, giving an off-white powder.  The solid 
was triturated with pentane and then filtered.  (2.65 g, 47% yield).  Along with additional crude bromide 
product from a parallel reaction, chromatographic purification (hexanes to 10:1 Et2O/hexanes) gave the 
pure product 3.528-7 as a colorless oil (5.65 g 93% yield). 
 
TLC (hexanes) 
Rf = 0.25, stained by KMnO4. 
 
1H-NMR (400 MHz, CDCl3) 
δ 5.21 (dt, J = 7.3 Hz, J = 1.2 Hz, 1H), 4.23 (s, 2H), 3.34 (t, J = 7.2 Hz, 2H), 2.60 (app q, 2H), 
1.80 (d, J = 1.0 Hz, 3H), 1.16-1.04 (m, 21H). 
 
13C-NMR (100 MHz, CDCl3) 
δ 138.8, 122.4, 62.4, 33.0, 31.5, 21.4, 18.3, 12.2. 
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In an unoptimized procedure, in the glovebox, alkyl bromide 3.52-7 (2.01 g, 6 mmol, 1 equiv) was 
weighed into a flame-dried 40 mL vial. Zn dust (1.18 g, 18 mmol, 3 equiv) was weighed into another 
flame-dried 40 mL vial equipped with a stir bar. 8 mL DMA was added to the vial containing the alkyl 
bromide to give a colorless solution. The vials were sealed with septum caps and brought out of the 
glovebox.  To the vial containing Zn dust was added I2 (45.7 mg, 0.18 mmol, 0.03 equiv). The vial was 
resealed and vac-filled with N2 (× 3). DMA (2 mL) was added, and the mixture stirred for 2 min during 
which the brown color of I2 disappeared. The solution of the alkyl bromide was then cannulated to the Zn 
dust, rinsing with DMA (2 mL × 2). The mixture was stirred at 80 °C for 14 h, then cooled to rt and taken 
into the glovebox.  
In the glovebox, (E)-ethyl 2,3-dibromoacrylate (52) (430 mg, 1.67 mmol) was weighed into a flame-dried 
40 mL vial equipped with a stir bar. THF (15 mL) was added, followed by PdCl2(PPh3)2 (35.1 mg, 0.05 
mmol, 0.03 equiv wrt dibromide). 2 of these reactions were prepared in parallel. The organozinc solution 
(5 mL) was filtered directly into each of the reaction vial. The reaction were sealed with PTFE-lined caps, 
brought out of the glovebox and stirred at 45 °C for 6 h, then cooled to rt. The reaction mixtures in the 2 
vials were combined into a separatory funnel containing 40 mL saturated aq. NH4Cl solution, rinsing with 
H2O and Et2O. Et2O (10 mL) was added and the layers mixed and separated. The aqueous layer was 
extracted with Et2O (30 mL × 2). The combined organics were washed with H2O, brine, dried over 
MgSO4 and Darco, filtered through celite and concentrated in vacuo. The crude product was purified by 
silica gel chromatography (20-25-30% CH2Cl2/hexanes). The mixed fractions were pooled and re-purified 
by silica gel chromatography (15-20-25% CH2Cl2/hexanes). The fractions containing the pure product 
were concentrated, then taken up in hexanes and stirred with activated charcoal. The mixture was filtered 
through celite and concentrated in vacuo to give a very slightly brown liquid as the product E-3.52 (526 
mg, 36% yield). 
 
TLC (30% CH2Cl2/hexanes) 
Rf = 0.41, visualized with UV, stained with KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.64 (t, J = 7.7 Hz, 1H), 5.15 (tq, J = 7.3, 1.3 Hz, 1H), 4.26 (q, J = 7.0 Hz, 2H), 4.22 (s, 2H), 
2.53 (q, J = 7.5 Hz, 2H), 2.22-2.13 (m, 2H), 1.78 (q, J = 1.3 Hz, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.22-0.96 
(m, 21H). 
 
 13C-NMR (125 MHz, CDCl3) 
δ 162.8, 147.8, 137.0, 123.9, 111.6, 62.1, 62.1, 31.6, 26.6, 21.1, 18.0, 14.1, 12.0. 
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HRMS (ESI+) 
Calculated for C20H38O3SiBr: 433.1774 
Found:    433.1772 
 
 
To a flame-dried 7 mL vial cooled under Argon and equipped was added zinc dust (248.1 mg, 3.79 mmol, 
1.5 equiv.) and iodine (32.3 mg, 0.127 mmol, 0.5 equiv.). The vial was sealed with a PTFE-lined cap, 
purged twice with argon, and charged with DMF (1.0 mL, 2.5 M). After stirring at room temperature for 5 
min until I2 color disappeared, 5-bromo-2-methyl-2-pentene (0.34 mL, 413.8 mg, 2.54 mmol, 1.0 equiv.) 
was added to the reaction vial via syringe under a positive pressure of argon. The vial was sealed with 
Teflon tape and parafilm after the gas inlet needle was removed. The reaction mixture was then placed in 
an 80 oC aluminum heat block and maintained at that temperature with stirring for 4 h. The reaction 
mixture was then allowed to cool to room temperature and was taken into the glovebox. There the 
reaction mixture was passed through a 0.2 μm filter to afford a bright yellow solution, which was used 
immediately. To a flame-dried 40 mL vial was added vinyl iodide 3.47 (351 mg, 1.0 mmol, 1.0 equiv.), 
PdCl2(PPh3)2 (21.0 mg, 0.03 mmol, 0.03 equiv.), and LiBr (452 mg; 5.2 mmol; 5.2 equiv.) followed by 
THF (9 mL, 0.1 M total). The resulting mixture was allowed to stir at room temperature for 5 min as a 
yellow suspension. After 5 min, alkyl zinc 3.46 solution in DMF (1.0 mL, 2.5 M, 2.5 equiv.) was added to 
the reaction mixture rinsing with THF for quantitative transfer, causing the reaction mixture to turn 
orange. The vial was sealed with a PTFE-lined cap and removed from the glovebox. The vials were 
placed in a 60 oC aluminum heat block and maintained at that temperature with stirring for 6 h. The 
reaction mixture was then cooled to room temperature and quenched with saturated aqueous NH4Cl (10 
mL). The mixture was transferred into a separatory funnel rinsing with EtOAc (10 mL) and H2O (10 mL) 
was added. The layers were separated and the aqueous layer was extracted with EtOAc (3 × 20 mL). The 
combined organic layers were washed with brine:H2O (1:1) (3 x 20 mL), dried over Na2SO4, filtered, and 
concentrated in vacuo to afford an orange brown oil. The crude material was adsorbed onto Celite from an 
acetone slurry and purified by silica gel chromatography (Hexanes:Acetone 4:1 to Hexanes:Acetone 1:1) 
to afford a pale yellow solid. The solid was triturated with Et2O:Hexanes (1:1) to give the product 3.49 as 
a white solid after filtration and drying (182 mg, 59%). 
 
TLC (EtOAc) 
Rf = 0.41, visualized by UV, stained with KMnO4. 
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1H-NMR (500 MHz, acetone-d6) 
δ 5.22 (tq, J = 7.2, 1.4 Hz, 1H), 5.11 (tquint, J = 7.1, 1.4 Hz, 1H), 4.18 (d, J = 16.9 Hz, 2H), 4.02 
(d, J = 16.9 Hz, 2H), 3.10 (s, 3H), 2.11 – 2.00 (m, 4H), 1.96 (dd, J = 8.4, 7.0 Hz, 2H), 1.66 – 1.64 (m, 
3H), 1.61 – 1.58 (m, 6H), 0.71 – 0.63 (m, 2H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 168.8, 133.6, 131.5, 128.5, 125.1, 62.6, 46.2, 40.4, 27.4, 25.8, 23.2, 17.7, 15.9. 
 
HRMS (ESI+) 
Calculated for C16H26BNO4Na:  330.1853 
Found:     330.1852 
 
 
To a solution of MIDA boronate 3.49 (307 mg, 1 mmol, 1 equiv) in THF (5 mL) was added 1N NaOH 
(aq) (5 mL, 5 mmol, 5 equiv) under ambient atmosphere and temperature. The reaction was stirred at 
room temperature for 20 min. The reaction was concentrated in vacuo to remove THF. With vigorous 
stirring, saturated NH4Cl (aq.) (5mL) was added. The mixture was extracted with Et2O (3 × 5 mL). The 
organic extracts were dried over Na2SO4, filtered and concentrated to 1 mL.  This solution was then 
transferred to a 7 mL vial, rinsing with THF (1mL). The vial was sealed with a septum cap and the 
solution concentrated to 1 mL under a stream of N2. THF (2 mL) was added under N2, and the solution 
concentrated to 1.25 mL under a stream of N2. This solution of the boronic acid (75% yield) was then 
taken into the glovebox for the subsequent coupling reaction. 1H-NMR (400 MHz, DMSO-d6): δ 7.28 (br 
s, 1H), 5.08-4.95 (m, 2H), 1.94 (q, J = 7.4 Hz, 4H), 1.83 (dd, J = 8.7, 6.2 Hz, 2H), 1.56 (dd, J = 6.3 Hz, 
3H), 1.48 (s, 6H), 0.58 (dd, J = 9.1, 7.0 Hz, 2H); 11B-NMR (128 MHz, DMSO-d6): δ 32.5. Note: over-
concentration of the boronic acid solution will cause boroxine formation. NMR data for boroxine: 1H-
NMR (400 MHz, DMSO-d6): δ 7.28 (br s, 1H), 5.12 (app t, J = 7.5 Hz, 1H), 5.03 (dt, J = 8.9, 1.5 Hz, 1H), 
1.99-1.84 (m, 6H), 1.59 (s, 3H), 1.51 (s, 3H), 1.50 (s, 3H), 0.49 (t, J = 7.7 Hz, 2H); 11B-NMR (128 MHz, 
DMSO-d6): δ 24.1. 
 
In the glovebox, a flame-dried 7 mL vial was charged with vinyl bromide E-3.52 (108 mg, 0.25 mmol, 1 
equiv), Ag2O (261 mg, 1.125 mmol, 4.5 equiv), and a stir bar. The boronic acid solution prepared above 
was then added, rinsing with THF (1.25 mL). Pd[P(o-tol)3]2 (17.8 mg, 0.025 mmol, 1 equiv) was then 
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added. The vial was sealed with a PTFE-lined cap, brought out of the glovebox and stirred at 60 °C in a 
heating block for 13.5 h. The reaction was then cooled to room temperature and filtered through celite, 
eluting with Et2O. The filtrate was concentrated in vacuo, azeotroping once with CH2Cl2. The crude 
product was purified by silica gel column chromatography (20% to 30% CH2Cl2/hexanes) to give the 
product 15 as a slightly yellow oil (73.2 mg, 58% yield). 
 
TLC (40% CH2Cl2/hexanes) 
Rf = 0.47, visualized by UV, stained with KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.83 (t, J = 7.5 Hz, 1H), 5.18 (dt, J = 7.0, 1.0 Hz, 1H), 5.12-5.08 (m, 2H), 4.23 (s, 2H), 4.20 (q, 
J = 7.3 Hz, 2H), 2.44 (q, J = 7.5 Hz, 2H), 2.26 (t, J = 7.0 Hz, 1H), 2.14-2.04 (m, 6H), 1.97 (app t, J = 8.5 
Hz, 2H), 1.77 (d, J = 1.0 Hz, 3H), 1.68 (s, 3H), 1.60 (s, 3H), 1.58 (s, 3H), 1.30 (t, J = 7.2 Hz, 3H), 1.14-
1.05 (m, 21H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 168.0, 141.1, 135.9, 135.7, 132.2, 131.3, 125.0, 124.3, 123.3, 62.0, 60.0, 39.7, 34.7, 29.8, 27.7, 
27.4, 26.7, 25.7, 18.3, 17.7, 16.0, 14.3, 12.0. 
 
HRMS (ESI+) 
Calculated for C31H57O3Si: 505.4077 
Found:    505.4077 
 
 
 
In the glovebox, the 40 mL vial containing 3.51 (214 mg, 0.424 mmol, 1 equiv) and a stir bar was charged 
with Mg turnings (412 mg, 16.96 mmol, 40 equiv). The vial was sealed with a septum cap and brought 
out of the glovebox and placed under N2. MeOH (8 mL) was added via syringe and the mixture was 
sonicated for 2 min, then stirred at rt with an N2 inlet needle. An exotherm formed as the Mg turnings 
dissolved. The reaction was cooled in an ice/water bath. The reaction was then stirred for 16 h, gradually 
warming to room temperature. The reaction was cooled to 0 °C in an ice/water bath, then quenched with 
the addition of saturated aq. NH4Cl (8 mL), forming a gelatinous mixture which was agitated manually. A 
small amount of H2O was added to dissolve the inorganic salts.  The mixture was transferred to a 
  
139 
 
separatory funnel, rinsing with Et2O. After mixing and phase separation, the aqueous layer was extracted 
with Et2O (15 mL). The aqueous layer was concentrated in vacuo to remove most of the MeOH. The 
resulting aqueous phase was extracted with Et2O (2 x 15 mL). The combined organics were dried over 
Na2SO4, filtered and concentrated in vacuo. The residue was diluted with benzene (5 mL) and the mixture 
further dried with Na2SO4, filtered into a 40 mL vial and concentrated and dried under high vacuum to 
give the product 3.57 as a mixture of the ethyl ester and methyl ester in the ratio 7.7 : 1 (200.8 mg, 0.397 
mmol, 94% yield). This material was used without further purification. 
 
TLC (40% CH2Cl2/hexanes) 
Rf = 0.47, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.15 (t, J = 7.0 Hz, 1H), 5.10-5.07 (m, 2H), 4.21 (s, 2H), 4.13 (q, J = 7.1 Hz, 2H), 3.66 (s, 3H 
for methyl ester), 2.31 (tt, J = 9.0. 5.55 Hz, 1H), 2.08-2.04 (m, 2H), 2.01 (m, 6H), 1.76 (app s, 3H), 1.68 
(app s, 3H), 1.68-1.60 (m, 1H), 1.60 (s, 3H), 1.57 (s, 3H), 1.58-1.55 (m, 1H), 1.48-1.40 (m, 2H), 1.30 
(quint, J = 7.8 Hz, 2H), 1.26 (t, J = 7.0 Hz, 3H), 1.14-1.05 (m, 21H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 176.3, 135.8 (Me), 135.7, 135.5, 131.3, 125.6, 125.5 (Me), 124.3, 123.6, 123.5 (Me), 61.9, 60.0, 
51.3 (Me), 45.2, 45.1 (Me), 39.7, 32.4, 32.1, 27.8 (Me), 27.7, 26.6, 25.8, 25.7, 21.0, 18.0, 17.7, 15.9, 14.3, 
12.0. Note: (Me) = peaks corresponding to the methyl ester. 
 
HRMS (ESI+) 
Calculated for C31H59O3Si: 507.4233 
Found:    507.4231  
 
 
The 40 mL vial containing 3.57 (200.8 mg, 0.0544 mmol, 1 equiv) was charged with a stir bar and sealed 
with a septum cap. The vial was vac-filled with N2 (× 3). THF (8 mL) was added via syringe and the 
solution cooled to -20 °C in a dry ice/ethylene glycol/ethanol bath. DIBAl-H (1M in hexanes, 2 mL, 2 
mmol, 5.04 equiv) was added dropwise. The reaction was stirred at -20 °C for 2 h. The reaction was 
quenched by adding saturated Rochelle’s salt solution (10 mL) was dropwise at -20 °C. Et2O (5 mL) was 
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then added. The mixture was warmed to room temperature and stirred for 1 h. The mixture was 
transferred to a separatory funnel, rinsing with H2O and Et2O (10 mL). After mixing and phase separation, 
the aqueous layer was extracted with Et2O (2 x 5 mL). The combined organics were washed with 1:1 
H2O/brine (20 mL), brine, dried over Na2SO4, filtered and concentrated in vacuo. The crude product was 
purified by silica gel chromatography (5% to 10% to 20% Et2O/hexanes) to give the product 3.58 as a 
colorless oil (169.9 mg, 90% yield). 
 
TLC (20% Et2O/hexanes) 
Rf = 0.24, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.19 (app dt,  = 7.0, 1.0 Hz, 1H), 5.11-5.07 (m, 2H), 4.22 (d, J = 12.5 Hz, 1H), 4.21 (d, J = 12.5 
Hz, 1H), 3.54 (dd, J = 5.5, 1.5 Hz, 2H), 2.11-1.94 (m, 8H), 1.77 (d,  = 1.0 Hz, 3H), 1.68 (s, 3H), 1.60 (s, 
6H), 1.50-1.25 (m, 7H), 1.15-1.06 (m, 21H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 135.3, 135.1, 131.3, 126.0, 124.5, 124.3, 65.6, 62.0, 40.1, 39.7, 30.9, 30.5, 27.9, 27.2, 26.7, 
25.7, 25.2, 21.0, 21.0, 18.0, 17.7, 16.0. 
 
HRMS (ESI+) 
Calculated for C29H57O2Si: 465.4128 
Found:    465.4126 
 
 
To a solution of 3.58 (165.3 mg, 0.356 mmol) in THF (3.6 mL) and pyridine (1.2 mL) in a polyethylene 
vial equipped with a stir bar was added HF·pyridine (0.4 mL) dropwise at 0 °C. The vial was purged with 
N2, and sealed with a screw cap. The reaction was gradually warmed to rt. After 3.5 h, another portion of 
HF·pyridine (0.4 mL) was added to the reaction at rt. The reaction was then stirred for another 3 h. The 
reaction was added portionwise to a stirring solution of saturated aqueous NaHCO3 (10 mL). Et2O (10 
mL) was added. The mixture was transferred to a separatory funnel and another 10 mL saturated aqueous 
NaHCO3 was added.  After phase separation, the aqueous layer was extracted with Et2O (2 × 10 mL). The 
combined organics were washed with H2O, brine, dried over Na2SO4, filtered and concentrated. The crude 
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product was purified by silica gel chromatography (20% to 30% to 40% EtOAc/hexanes) to give the pure 
product 3.59 as a colorless oil (98.2 mg, 89% yield). 
 
TLC (40% EtOAc/hexanes) 
Rf = 0.25, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 5.29 (app t, J = 7.5 Hz, 1H), 5.12-5.07 (m, 2H), 4.16 (d, J = 11.5 Hz, 1H), 4.10 (d, J = 11.5 Hz, 
1H), 3.58 (dd, J = 10.5, 5.0 Hz, 1H), 3.51 (dd, J = 11.0, 6.0 Hz, 1H), 2.10-1.97 (m, 8 H), 1.80 (d, J = 1.3 
Hz, 3H), 1.68 (d, J = 1.0 Hz, 3H), 1.60 (s, 6H), 1.50-1.25 (m, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 135.2, 134.4, 131.3, 128.5, 124.4, 124.3, 65.5, 61.5, 39.7 (2C), 30.9, 30.2, 27.6, 26.9, 26.7, 
25.7, 25.2, 21.3, 17.7, 16.0. 
 
HRMS (ESI+) 
Calculated for C20H37O2: 309.2794 
Found:    309.2794 
 
 
To a Schlenk tube (1 cm diameter) sealed with a rubber septum and vac-filled with N2 (×3) was added 
CH2Cl2 (0.2 mL) followed by DMSO (0.015 mL, 0.211 mmol, 8.7 equiv). The solution was cooled to -78 
°C in a dry ice/acetone bath. Oxalyl chloride (2.0 M in CH2Cl2, 0.05 mL, 0.1 mmol, 4.1 equiv) was added 
dropwise via syringe. The resulting solution was stirred at -78 °C for 30 min. A solution of diol 3.59 (7.5 
mg, 0.0243 mmol, 1.0 equiv) in CH2Cl2 (0.2 mL) in a 7 mL vial was added dropwise to the reaction flask 
via syringe, rinsing with CH2Cl2 (0.2 mL). The solution was stirred for 30 min at – 78 °C, then NEt3 
(0.030 mL, 0.215 mmol, 8.8 equiv) was added into the reaction dropwise. The reaction was stirred for 5 
min at the same temperature, then the cold bath was removed and the reaction stirred at room temperature 
for another 45 min. TLC showed complete conversion of the diol. The reaction was cooled to 0 °C in an 
ice/water bath. Dry MeNH2 gas was then passed above the reaction solution over 3 min via an inlet needle 
with an outlet needle, causing an increase in reaction volume and dissolution of the solids. The reaction 
was stirred for 3.5 h, gradually warming to room temperature in the ice/water bath. The flask was then 
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opened to the Schlenk line, causing evaporation of the dissolved MeNH2. The solvent was removed under 
a stream of N2, giving an off-white oily solid. The rubber septum was quickly replaced with a new septum 
under positive N2 flow. The Schlenk tube was evacuated and filled with N2, then evacuated again, and the 
residue was dried under high vacuum overnight. The flask was filled with N2. Dry AcOH (0.4 mL) was 
added to dissolve the brown residue. The solution was stirred at 80 °C (oil bath temperature) for 8.5 h. 
The reaction was cooled to 0 °C in an ice/water bath. CH2Cl2 (2 mL) and 3N NaOH were added with 
stirring until pH>10. The mixture was transferred to a separatory funnel and the layers separated. The 
aqueous layer was then extracted with CH2Cl2 (2 × 2 mL). The organics were dried over Na2SO4, filtered 
and concentrated in vacuo. 1H-NMR showed the crude product as the ammonium salt. The brown residue 
was taken up in CH2Cl2 (5 mL) and added to the aqueous layers were from the extraction which were re-
adjusted to pH=14 with 6N NaOH. After mixing and phase separation, the aqueous layer was extracted 
with CH2Cl2 (2 × 5 mL). The combined organics were washed with brine, dried over Na2SO4 and 
concentrated. The crude product was purified by silica gel column chromatography (20% to 50% 
EtOAc/pentane) to give the product 3.5 as a colorless oil (2.7 mg, 39% yield).  
 
1H-NMR (500 MHz, CDCl3) 
δ 2.89 (s, 1H), 2.54 (d, J = 4.5, 1H), 1.89 (t, J = 5.0 Hz, 1H), 1.74-1.38 (m, 15H), 1.17 (dd, J = 
9.5, 3.0, 1H) 0.98-0.92 (m, 1H), 0.88 (d, J = 6.5, 3H), 0.87 (d, J = 7.0, 3H), 0.74 (s, 3H), 0.70 (s, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 60.3, 54.8, 50.4, 49.7, 47.3, 43.4, 39.4, 38.6, 36.4, 35.6, 34.5, 28.6, 27.8, 26.6, 22.8, 21.1 (2C), 
21.0, 18.4, 21.1 (3C), 21.0. 
 
HRMS (ESI+) 
Calculated for C20H34N:  288.2691 
Found:    288.2697 
 
 
In an unoptimized procedure, anhydrous K2CO3 (36.5 mg, 0.264 mmol, 4 equiv) was weighed into a 
flame-dried 7 mL vial equipped with a stir bar. The vial was sealed with a septum cap, evacuated and 
filled with N2 (×3). Amine 3.5 (19 mg, 0.066 mmol, 1 equiv) was dissolved in PhH (0.75 mL) and added 
  
143 
 
to the vial. The suspension was cooled to 0 °C, then bromoacetyl bromide (11.5 µL, 0.132 mmol, 2 equiv) 
was added via syringe and the reaction was warmed to room temperature. After 1 h, another portion of 
bromoacetyl bromide (11.5 µL, 0.132 mmol, 2 equiv) was added. The reaction was left to stir for another 
15 h at room temperature. The reaction was filtered through celite and silica gel, eluting with CH2Cl2. The 
brown filtrate was treated with Darco and filtered through celite. The filtrate was concentrated in vacuo, 
giving a brown residue, which was purified by silica gel chromatography (10-20% EtOAc/hexanes) to 
give a white solid as the pure product (6.7 mg, 25%). The solid was taken up in EtOH (~ 1 mL) and H2O 
was added, causing the solution to become cloudy. The precipitate was re-dissolved in a minimal amount 
of EtOH and the solution filtered through a 0.2 µM filter into a 7 mL vial. The solution was then left to 
slowly evaporate, giving crystals for X-ray analysis. 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.59, visualized by UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 4.11 (br s, 1H), 4.08 (d, J = 11.5 Hz, 1H), 3.80, (d, J = 11.5 Hz, 1H), 3.50 (d, J = 4.7 Hz, 1H), 
2.20 (t, J = 5.3 Hz, 1H), 1.77-1.13 (m, 17H), 1.09 (d, J = 6.2 Hz, 3H), 0.87 (s, 3H), 0.80 (s, 3H), 0.78 (d, J 
= 6.5 Hz, 3H). 
 
13C-NMR (126 MHz, CDCl3) 
δ 169.9, 61.9, 55.4, 53.3, 51.4, 46.6, 45.3, 39.5, 38.4, 36.6, 36.0, 35.6, 28.8, 27.4, 26.0, 23.1, 21.3, 
20.6, 20.4, 19.5. 
 
HRMS (ESI+) 
Calculated for C22H35NOBr: 408.1902 
Found:    408.1906 
 
 
X-ray Crystal Structure Data for N-bromoacyl-3.5 
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N-bromoacyl-3.5 
 
Crystal data and structure refinement for N-bromoacyl-3.15 
Identification code  cd70mas 
Empirical formula  C22 H34 Br N O 
Formula weight  408.41 
Temperature  104(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 8.8647(3) Å = 90°. 
 b = 17.0519(6) Å = 90°. 
 c = 25.7965(9) Å  = 90°. 
Volume 3899.4(2) Å3 
Z 8 
Density (calculated) 1.391 Mg/m3 
Absorption coefficient 2.119 mm-1 
F(000) 1728 
Crystal size 0.754 x 0.099 x 0.026 mm3 
Theta range for data collection 2.389 to 26.429°. 
Index ranges -11<=h<=11, -21<=k<=21, -32<=l<=32 
Reflections collected 50900 
Independent reflections 4005 [R(int) = 0.0712] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Integration 
Max. and min. transmission 0.9626 and 0.5182 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4005 / 0 / 230 
Goodness-of-fit on F2 1.077 
Final R indices [I>2sigma(I)] R1 = 0.0262, wR2 = 0.0704 
R indices (all data) R1 = 0.0334, wR2 = 0.0721 
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CHAPTER 4 
SYNTHESIS OF MANY DIFFERENT TYPES OF SMALL MOLECULES USING ONE 
AUTOMATED PROCESS 
 
Junqi Li, Steven Ballmer, Eric Gillis, Seiko Fujii, Michael Schmidt, Andrea Palazzolo, Jonathan 
Lehmann, Gregory Morehouse, and Martin D. Burke 
 
Small molecule synthesis usually relies on procedures highly customized for each target. A 
broadly applicable automated process could greatly increase the accessibility of this class of compounds 
to enable investigations of their practical potential.  In this chapter, we report a small molecule 
synthesizer that can execute the synthesis of 14 distinct classes of small molecules, including Csp3-rich 
polycyclic natural product frameworks, using the same fully automated process based on the iterative 
coupling approach described in Chapters 1 to 3. Key to enabling automation is the discovery of a catch-
and-release chromatographic purification protocol applicable to all of the corresponding intermediates. 
This chapter also details the development of a protecting group strategy that is suitable for the synthesis 
of a library of natural products and derivatives.  Investigations in these areas have provided general 
guidelines on the types of protecting groups suitable for the iterative coupling process. More broadly, the 
successful synthesis of different types of small molecules using the same automated process illuminates 
an actionable roadmap to a more general and automated approach for small molecule synthesis. 
Dr. Eric Gillis discovered the general binary elution profile of MIDA boronates, constructed the 
small molecule synthesizer, and wrote the code for the operating software. Dr. Steven Ballmer optimized 
the synthesizer and operated the synthesizer together with Michael Schmidt. The work described in this 
chapter was completed in collaboration with Dr. Seiko Fujii. Portions of this chapter were adapted from 
Li, J.; Ballmer, S. G.; Gillis, E. P.; Fujii, S.; Schmidt, M. J.; Palazzolo, A. M. E.; Lehmann, J. W.; 
Morehouse, G. F.; Burke, M. D. Science 2015, 347, 1221-1226. 
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4-1 INTRODUCTION 
Small molecules perform many important functions in nature, medicine, and technology. 
However, efforts to discover and optimize new small molecule function are often impeded by limitations 
in synthetic access to this class of compounds. For peptides1 and oligonucleotides2, the development of 
automated synthesis platforms removed this bottleneck. The resulting expanded access to these molecules 
permitted widespread exploration and applications of their functional potential. Substantial progress has 
also been made towards automating the synthesis of oligosaccharides,3 and some organic polymers.4 In 
each of these cases, automation was enabled by the development of a general building block-based 
synthesis strategy and a common purification process for the corresponding intermediates. Such 
standardization reduced the number of processes employed and thus decreased the number of challenges 
involved in automating the synthesis platform.  
In contrast, despite tremendous progress in the field, small molecule syntheses typically employ 
strategies and purification methods that are highly customized for each target. Automation of small 
molecule synthesis has thus focused on expanding the types of reactions and purification processes that 
can be implemented on a synthesizer. While the use of advanced engineering and robotics can assist with 
such an approach,5 this approach has two inherent limitations in both the planning and execution stages of 
synthesis: i) the need for the chemist to design the synthesis to each target or family or targets, and ii) 
even with the aid of computer programs in searching reaction databases, the conditions for most 
transformations can often times be highly substrate-dependent, and purification processes need to be 
optimized for each intermediate. These limitations are a result of the lack of standardization of the way 
molecules are constructed.6,7,8 Consequently, automation has not received widespread utilization in both 
academic and industrial settings to the extent seen with peptide and oligonucleotide synthesizers. 
Synthesis thus has remained a bottleneck in the study of small molecule function, and the exclusive 
domain of expert chemists.  
To enable the more generalized automation of small molecule synthesis, we asked whether many 
different types of small molecules could be prepared using a common building block-based strategy and a 
common purification process. Small molecules can be very diverse in structure, and thus automating the 
synthesis of the entire set of targets shown in Figure 4-1 represents a major challenge. However, like 
peptides, oligonucleotides and oligosaccharides, most natural products (such as 4.1-4.4) are 
biosynthesized via the iterative assembly of a small set of building blocks, such as malonyl coenzyme A, 
isopentenyl pyrophosphate, and pyruvic acid.9 Many materials and pharmaceuticals (such as 4.5-4.9) 
comprise collections of aryl and/or heteroaryl components.10 Even topologically complex natural products 
containing macrocyclic or polycyclic frameworks (such as 4.10–4.14) are usually biosynthesized via 
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iterative building block-based assembly of linear precursors, which are then (poly)cyclized to yield more 
complex molecular architectures.11,12,13  
Figure 4-1. A collection of compounds representing the structural and functional diversity of small molecules. 
 
This analysis has inspired us to develop the iterative coupling platform that is analogous to 
peptide synthesis, as described in Chapters 1-3. Supporting the notion that many small molecules might 
be accessible via a common, biosynthesis-inspired strategy involving the iterative assembly of building 
blocks, we recently demonstrated that more than 75% of all polyene natural product motifs can be 
prepared using just 12 building blocks and one coupling reaction.14 In Chapter 3, we have also shown that 
utilizing a linear-to-cyclized strategy, the same platform can be used to access the cyclic targets 10-14. 
Having established the strategy that can potentially access a wide range of complex small molecules, we 
are now faced with the challenges in translating the chemistry into an automated platform.  
 
4-2 A GENERALIZED PURIFICATION PROTOCOL 
 The key challenge in automating small molecule synthesis is finding a generalized purification 
method that can be used for all intermediates during synthesis. Small molecule synthesis typically 
involves purifications customized for each intermediate, such as chromatography with eluents optimized 
for each compound. Such customization is incompatible with generalized automated purification. Solid-
phase synthesis can address this problem for peptides1, oligonucleotides2, oligosacharides3, and some 
organic polymers.4a In some cases, syntheses of natural products and pharmaceuticals have also been 
aided by solid-phase methods.15 This approach is well-established, compatible with a wide range of 
chemistries, and has been employed in industry. However, small molecules do not possess a common 
functional group handle for attachment to solid support which precludes generalized application of this 
approach. Thus, a different solution was needed.  
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Figure 4-2. MIDA boronates as key intermediates (highlighted in yellow) in iterative coupling-based syntheses. 
 
We recognized that each iteration of building block assembly in our platform generates a MIDA 
boronate as the key intermediate (Figure 4-2). This led us to question whether the MIDA boronate motif 
could serve as a surrogate common handle for purification. In this vein, we discovered that MIDA 
boronates uniformly possess highly unusual binary affinity for silica gel with certain pairs of eluents 
(Figure 4-3). Specifically, all MIDA boronates 4.15a-t, with appended fragments representing a wide 
range of sizes, polarities, and functional group content, show minimal mobility on thin layer silica gel 
chromatography when eluting with MeOH:Et2O (Figure 4-3, left). However, all of the same MIDA 
boronates are rapidly eluted with THF (Figure 4-3, right).  
 
Figure 4-3. MIDA boronates uniformly show binary elution properties on silica gel thin-layer chromatography. 
 
This phenomenon enabled us to develop a new type of catch-and-release purification protocol 
applicable to any intermediate that contains a MIDA boronate (Figure 4-4). A crude reaction mixture is 
passed over silica gel and the MIDA boronate is temporarily caught while excess reagents and byproducts 
are removed via washing with MeOH:Et2O. The MIDA boronate is then cleanly released by switching the 
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eluent to THF. The MIDA boronate motif can thus serve as both a latent reactive functional group for 
iterative coupling and a traceless common functional group handle for generalized purification.  
 
Figure 4-4. Catch-and-release chromatography purification protocol for MIDA boronates. 
 
4-3 A SMALL MOLECULE SYNTHESIZER 
Having established a common purification method, we designed and built a synthesizer that 
iteratively assembles MIDA boronate building blocks in a fully automated fashion (Fig. 4-5). This device 
comprises three modules that sequentially execute the deprotection, coupling, and purification steps 
required for each cycle. All solutions are automatically transferred via computer-controlled syringe 
pumps running custom designed software. Thus, each automated synthesis simply requires placing pre-
packed cartridges onto the synthesizer and pressing “start”. 
 
 
 
 
 
 
 
Figure 4-5. Photograph of the small molecule synthesizer and the 3 modules for deprotection, coupling and 
purification. 
 
 The fully automated synthesis commences at the deprotection module, where THF and water are 
transferred via a syringe pump into a cartridge containing the MIDA boronate and NaOH. After 
deprotection, the reaction is quenched and the resulting THF solution of the freshly prepared boronic acid 
is separated from the water-soluble MIDA ligand. The coupling module then heats and stirs a solution of 
the next building block and the coupling reagents. The synthesizer then adds the freshly prepared solution 
of boronic acid to the coupling reaction. At the end of the reaction, the synthesizer filters and transfers the 
crude reaction mixture to the purification module, which executes the catch-and-release purification 
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protocol with MeOH:Et2O followed by THF. The THF solution of the purified product is then transferred 
directly into the deprotection module to start the next iteration of the synthesis. 
To first test the capacity of this synthesizer to execute one cycle of deprotection, coupling, and 
purification, we subjected a series of commercially available aryl, heteroaryl, vinyl, and alkyl MIDA 
boronates to automated deprotection and coupling with a model bifunctional building block, 4-
bromophenyl MIDA boronate (Table 4-1). Using a standard set of hydrolysis conditions (NaOH, 
THF:H2O, 23 oC, 20 min), and coupling conditions (PdXPhos16, K3PO4), we obtained the desired cross-
coupling products in good yields and purities in all cases (entries 1-3). The synthesizer was also capable 
of executing a Csp3 coupling using Pd[P(o-tol3)]2 and Ag2O/K2CO317 (entry 4).  
 
Table 4-1. Fully automated cycles of deprotection, coupling, and purification. Coupling conditions: XPhos 2nd 
generation palladacycle, K3PO4, THF, 55 °C, 16 h for entries 1-3, and Pd[P(o-tol)3]2, Ag2O, K2CO3, THF, 55 °C, 16 
h for Csp3 coupling in entry 4. 
 
Accessing many pharmaceuticals and materials represented by structures 5-9 requires the 
flexibility to link building blocks via carbon-heteroatom and/or carbon-carbon bonds. The stability of 
MIDA boronates towards many reaction conditions18,19 and the synthetic versatility of boronic acids20  
allowed us to add carbon-heteroatom bond formations to the same platform. The synthesizer successfully 
executed a series of automated carbon-heteroatom bond formation, including a Buchwald-Hartwig 
amination, O-alkylation, and amide bond formations (Table 4-2). Despite the different reagents and 
byproducts, the same catch-and-release process purified all of the corresponding MIDA boronate products. 
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Table 4-2. Fully automated cycles of deprotection, coupling, and purification for carbon-heteroatom bond formation. 
 
4-4 AUTOMATED SYNTHESIS OF MATERIALS, PHARMACEUTICALS AND NATURAL 
PRODUCTS 
Having confirmed the capacity to reliably execute single cycles of deprotection, coupling, and 
purification, we next targeted the automated synthesis of a wide range of linear small molecules (4.1-4.9) 
via multiple carbon-carbon and/or carbon-heteroatom bond formations (Figure 4-6). These include natural 
products from major biosynthetic pathways (4.1-4.4), materials components (4.5, 4.6), and 
pharmaceuticals/biological probes (4.7-4.9). Most of the corresponding building blocks are commercially 
available. Similar to automated peptide, oligonucleotide, and oligosaccharide syntheses, all of the 
synthesizer-generated final products were purified using standard chromatographic techniques, and any 
protecting groups other than MIDA were easily removed in a separate step. In each case, a single 
automated run successfully delivered the targeted small molecule in multimilligram quantities, fulfilling 
the requirements of most functional discovery assays. 
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Figure 4-6. Automated synthesis of natural products, materials, pharmaceuticals, and biological probes via iterative 
coupling of building blocks indicated by different colors. 
 
 
4-5 AUTOMATED SYNTHESIS OF A NATURAL PRODUCT-DERIVED LIBRARY 
The development of small molecules with optimized functions often requires efficient access to 
many structural derivatives of a parent compound. To test if this platform could enable such access, we 
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targeted the automated preparation of many derivatives of the complex neolignan natural product 
ratanhine 4. In this experiment, we did not optimize of any of the deprotection, coupling, or purification 
conditions used to construct 4.37 (Figure 4-6). We input four sets of building blocks representing 
common substructural elements found throughout the neolignan family and/or other pharmaceutically 
relevant motifs (Figure 4-7). These building blocks included variations in oxidation states, methylation 
patterns, fluorine content, aromatic ring identity, and size. They also represent pre-programmed oligomer 
lengths of 3 to 4 units based on whether the third building block was a bifunctional halo-MIDA boronate 
or a capping halide. 
 
Figure 4-7. Targeted automated synthesis of a 20-membered library of ratanhine derivatives by mixing and 
matching building blocks. 
 
One critical element for a successful library synthesis is a protecting group scheme that is 
compatible with the coupling chemistry and removal of protecting groups at the end of the synthesis can 
be carried out without the need for optimization of conditions for each library member. Since the 
deprotection of the MIDA boronate after each coupling reaction is carried out under aqueous basic 
conditions, the protecting group must be inert under these conditions. The presence of electron-rich aryl 
and heteroaryl groups meant that the products are likely to be acid-sensitive, while the C=C functionality 
preclude the use of catalytic hydrogenolysis during deprotection. In addition, similar to peptide synthesis, 
it is ideal to have a one-step procedure for global deprotection to minimize manipulations after automated 
synthesis. Taking into account these considerations, silicon-based protecting groups would be suitable for 
the protection of the free alcohols and phenols in the target library. 
4.63 was first chosen as a model system for initial deprotection studies as it contains the allylic 
alcohol and phenol functional groups that will be present in the most complex member of the library 
(Figure 4-8). Preliminary investigations on deprotection of the methoxymethyl acetal (MOM) group, 
which was used as the protecting group previously in the synthesis of ratanhine, showed that the starting 
material and/or product decomposed before complete deprotection could be achieved under dilute 
aqueous HCl conditions.  
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Figure 4-8. 4.63 as a model system for deprotection studies. 
 
It was thus decided that silyl groups were the most suitable for protecting the alcohols and 
phenols as silyl ethers are stable under the conditions in the automated synthesis and can be removed 
using a variety of fluoride sources. Using TIPS groups on the phenols added significant steric bulk on the 
aryl bromide coupling partner 4.65, resulting in incomplete conversion from 4.65 to 4.66 and partial 
deprotection of the more labile silyl aryl ethers under the coupling conditions. Although global 
deprotection of the mixture of products proceeded with a 60% yield without optimization, the TIPS group 
was deemed unsuitable for the synthesis of the library members that require an additional coupling step 
(Figure 4-7, bottom).  
 
 
Scheme 4-1. A) Synthesis of 4.66. B) Deprotection of 4.66. 
 
The SEM group was tested next. Removal of the SEM groups with MgBr2 and n-BuSH was 
successful, however, under the reaction conditions nucleophilic displacement of the protected allylic 
alcohol occurred, giving 4.69 as the only product. Simultaneously, we tested the TBDPSE group in a 
simpler and more synthetically accessible model system and found that one of the TBDPSE groups could 
be removed cleanly using TBAF in THF, but the reaction stalled after the removal of the first TBDPSE 
group. We reasoned that the phenoxide formed under the basic reaction conditions after the first TBDPSE 
deprotection electronically deactivated the aryl ring towards the second TBDPSE deprotection.  
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Scheme 4-2. Deprotection studies on 4.68 and 4.70. 
 
We proceeded to test the use of TBDPSE groups in three representative library members 4.73, 
4.75, and 4.77. Global deprotection of 4.73 resulted in clean formation of the desired product 4.74 using 
TBAF·3H2O and DMSO (Scheme 4-3A). The non-polar library members were found to be more soluble 
in DMPU, so a 1:1 DMSO/DMPU was later used as the solvent mixture. The basic reaction conditions 
and presence of water were sufficient to cleave the benzoate group in 4.75, so the same conditions were 
used for the deprotection of 4.75 (Scheme 4-3B).  
 
 
Scheme 4-3. Conditions for deprotection of representative library members 4.73 and 4.75. 
 
These conditions were however, not suitable for the deprotection of 4.77 due to competitive 
deprotection of the benzoate group. An anhydrous source of fluoride was needed. The TBDPSE groups 
were inert towards HF·pyridine. CsF in DMSO was tested, and it was found that the reaction gave a 
mixture of the desired product 4.78 and the benzoate cleaved product 4.79 in a 3:1 mixture, which could 
not be separated by silica gel chromatography (Scheme 4-4).  
 
 
Scheme 4-4. Deprotection of 4.77. 
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We also observed that one TBDPSE group was cleaved more quickly than the other, giving 4.81 
as the only mono-protected product. When 4.81 was subjected to the same conditions, no benzoate 
cleavage product was found. We hypothesized that deprotection of the TBDPSE at the terminal position 
leads to formation of the phenoxide which reduces the electrophilicity of the benzoate group, thus 
preventing benzoate cleavage (Scheme 4-5).  
 
 
Scheme 4-5. Sequential deprotection of the silyl groups of 4.80. 
 
 We thus switched the terminal protecting group to the less sterically bulky and thus more labile 
TMSE protecting group. Indeed, global deprotection of all three silyl groups in a one-pot procedure 
generated only 4.82 and no benzoate cleavage was observed (Scheme 4-6). 
 
 
Scheme 4-6. Deprotection of 4.82 containing a TMSE group in place of the TBDPSE group at the terminal position. 
 
With the conditions optimized for the removal of the silyl groups, we proceeded to construct the 
library on the synthesizer. Importantly, this synthesis was conducted without any changes to the coupling 
conditions used in the syntehsis of 4.37. In the event, the synthesizer successfully generated 20 out of 20 
of the targeted derivatives, collectively representing all possible combinations of this four-component 
matrix of building blocks (Figure 4-9). Removal of the TIPS, TBDPSE, TMSE or Bz protecting groups 
were carried out successfully on all library members using the pre-determined conditions.  
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Figure 4-9. Automated synthesis of ratanhine derivatives. Conditions: deprotection – NaOH, THF:H2O; coupling – 
cycle 1: Pd(OAc)2, SPhos, K2CO3, THF, 55 °C, 16h. cycle 2: Pd(OAc)2, XPhos, K3PO4, THF, 55 °C, 14 h. cycle 3: 
Pd(OAc)2, SPhos, K3PO4, THF, 55 °C, 24 h; purification – SiO2, MeOH:Et2O; THF. 
 
 
4-6 SEMI-AUTOMATED SYNTHESIS OF CYCLIC NATURAL PRODUCTS VIA THE LINEAR-TO-
CYCLIZED STRATEGY 
Finally, we tested whether the range of macro- and polycyclic natural products and natural 
product-like cores 4.10-4.14 described in Chapter 3 could be generated using the same automated 
building block assembly process and the linear-to-cyclized strategy (Figure 4-10). In the event, the Csp3 
Suzuki and Negishi couplings optimized manually translated to the automated platform, generating the 
linear precursors in multimilligram quantities. The linear precursors were then successfully cyclized with 
a macrocyclization (entry 1), Diels-Alder reactions (entries 2 and 3), a cation-pi cyclization (entry 4) and 
a cascade sequence involving hetero-Diels-Alder reactions and aza-Prins-cyclization (entry 5). The 
successful automated synthesis of the linear precursors to complex polycyclic thus has the potential to 
become a valuable tool for accelerating method development for new types of stereoselective cyclizations 
by providing facile stereocontrolled access to the linear substrates and their analogs.  
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Figure 4-10. Synthesis of Csp3-rich macro- and polycyclic natural products and natural product-like cores.  
 
4-7 SUMMARY AND CONCLUSIONS 
 Thus, many different types of small molecules can be synthesized using one automated building 
block assembly platform. This advance was enabled by standardizing the synthesis and purification 
processes used to assemble these structures. Importantly, a majority of the building blocks employed 
herein are already commercially available. 
Further expanding the scope of this automated synthesis platform represents an actionable 
roadmap toward a general and broadly accessible solution to the small molecule synthesis problem. This 
roadmap includes identifying highly redundant substructural elements found in many small molecules and 
transforming these substructures into suitable building blocks for synthesis.  The identification process 
can be highly aided by the increasingly comprehensive nature of searchable small molecule databases, for 
e.g. the Dictionary of Natural Products21, Pubchem22, ChemDB23 etc., as well as databases that aim to 
map the entire theoretical possible chemical space.24 Developing programs that can carry out global 
analyses of natural products to identify the most commonly occurring substructures within each class of 
natural products would be very helpful in this process. 
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Once substructures are identified, better methods for making these building blocks and iteratively 
coupling them together. This includes the development of more general methods for Csp2-Csp2 couplings, 
a greater scope in stereospecific Csp3-Csp2 couplings6,25, and discovering conditions for stereospecific 
Csp3-Csp3 couplings. An important third goal is advancing the capacity for biosynthesis-inspired 
cyclizations of linear precursors to yield complex natural product frameworks. Catalyst-controlled 
stereoselective cyclizations remains a frontier area in synthesis.26 Achieving these objectives stands to 
better enable the scientific community to bring the substantial power of small molecule synthesis to bear 
upon many important unsolved problems in society. 
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CHAPTER 4 
EXPERIMENTAL SECTION 
 
Materials.  Commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, Alfa Aesar, TCI 
America, or Frontier Scientific, and were used without further purification unless otherwise noted. Most 
of the building blocks used in these studies are available from commercial sources. The following MIDA 
boronates were purchased from Sigma-Aldrich: 4.15a (697311), 4.15b (700231), 4.15c (721573), 4.15d 
(710032), 4.15e (MIDA071), 4.15f (698229), 4.15g (697494), 4.15h (698164), 4.15i (698016), 4.15j 
(698148), 4.15k (704547), 4.15l (MIDA032), 4.15m (736600), 4.15n (748714), 4.15o (723711), 4.15p 
(738514), 4.15q (699861), 4.15r (MIDA020), 4.15s (MIDA076), 4.15t (704873), 4.16a (730335), 4.16b 
(733539), 4.16c (703710), 4.18 (698083), 4.21a (RNI00021), 4.21b (698067), 4.23 (MIDA034), 4.27 
(MIDA013), 4.30 (698032), 4.33 (701831), 4.54 (MIDA039), 4.60 (MIDA014), 61 (MIDA017), 4.38 
(MIDA083), 4.39 (MIDA084), 4.41 (MIDA080), 4.42 (701092), 4.45 (723711), 4.46 (MIDA081), 4.49 
(MIDA085), 2-furanyl MIDA boronate (701017). XPhos 2nd generation palladacycle refers to chloro(2-
dicyclohexylphosphino-2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]palladium(II) 
(741825, Sigma-Aldrich). Solvents were purified via passage through packed columns as described by 
Pangborn and coworkers1  (THF, Et2O, CH3CN, CH2Cl2: dry neutral alumina; hexane, benzene, and 
toluene, dry neutral alumina and Q5 reactant; DMSO, DMF: activated molecular sieves). All water was 
deionized prior to use. Diisopropylethylamine was freshly distilled under an atmosphere of nitrogen from 
CaH2. NMR and MS data for the automated synthesis of targets 4.1 – 4.9, library members 4.83 – 4.101, 
and linear precursors 4.107, 4.111, 4.116, 4.121, and 4.122 have been reported elsewhere.2 
 
General Experimental Procedures.  Unless noted, all reactions were performed in flame-dried round-
bottom or modified Schlenk flasks fitted with rubber septa under a positive pressure of argon.  Organic 
solutions were concentrated via rotary evaporation under reduced pressure with a bath temperature of 23 
oC unless otherwise noted. Reactions were monitored by analytical thin layer chromatography (TLC) 
performed using the indicated solvent on E. Merck silica gel 60 F254 plates (0.25mm).  Compounds were 
visualized by exposure to a UV lamp (λ = 254 nm), and/or a solution of KMnO4, followed by brief 
heating using a Varitemp heat gun. Column chromatography was performed using Merck silica gel grade 
9385 60Å (230-400 mesh). 
 
Structural analysis.  1H NMR and 13C NMR spectra were recorded at 20 oC on Varian Unity 500, Varian 
Unity Inova 500NB or Varian Unity 500 instruments.  Chemical shifts (δ) are reported in parts per million 
(ppm) downfield from tetramethylsilane and referenced to residual protium in the NMR solvent (CHCl3, δ 
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= 7.26; acetone, δ = 2.05, center line) or to added tetramethylsilane (δ = 0.00).  Data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sept = 
septet, m = multiplet, b = broad, app = apparent), coupling constant (J) in Hertz (Hz), and integration.  
Chemical shifts (δ) for 13C NMR are reported in ppm downfield from tetramethylsilane and referenced to 
carbon resonances in the NMR solvent (CDCl3, δ = 77.0, center line; acetone, δ = 39.5, center line). 
Carbons bearing boron substituents were not observed (quadrupolar relaxation). High resolution mass 
spectra (HRMS) were performed by Furong Sun and Dr. Haijun Yao at the University of Illinois School 
of Chemical Sciences Mass Spectrometry Laboratory.   
 
1. Manual deprotections of ratanhine library members 
 
Deprotection condition 1 (for library members 4.83-4.86 and 4.89-4.94) 
To a 7-mL vial containing the protected library member and a PTFE-coated magnetic stir bar was added 
TBAF·3H2O (2.2–15 equiv) followed by 1:1 DMSO/DMPU under ambient atmosphere. The vial was 
sealed with a Teflon-lined cap and stirred at 50 C for 30 minutes–6 hours. The reaction was then cooled 
to room temperature and diluted with a solution of 1:1 saturated NH4Cl/H2O (1.5–2 mL). The layers were 
mixed and the aqueous layer was removed. The organic layer was washed with H2O (2 × 1.5 mL). The 
combined aqueous phase was extracted with EtOAc (3 mL). The organic phase was dried over anhydrous 
MgSO4, filtered, and concentrated in vacuo. The crude product was purified by silica gel chromatography 
to give the pure product as a white or off-white solid. 
 
 
Deprotection condition 1 was followed to give deprotected 4.83 (7.1 mg, 50% yield).  
 
TLC (20% EtOAc/hexanes) 
Rf = 0.14, visualized by shortwave UV 
 
 1H-NMR (500 MHz, acetone-d6) 
δ 8.77 (br s, 1H), 7.83 (d, J = 8.5 Hz, 1H), 7.54 (d, J = 2.0 Hz, 1H), 7.41 (d, J = 8.5 Hz, 1H), 7.29 
(dd, J = 8.5, 2.0 Hz, 1H), 7.16 (d, J = 1.0 Hz, 1H), 6.64 (d, J = 2.0 Hz, 1H), 6.60 (dd, J = 8.0, 2.0 Hz, 1H), 
6.51 (d, J = 16, 1.5 Hz, 1H), 6.25 (dq, J = 15.5, 7 Hz, 1H), 3.99 (s, 3H), 1.86 (dd, J = 7.0, 2.0 Hz, 3H). 
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13C-NMR (125 MHz, acetone-d6) 
δ 160.2, 159.2, 154.2, 153.8, 134.0, 132.3, 131.3, 128.5, 124.5, 122.7, 118.7, 111.9, 111.2, 108.5, 
104.6, 100.2, 55.9, 18.6. 
 
HRMS (ESI+) 
Calculated for C18H17O3: 281.1178 
Found:    281.1181  
 
 
Deprotection condition 1 was followed to give deprotected 4.84 (11.7 mg, 78% yield).  
 
TLC (30% EtOAc/hexanes) 
Rf = 0.3, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 8.73 (br s, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.13 (s, 1H), 7.11 (d, J = 1.0 Hz, 1H), 6.93 (d, J = 1.0 
Hz, 1H), 6.64 (d, J = 2.0 Hz, 1H), 6.60 (dd, J = 8.5, 2.0 Hz, 1H), 6.48 (dd, J = 16, 1.5 Hz, 1H), 6.25 (dq, J 
= 16, 6.5 Hz, 1H), 4.03 (s, 3H), 3.98 (s, 3H), 1.86 (dd, J = 6.5, 1.5 Hz, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 160.2, 159.1, 154.0, 145.9, 142.9, 135.0, 132.7, 132.6, 128.5, 124.6, 111.9, 111.6, 108.5, 105.1, 
104.8, 100.2, 56.4, 55.9, 18.6. 
 
HRMS (ESI+) 
Calculated for C19H19O4: 311.1283 
Found:     311.1277 
 
 
Deprotection condition 1 was followed to give deprotected 4.85 (6.0 mg, 56% yield). 
  
165 
 
 
TLC (50% EtOAc/hexanes) 
Rf = 0.27, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 8.78 (br s, 1H), 7.83 (d, J = 8.5 Hz, 1H), 7.61 (d, J = 1.5 Hz, 1H), 7.43 (d, J = 8.5 Hz, 1H), 7.36 
(dd, J = 9.0, 2.0 Hz, 1H), 7.18 (d, J = 0.5 Hz, 1H), 6.70 (d, J = 16.0 Hz, 1H), 6.64 (d, J = 2.5 Hz, 1H), 
6.60 (dd, J = 8.5, 2.5 Hz, 1H), 6.38 (dt, J = 16, 5.5 Hz, 1H), 4.25 (t, J = 5.5 Hz, 2H), 3.99 (s, 3H), 3.84 (t, 
J = 5.5 Hz, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 160.2, 159.1, 154.2, 153.9, 133.3, 131.3, 130.5, 129.6, 128.5, 123.0, 119.2, 111.8, 111.2, 108.4, 
104.5, 100.2, 63.4, 55.8. 
 
HRMS (ESI+)  
Calculated for C18H17O4: 297.1127 
Found:    297.1128  
 
 
Deprotection condition 1 was followed to give deprotected 4.86 (7.4 mg, 35% yield). 
 
TLC (60% EtOAc/hexanes) 
Rf = 0.22, visualized by shortwave UV; 1H-NMR (500 MHz, acetone-d6): δ 8.75 (br s, 1H), 7.85 
(d, J = 8.0 Hz, 1H), 7.18 (d, J = 1.5 Hz, 1H), 7.15 (s, 1H), 6.99 (d, J = 1.0 Hz, 1H), 6.66 (dt, J = 17, 1.5 
Hz, 1H), 6.64 (d, J = 2.0 Hz, 1H), 6.60 (dd, J = 8.5, 2.5 Hz, 1H), 6.38 (dt, J = 16, 5.5 Hz, 1H), 4.25 – 4.24 
(m, 2H), 4.04 (s, 3H), 3.99 (s, 3H), 3.84 (br s, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 160.2, 159.1, 154.2, 146.0, 143.2, 134.4, 132.8, 130.9, 129.7, 128.5, 112.3, 111.9, 108.5, 105.4, 
104.8, 100.2, 63.4, 56.4, 55.9. 
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HRMS (ESI+)  
Calculated for C19H19O5: 327.1232 
Found:    327.1223 
 
 
Deprotection condition 1 was followed to give deprotected 4.89 (3.1 mg, 63% yield). 
 
TLC (60% EtOAc/hexanes) 
Rf = 0.36, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 8.37 (dd, J = 2.5, 0.5 Hz, 1H), 7.90 (d, J = 8.5 Hz, 1H), 7.70 (d, J = 1.5 Hz, 1H), 7.52 (d, J = 8.5 
Hz, 1H), 7.50 (dd, J = 9.0, 3.0 Hz, 1H), 7.45 (dd, J = 8.5, 1.5 Hz, 1H), 7.33 (d, J = 1 Hz, 1H), 6.72 (dt, J = 
15.5, 1.5 Hz, 1H), 6.41 (dt, J = 16.0, 5.5 Hz, 1H), 4.26 (t, J = 8.0 Hz, 2H), 3.96 (s, 3H), 3.87 (br t, J = 5.0 
Hz, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 157.1, 156.6, 155.4, 142.4, 139.2, 133.8, 130.4, 130.2, 130.1, 124.1, 121.2, 120.9, 119.8, 111.9, 
103.5, 63.3, 56.2. 
 
HRMS (ESI+) 
Calculated for C17H16NO3: 282.1130 
Found:    282.1132 
 
 
Deprotection condition 1 was followed to give deprotected 4.90 (3.9 mg, 67% yield) 
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TLC (60% EtOAc/hexanes) 
Rf = 0.27, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 8.36 (dd, J = 2.5, 0.5 Hz, 1H), 7.90 (d, J = 8.5 Hz, 1H), 7.49 (dd, J = 9.0, 3.0 Hz, 1H), 7.30 (s, 
1H), 7.25 (d, J = 1.0 Hz, 1H), 7.08 (d, J = 1.5 Hz, 1H), 6.68 (app d, J = 15.5 Hz, 1H), 6.41 (dt, J = 16, 5.5 
Hz, 1H), 4.25 (t, J = 5.5 Hz, 2H), 4.06 (s, 3H), 3.95 (s, 3H), 3.86 (br t, J = 5.5 Hz, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 159.9, 156.5, 146.3, 144.6, 142.4, 139.2, 134.8, 131.8, 130.4, 130.2, 121.2, 120.8, 112.6, 105.9, 
103.8, 63.3, 56.3, 56.2. 
 
HRMS (ESI+)  
Calculated for C18H18NO4:  312.1236 
Found:     312.1239  
  
 
Deprotection condition 1 was followed to give deprotected 4.91 (12.6 mg, 81% yield) 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.36, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 9.30 (br s, 1H), 7.96 (d, J = 8.5 Hz, 1H), 7.63 (d, J = 1.0 Hz, 1H), 7.47 (d, J = 8.5 Hz, 1H), 7.38 
(dd, J = 8.5, 1.5 Hz, 1H), 7.10 (s, 1H), 7.03 (dd, J = 8.5, 2.0 Hz, 1H), 6.98 (m, 1H), 6.52 (dd, J = 15.5, 1.5 
Hz, 1H), 6.28 (dq, J = 15.5, 6.5 Hz, 1H), 1.87 (dd, J = 6.5, 1.5 Hz, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 159.7, 154.2, 152.0, 147.2, 134.4, 131.9, 130.5, 130.0, 125.0, 123.7, 121.5 (JC-F = 257 Hz), 
119.1, 115.9, 115.7, 111.5, 109.3, 105.3, 18.5. 
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HRMS (ESI+) 
Calculated for C18H14O3F3: 335.0895 
Found:    335.0889 
 
 
Deprotection condition 1 was followed to give deprotected 4.92 (14.3 mg, 77% yield). 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.27, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 9.33 (br s, 1H), 7.96 (d, J = 9.0 Hz, 1H), 7.19 (d, J = 0.5 Hz, 1H), 7.07 (s, 1H), 7.03 (dd, J = 8.5, 
2.0 Hz, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.97 (m, 1H), 6.49 (dd, J = 15.5, 1.5 Hz, 1H), 6.28 (dq, J = 16.0, 
6.5 Hz, 1H), 4.04 (s, 3H), 1.86 (dd, J = 6.5, 3.0 Hz, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 159.7, 151.7, 147.1, 146.0, 143.5, 135.4, 132.2, 131.9, 129.9, 125.0, 121.5 (JC-F = 256 Hz), 
115.9, 115.7, 111.8, 109.2, 105.8, 105.6, 56.3, 18.5. 
 
HRMS (ESI+) 
Calculated for C19H16O4F3: 365.1001 
Found:    365.0997 
 
 
Deprotection condition 1 was followed to give deprotected 4.93 (7.1 mg, 73% yield). 
 
TLC (40% EtOAc/hexanes) 
Rf = 0.21, visualized by shortwave UV. 
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1H-NMR (500 MHz, acetone-d6) 
δ 9.30 (br s, 1H), 7.97 (d, J = 8.5 Hz, 1H), 7.10 (d, J = 1.5 Hz, 1H), 7.50 (d, J = 8.5 Hz, 1H), 7.44 
(dd, J = 8.5, 2.0 Hz, 1H), 7.12 (d, J = 0.5 Hz, 1H), 7.04 (dd, J = 8.5, 2.5 Hz, 1H), 6.98 (quint, J = 2 Hz, 
1H), 6.72 (d, J = 16 Hz, 1H), 6.41 (dt, J = 16.0, 5.0 Hz, 1H), 4.26 (d, J = 5.0 Hz, 2H), 3.84 (br s, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 159.8, 154.4, 152.1, 147.2, 133.8, 130.6, 130.1, 130.0 (2C), 124.0, 121.5 (JC-F = 256 Hz), 119.7, 
115.9, 115.7, 111.6, 109.3, 105.3, 63.3. 
 
HRMS (ESI+) 
Calculated for C18H14O4F3: 351.0844 
Found:    351.0849 
 
 
Deprotection condition 1 was followed to give deprotected 4.94 (11.4 mg, 67% yield). 
 
TLC (40% EtOAc/hexanes) 
Rf = 0.13, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 9.30 (br s, 1H), 7.97 (d, J = 8.5 Hz, 1H), 7.26 (d, J = 0.5 Hz, 1H), 7.09 (s, 1H), 7.06 (d, J = 1.0 
Hz, 1H), 7.04 (dd, J = 8.5, 2.5 Hz, 1H), 6.97 (m, 1H), 6.68 (d, J = 15.5 Hz, 1H), 6.41 (dt, J = 16.0, 5.0 Hz, 
1H), 4.26 (d, J = 5.0 Hz, 2H), 4.06 (s, 3H), 3.85 (br s, 1H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 159.7, 151.8, 147.1, 146.1, 143.7, 134.8, 131.9, 130.4, 130.1, 129.9, 121.5 (JC-F = 256 Hz), 
115.9, 115.7, 112.4, 109.2, 106.0, 105.6, 63.3, 56.4. 
 
HRMS (ESI+) 
Calculated for C19H16O5F3: 381.0950 
Found:    381.0946 
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Deprotection condition 2 (for library members 4.95-4.98) 
To a 1-mL Reacti-vial™ containing the protected tetramer library member and a PTFE-coated magnetic 
stir bar was added TBAF·3H2O (15-20 equiv) followed by DMSO under ambient atmosphere. The vial 
was sealed with a cap and stirred at 50 C for 5 hours. The reaction was then cooled to room temperature, 
diluted with 8 mL Et2O and washed with a solution of 1:1 saturated NH4Cl/H2O (4 mL). The aqueous 
layer was extracted with 4 mL Et2O. The combined organic layers were washed with H2O (2 × 4 mL), 
then with brine (4 mL). The organic phase was dried over anhydrous MgSO4, filtered, and concentrated in 
vacuo. The crude product was purified by silica gel chromatography. 
 
 
Deprotection condition 2 was followed to give deprotected 4.95 (1.0 mg, 48% yield). 
 
TLC (40% EtOAc/pentane) 
Rf = 0.49, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.77 (s, 1H), 7.53 (d, J = 1.5 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 7.27 (dd, J = 8.5, 2.0 Hz, 1H), 
7.18-7.17 (m, 3H), 6.82 (dd, J = 6.5, 3.0 Hz, 1H), 6.68 (s, 1H), 6.50 (dd, J = 16.0, 1.5 Hz, 1H), 6.31 (dd, J 
= 15.5, 1.5 Hz, 1H), 6.24 (dq, J = 16.0, 6.5 Hz, 1H), 6.05 (dq, J = 15.5, 7.0 Hz, 1H), 5.69 (d, J = 2.5 Hz, 
1H), 5.66 (d, J = 2.5 Hz, 1H), 3.99 (s, 3H), 1.85 (dd, J = 6.5, 1.5 Hz, 1H), 1.78 (dd, J = 6.5, 1.5 Hz, 1H). 
 
HRMS (ESI+) 
Calculated for C29H27O4: 439.1909 
Found:    439.1904 
 
 
Deprotection condition 2 was followed to give deprotected 4.96 (1.1 mg, 38% yield). 
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TLC (40% EtOAc/pentane) 
Rf = 0.46, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.81 (s, 1H), 7.18-7.14 (m, 3H), 7.10 (d, J = 1.0 Hz, 1H), 6.90 (d, J = 1.0 Hz, 1H), 6.82 (dd, J = 
7.5, 1.5 Hz, 1H), 6.67 (s, 1H), 6.46 (dd, J = 16, 1.5 Hz, 1H), 6.30 (dd, J = 15.5, 1.0 Hz, 1H), 6.24 (dq, J = 
15.5, 6.5 Hz, 1H), 6.04 (dq, J = 15.5, 6.5 Hz, 1H), 5.70 (d, J = 1.5 Hz, 1H), 5.67 (d, J = 2.0 Hz, 1H), 3.98 
(s, 3H), 3.96 (s, 3H), 1.85 (dd, J = 7.0. 2.0 Hz, 3H), 1.78 (dd, J = 6.5, 1.5 Hz, 3H) 
 
HRMS (ESI+) 
Calculated for C30H29O5: 469.2015 
Found:    469.2014 
 
 
Deprotection condition 2 was followed to give deprotected 4.97 (0.039 mg, 14% yield). The yield of the 
deprotection of 78 was determined by 1H-NMR using an internal standard. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.78 (s, 1H), 7.60 (d, J = 1 Hz, 1H), 7.40 (d, J = 8 Hz, 1H), 7.33 (dd, J = 8.5, 1.5 Hz, 1H), 7.19-
7.17 (m, 3H), 6.82 (d, J = 9 Hz, 1H), 6.70-6.68 (m, 2H), 6.37 (dt, J = 16, 5.5 Hz, 1H), 6.31 (dd, J = 15.5, 
1 Hz, 1H), 6.05 (dq, J = 15.5, 6.5 Hz, 1H), 5.69 (d, J = 2 Hz, 1H), 5.66 (d, J = 2 Hz, 1H), 4.24 (dd, J = 5, 
2 Hz, 2H), 3.99 (s, 3H), 1.78 (dd, J = 6.5, 1.5 Hz, 3H). 
 
HRMS (ESI+) 
Calculated for C29H27O5: 455.1858 
Found:    455.1866 
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Deprotection condition 2 was followed to give deprotected 4.98 (0.3 mg, 21% yield). 
 
TLC (40% EtOAc/pentane) 
Rf = 0.48, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.81 (s, 1H), 7.18 – 7.14 (m, 4H), 6.97 (d, J = 1.0 Hz, 1H), 6.82 (dd, J = 7.0, 1.5 Hz, 1H), 6.67 
– 6.63 (m, 2H), 6.37 (dt, J = 16, 5.5 Hz, 1H), 6.30 (dd, J = 15.5, 1.5 Hz, 1H), 6.04 (dq, J = 16.0, 7.0 Hz, 
1H), 5.69 (d, J = 2.0 Hz, 1H), 5.66 (d, J = 2.0 Hz, 1H), 4.23 (d, J = 4.5 Hz, 2H), 3.98 (s, 3H), 3.98 (s, 3H), 
1.78 (dd, J = 6.5, 2.0 Hz, 3H). 
 
HRMS (ESI+) 
Calculated for C30H29O6: 485.1964 
Found:    485.1952 
 
Deprotection condition 3 (for library members 4.37 and 4.99-4.101) 
To a 1-mL Reacti-vial™ containing the protected library member and a PTFE-coated magnetic stir bar 
was added CsF (25-30 equiv) and 18-crown-6 (2 equiv) followed by DMSO in a glovebox. The vial was 
sealed with a cap and stirred at 50 C for 14 hours. The reaction was then cooled to room temperature, 
diluted with 8 mL EtOAc and washed with a solution of 1:1 saturated NH4Cl/H2O (8 mL). The aqueous 
layer was extracted with 4 mL EtOAc. The combined organic layers were washed with H2O (2 × 4 mL), 
then with brine (8 mL). The organic phase was dried over anhydrous MgSO4, filtered, and concentrated in 
vacuo. The crude product was purified by silica gel chromatography. 
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Deprotection condition 3 was followed to give 4.4 as an off-white solid (0.2 mg, 0.00036 mmol, 7% 
yield). 
 
TLC (40% EtOAc/pentane) 
Rf = 0.44, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.83 (dt, J = 9.0, 2.0 H, 2H), 7.77 (s, 1H), 7.53 (s, 1H), 7.43 (dd, J = 8.5, 2.0 Hz, 1H), 7.37 (d, J 
= 8.5 Hz, 1H), 7.34 (d, J = 2.5 Hz, 1H), 7.28 (d, J = 8.0, 1.0 Hz, 1H), 7.17 (d, J = 8.5 Hz, 1H), 7.14 (s, 
1H), 6.83 (dt, J = 8.5, 2.0 Hz, 2H), 6.55 (s, 1H), 6.50 (dd, J = 15.5, 1.5 Hz, 1H), 6.44 (dd, J = 16.0, 1.5 Hz, 
1H), 6.31-6.21 (m, 2H), 5.61 (d, J = 1.5 Hz, 1H), 5.57 (d, J = 2.0 Hz, 1H), 3.96 (s, 3H), 1.87 (dd, J = 6.5, 
1.5 Hz, 3H), 1.84 (dd, J = 6.5, 1.5 Hz, 3H) 
 
HRMS (ESI+) 
Calculated for C36H31O6: 559.2121 
Found:    559.2128 
 
 
Deprotection condition 3 was followed to give deprotected 4.99 (1.1 mg, 52% yield). 
 
TLC (40% EtOAc/pentane) 
Rf = 0.39, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.85 (app d, J = 9.0 Hz, 2H), 7.81 (s, 1H), 7.43 (dd, J = 8.5, 2.5 Hz, 1H), 7.33 (d, J = 2.5 Hz, 
1H), 7.18 (d, J = 8.5 Hz, 1H), 7.12 – 7.10 (m, 2H), 6.92 (d, J = 1.5 Hz, 1H), 6.84 (app d, J = 9.0 Hz, 2H), 
6.55 (s, 1H), 6.49 – 6.42 (m, 2H), 6.30 – 6.21 (m, 2H), 5.62 (d, J = 2.0 Hz, 1H), 5.58 (d, J = 1.5 Hz, 1H), 
3.97 (s, 3H), 3.96 (s, 3H), 1.86 (dd, J = 6.5, 1.5 Hz, 3H), 1.83 (dd, J = 7.0, 2.0 Hz, 3H). 
 
HRMS (ESI+) 
Calculated for C37H33O7: 589.2226 
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Found:     589.2224 
 
 
Deprotection condition 3 was followed to give deprotected 4.100 (0.15 mg, 22% yield). 
 
TLC (60% EtOAc/pentane) 
Rf = 0.24, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.82 (app d, J = 8.5 Hz, 2H), 7.77 (s, 1H), 7.60 (d, J = 1.5 Hz, 1H), 7.43 (dd, J = 8.0, 2.0 Hz, 
1H), 7.40 (d, J = 8.0 Hz, 1H), 7.35-7.33 (m, 2H), 7.17 (d, J = 8.5 Hz, 1H), 7.15 (d, J = 1.0 Hz, 1H), 6.83 
(app d, J = 9.0 Hz, 2H), 6.69 (app d, J = 16.0 Hz, 1H), 6.56 (s, 1H), 6.44 (d, J = 16 Hz, 1H), 6.38 (dt, J = 
16.0, 5.5 Hz, 1H), 6.27 (dq, J = 16, 6.5 Hz, 1H), 5.61 (d, J = 1.5 Hz, 1H), 5.58 (d, J = 2.0 Hz, 1H), 4.25-
4.24 (m, 2H), 3.97 (s, 3H), 1.84 (dd, J = 6.5, 1.5 Hz, 3H). 
 
HRMS (ESI+) 
Calculated for C36H31O7: 575.2070 
Found:    575.2070 
 
 
Deprotection condition 3 was followed to give deprotected 4.101 (0.3 mg, 14% yield). 
 
TLC (60% EtOAc/pentane) 
Rf = 0.23, visualized by shortwave UV. 
 
1H-NMR (500 MHz, acetone-d6) 
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δ 7.85 (dt, J = 8.5, 2.0 Hz, 2H), 7.81 (s, 1H), 7.43 (dd, J = 8.0, 2.0 Hz, 1H), 7.33 (d, J = 2.0 Hz, 
1H), 7.18-7.17 (m, 2H), 7.13 (s, 1H), 6.98 (s, 1H), 6.84 (dt, J = 9.0, 2.0 Hz, 2H), 6.66 (app d, J = 16.0 Hz, 
1H), 6.55 (s, 1H), 6.44 (dd, J = 16.5, 1.5 Hz, 1H), 6.37 (dt, J = 16.0, 5.5 Hz, 1H), 6.27 (dq, J = 16.0, 6.5 
Hz, 1H), 5.62 (d, J = 1.5 Hz, 1H), 5.58 (d, J = 1.5 Hz, 1H), 4.25-4.24 (m, 2H), 3.99 (s, 3H), 3.96 (s, 3H), 
1.83 (dd, J = 6.5, 1.5 Hz, 3H) 
 
HRMS (ESI+) 
Calculated for C37H33O8: 605.2175 
Found:    605.2167 
 
2. Manual synthesis of 4.9-4.14 from linear precursors generated by the synthesizer 
 
 
 
 
A 7 mL vial containing protected seco acid 4.107-1 (85.6 mmol, 0.115 mmol, 1 equiv) and a stir bar was 
charged with TBAF·3H2O (185 mg, 0.586 mmol, 5.1 equiv) in the glovebox. The vial was sealed with a 
septum cap and brought out of the glovebox. DMSO (2.3 mL) was added via syringe and the reaction was 
stirred at 50 °C for 70 min in a heating block. The reaction was cooled to room temperature, then 
partitioned between H2O (20 mL) and Et2O (20 mL). After mixing thoroughly and separating the phases 
(both phases should become clear), the aqueous layer was extracted with Et2O (20 mL, then with 10 mL). 
The combined organics were washed with brine, dried over MgSO4, filtered and concentrated to ~ 5mL. 
Celite was added to the solution and the crude product was adsorbed onto celite in vacuo. The celite pad 
was loaded onto a florisil column (5 cm length, 2 cm diameter) equilibrated with 60% EtOAc/hexanes. 
The impurities were eluted with 80% EtOAc/hexanes + 0.1% AcOH. The product was eluted with 80% 
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EtOAc/hexanes + 0.2% AcOH. The fractions containing the product were concentrated to ~ 5 mL and 
then azeotroped with n-heptane to remove residual AcOH. After complete removal of solvent, the residue 
was triturated with 1:5 DCM:pentane, causing an off-white solid to precipitate. The suspension was then 
concentrated in vacuo and dried under high vacuum to give an off-white fluffy solid as the product 4.107-
1 (41 mg, 73%).  1H-NMR matches literature data.3 
 
 
The following procedure is modified from a known literature procedure.3 A dry 40 mL vial equipped with 
a stir bar was charged with PPh3 (99.2 mg, 0.378 mmol, 5.05 equiv). The vial was sealed with a septum 
cap, evacuated and filled with N2 (×3). THF (2.5 mL) was added, followed by PhMe (5 mL). A dry 7 mL 
vial was charged with seco acid 4.107-1 (36.4 mg, 0.0748 mmol, 1 equiv), sealed with a septum cap, 
evacuated and filled with N2 (×3). THF (0.4 mL) and PhMe (2 mL) was added. Diethyl azodicarboxylate 
solution (40 wt% in PhMe, 0.17 mL, 0.374 mmol, 5 equiv) was then added to the 40 mL vial via syringe, 
giving a very light yellow solution. A 3 mL syringe was charged with 1.2 mL of the seco acid solution, 
which was added to the 40 mL vial over 6 h with the aid of a syringe pump. The reaction was then stirred 
for another 1 h. Another portion of PPh3 (99.2 mg, 0.378 mmol, 5.05 equiv) was added as a solid. The 
vial was flushed briefly with N2 and re-sealed with a septum cap. Another portion of diethyl 
azodicarboxylate solution (40 wt% in PhMe, 0.17 mL, 0.374 mmol, 5 equiv) was added. The 3 mL 
syringe was then charged with the remaining seco acid solution and added to the reaction over 5 h. The 
reaction was then stirred for another 5 h. THF (0.3 mL) was used to rinse out the 7 mL vial, adding the 
rinse to the reaction over 1h. The reaction was stirred for another 3.5 h, then transferred to a recovery 
flask, rinsing with EtOAc. Celite was added and the crude product adsorbed in vacuo. The crude product 
was purified by silica gel column (hexanes to 5% to 10% to 15% EtOAc/hexanes) to give an off-white 
solid as the pure product 4.107-2 (12.4 mg, 35%). TLC (30% Et2O/hexanes): Rf = 0.28, visualized by 
short wave UV; 1H-NMR matches literature data.3  
 
Supplementary 1H-NMR: (500 MHz, CDCl3) 
δ 7.43-7.38 (m, 4H), 7.35-7.31 (m, 4H), 7.29-7.27 (m, 2H), 6.55 (d, J = 2.5 Hz, 1H), 6.57 (d, J = 
2.0 Hz, 1H), 6.31 (d, J = 3.0 Hz, 1H), 6.09 (d, J = 3.0 Hz, 1H), 5.30-5.24 (m, 1H), 5.09 (d, J = 11.5 Hz, 
1H), 5.05 (d, J = 12.5 Hz, 1H), 5.04 (d, J = 11.5 Hz, 1H), 5.00 (d, J = 12.0 Hz, 1H), 3.28 (dd, J = 17.0, 
14.5 Hz, 2H), 2.83 (ddd, J = 15.5, 6.5, 2.5 Hz, 1H), 2.73 (ddd, J = 15, 11.5, 2.5 Hz, 1H), 2.07-2.03 (m, 
1H), 1.86-1.79 (m, 1H), 1.27 (d, J = 6.5 Hz, 3H). 
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In an unoptimized procedure, a solution of the dibenzyl ether 4.107-2 (12.1 mg, 0.0258 mmol) in a 7 mL 
vial was charged with 10% Pd/C (2 mg) The vial was sealed with a septum cap and H2 gas was bubbled 
through the stirring suspension for 8 min from a balloon. The outlet needle was removed and the reaction 
was stirred under H2 atmosphere at room temperature. After 1 h, another portion of 10% Pd/C (1.4 mg) 
was added to the reaction. The vial was flushed with H2 for 3 min, then left to stir. After another 2 h, a 
third portion of 10% Pd/C (5 mg) was added and the reaction was left to stir for another 25 min. The 
reaction was then purged with N2 for 5 min, then filtered through celite, rinsing with EtOAc. The filtrate 
was concentrated in vacuo, azeotroping once with CH2Cl2. The crude product was purified by silica gel 
chromatography (20% to 30% to 40% EtOAc/pentane) to give a mixture of citreofuran and the 
tetrahydrofuran side product arising from reduction of the furan ring. The pure product 4.10 (0.99 mg, 
13%) was obtained after HPLC purification (Agilent Prep-C18, 10 µm, 30 x 150 mm, product number: 
413910-302, 25 mL/min, gradient: 40% to 70% EtOH/H2O in 25 min) 1H-NMR matches literature data.3 
 
 
 
 
To a polyethylene vial containing a solution of 4.111-1 in THF (0.4 mL) was added HF·pyridine (0.09 
mL), followed by THF (0.3 mL). The vial was capped and stirred at room temperature for 3 h. The 
reaction was quenched with the dropwise addition of saturated aqueous NaHCO3 (5 mL). The mixture 
was stirred for 5 min, then transferred to a separatory funnel saturated aqueous NaHCO3 (3 mL), rinsing 
with Et2O (8 mL). After mixing and phase separation, the aqueous layer was extracted with Et2O (4 mL × 
2). The combined organics were washed with H2O, brine, dried over MgSO4, filtered and concentrated in 
vacuo, azeotroping once with CH2Cl2. The crude product was purified by silica gel chromatography (30% 
to 40% Et2O/pentane) to give a colorless liquid as the product 4.111-1 (7.3 mg, 60%).  
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TLC (50% Et2O/hexanes) 
Rf = 0.32, visualized by UV, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.63 (td, J = 7.5, 1.5 Hz, 1H), 6.23 (dd, J = 15.0, 10.0 Hz, 1H), 6.04 (dd, J = 15.0 Hz, 10.5 Hz, 
1H), 5.73 (dt, J = 15.5 Hz, 6.0 Hz, 1H), 5.67 (dt, J = 15.0, 7.5 Hz, 1H), 4.17 (app d, J = 5.5 Hz, 1H), 2.20-
2.08 (m, 3H), 1.99-1.93 (m, 1H), 1.78 (d, J = 1.0 Hz, 3H), 1.56-1.41 (m, 11H), 1.33 (t, J = 9.5 Hz, 1H), 
1.27-1.21 (m, 1H), 0.89 (d, J = 6.5 Hz, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 167.6, 141.2, 133.7, 131.9, 130.8, 129.6, 129.0, 79.9, 63.5, 40.0, 35.2, 32.9, 28.1, 26.3, 19.4, 
12.3. 
 
HRMS (ESI+) 
Calculated for C18H30O3Na: 317.2093 
Found:    317.2096 
 
 
The following procedure is modified from a known literature procedure4: A Schlenk bomb containing 
alcohol 4.111-1 (7.3 mg, 0.0248 mmol) and a stir bar was charged with 1,2-dichlorobenzene (2.5 mL) 
under a stream of N2. Methlyene blue (~ 1 mg) was added, forming a blue solution. The solution was 
degassed with 6 freeze-pump-thaw cycles. The flask was sealed under vacuum, then warmed to room 
temperature and placed in a sand bath and warmed to ~150 °C. The reaction temperature was allowed to 
equilibrate for another 15 min before introducing N2 gently into the reaction vessel. The vessel was sealed 
again and stirred at 200-210 °C (bath temperature). The reaction was stirred for a total of 68 h at that 
temperature. The reaction was cooled to room temperature, then transferred to a 15 mL rbf, rinsing with 
CH2Cl2. The CH2Cl2 was removed by rotary evaporation. The remaining solvent was removed by 
distillation under vacuum, giving a blue residue. The crude product was loaded onto a silica gel column 
equilibrated with 10% Et2O/pentane. The product was eluted with 20% Et2O/pentane. This semi-purified 
product was purified on a second silica gel column (100% CH2Cl2) to give oblongolide 4.11 as a white 
solid (1.3 mg, 24%) in 85-90% purity. 1H-NMR matches literature data.4  
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Supplementary data: 1H-NMR (500 MHz, CDCl3) 
δ 5.61 (d, J = 10.0 Hz, 1H), 5.55 (ddd, J = 10.0, 4.5, 2.5 Hz, 1H), 4.39 (t, J = 9.0 Hz, 1H), 3.83 
(dd, J = 11.0, 8.5 Hz, 1H), 2.75-2.70 (m, 1H), 1.96-1.74 (m, 3H), 1.52-1.45 (m, 1H), 1.35-1.21 (m, 3H), 
1.14 (s, 3H), 0.97-0.84 (m, 4H), 0.79 (q, J = 12.3 Hz, 1H). 
 
 
 
 
To a solution of ketal 4.116 (18.8 mg, 0.0602 mmol) in THF (2 mL) in a 7 mL vial was added 2N HCl (1 
mL) dropwise under ambient atm at 0 °C. The addition was completed in less than 1 min. The vial was 
capped with a PTFE-lined cap and stirred at 0 °C for 2 h 10 min. The reaction was quenched with the 
slow addition of saturated aqueous NaHCO3 (2 mL) at the same temperature. The mixture was stirred 
vigorously until bubbling ceased. The mixture was then transferred to a separatory funnel containing 
saturated aqueous NaHCO3 (5 mL) and Et2O (5 mL), rinsing with Et2O (5 mL). After mixing and phase 
separation, the aqueous layer was extracted with Et2O (2 × 5 mL). The combined organics were washed 
with brine, dried over MgSO4, filtered and concentrated in vacuo at room temperature. The crude product 
was taken up in a minimum amount of 60% DCM/pentane and loaded onto a silica gel column 
equilibrated with 60% DCM/pentane. The crude product was purified by silica gel chromatography (60% 
to 70% DCM/pentane) to afford the product 4.116-1 as a single isomer (8.5 mg, 62%). 1H-NMR matches 
literature data.5 
 
Supplementary 1H-NMR (500 MHz, CDCl3) 
δ 9.52 (d, J = 8.0 Hz, 1H), 7.38 (app d, J = 8.0 Hz, 2H), 7.31 (app t, J = 7.5 Hz, 2H), 7.21 (d, J = 
7.5 Hz, 1H), 6.86 (dt, J = 15.5, 6.5 Hz, 1H), 6.75 (dd, J = 15.5, 10.0 Hz, 1H), 6.47 (d, J = 15.5 Hz, 1H), 
6.23 (dd, J = 15.0, 10.5 Hz, 1H), 6.14 (ddt, J = 15.5, 6.5, 1.0 Hz, 1H), 5.79 (dt, J = 15.0, 7.5 Hz, 1H), 2.38 
(app q, J = 7.0 Hz, 2H), 2.22 (app q, J = 8.0 Hz, 2H), 1.67 (quint, J = 7.5 Hz, 1H). 
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The following procedure is modified from a published procedure5: A solution of imidazolidinone catalyst 
(29.4 mg, 0.118 mmol) in MeCN (1.2 mL) in a 7 mL vial was cooled to -35 °C in a dry ice/ethylene 
glycol/EtOH bath with stirring. TFA (9 µL, 0.118 mmol) and H2O (24 µL) were added. The solution was 
stirred for 5 min at the same temperature. 75 µL of this solution was then added to the 2 mL vial 
containing aldehyde 4.116-1. The vial was capped with a PTFE-lined cap and left to stand in a -18 °C 
freezer for 39 h.  The reaction was then warmed to room temperature and loaded directly onto a silica gel 
column equilibrated with 5% EtOAc/pentane, rinsing with  a small amount of the same solvent mixture. 
The product was eluted with 5% EtOAc/pentane. The fractions containing the product were concentrated 
in vacuo at room temperature to give the product 4.12 as a crystalline solid (6.7 mg, 79% yield). The d.r. 
was determined to be 17:1 1H-NMR. The e.r. was determined to be 95.5:4.5 by chiral HPLC (Chiralcel-
OD-H, 15% IPA/hexane isocratic elution, flow rate = 0.75 mL/min, tr (minor) = 5.33 min, tr (major) = 
5.85 min).  1H-NMR matches reported literature data.5  
 
 
 
 
In the glovebox, the 7 mL vial containing 4.122 (34.6 mg, 0.0685 mmol, 1 equiv) and a stir bar was 
charged with Mg turnings (70.5 mg, 2.90 mmol, 42.3 equiv). The vial was sealed with a septum cap and 
brought out of the glovebox and placed under N2. MeOH (1.4 mL) was added via syringe and the mixture 
was sonicated for 2 min, then stirred at rt with an N2 inlet needle. Note: an exotherm formed as the Mg 
turnings dissolved, but the reaction was not cooled. The reaction was stirred for 16 h, then quenched with 
the addition of sat. aq. NH4Cl (2 mL). The mixture was transferred to a separatory funnel, rinsing with 
Et2O (10 mL) and H2O (5 mL). After mixing and phase separation, the aqueous layer was extracted with 
Et2O (2 x 5 mL). The combined organics were washed with H2O (10 mL), brine, dried over Na2SO4, 
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filtered and concentrated in vacuo. The residue was taken up in CH2Cl2, filtered through a pad of Na2SO4 
and concentrated in vacuo. After drying under high vacuum, the material was re-subjected to the above 
reaction conditions to consume the remaining starting material. After the same work-up procedure 
described above, the desired reduced product 4.122-1 was obtained as a 4:1 mixture of ethyl:methyl ester 
(29.1 mg, 84% yield). This material was used without further purification. NMR data matches that of 
product from manual synthesis (Chapter 3). 
 
 
The 7 mL vial containing ester 4.122-1 (27.6 mg, 0.0544 mmol, 1 equiv) was charged with a stir bar and 
sealed with a septum cap. The vial was vac-filled with N2 (× 3). THF (1.1 mL) was added via syringe and 
the solution cooled to -25 °C in a dry ice/ethylene glycol/ethanol bath. DIBAl-H (1M in hexanes, 0.27 mL, 
0.27 mmol, 4.96 equiv) was added dropwise. The reaction was stirred at -20 °C for 2 h. The reaction was 
quenched by adding sat. Rochelle’s salt solution (1.5 mL) was dropwise at -20 °C. Et2O (1.5 mL) was 
then added. The mixture was stirred vigorously for 10 min, then H2O (1 mL) and Et2O (1mL) were added. 
After stirring for another 10 min, the mixture was transferred to a separatory funnel, rinsing with H2O 
(8mL) and Et2O (8 mL). After mixing and phase separation, the aqueous layer was extracted with Et2O (2 
x 5 mL). The combined organics were washed with H2O, brine, dried over Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified by silica gel chromatography (5% to 10% to 20% 
Et2O/hexanes) to give the product 4.122-2 as a colorless oil (22.5 mg, 89% yield). NMR data matches that 
of product from manual synthesis (Chapter 3). 
 
 
To a solution of 4.122-2 (22.3 mg, 0.048 mmol) in THF (0.75 mL) and pyridine (0.25 mL) in a 
polyethylene vial equipped with a stir bar was added HF·pyridine (0.18 mL) dropwise at 0 °C. The vial 
was purged with N2, and sealed with a screw cap. The reaction was gradually warmed to rt. After 5 h, 
another portion of HF·pyridine (0.05 mL) was added to the reaction at rt. The reaction was then stirred for 
another 1.5 h, then quenched by the slow addition of sat. aqueous NaHCO3 (3 mL). The mixture was 
transferred to a separatory funnel containing sat. aq. NaHCO3 (10 mL), rinsing with Et2O (10 mL). After 
mixing and phase separation, the aqueous layer was extracted with Et2O (3 × 5 mL). The combined 
organics were washed with H2O, brine, dried over Na2SO4, filtered and concentrated. The crude product 
was purified by silica gel chromatography (20% to 30% to 40% EtOAc/hexanes) to give the pure product 
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4.122-3 as a colorless oil (13.7 mg, 93% yield). NMR data matches that of product from manual synthesis 
(Chapter 3). 
 
 
The following procedure was modified from a published procedure6: To a Schlenk tube sealed with a 
rubber septum and vac-filled with N2 (3×) was added CH2Cl2 (0.3 mL) followed by DMSO (30 µL, 0.386 
mmol, 8.7 equiv). The solution was cooled to -78 °C in a dry ice/acetone bath. Oxalyl chloride (2.0 M in 
CH2Cl2, 90 µL, 0.18 mmol, 4.05 equiv) was added dropwise via syringe. The resulting solution was 
stirred at -78 °C for 30 min. A solution of diol 4.122-3 (13.7 mg, 0.0444 mmol, 1.0 equiv) in CH2Cl2 (0.3 
mL) in a 7 mL vial was added dropwise to the reaction flask via syringe, rinsing with CH2Cl2 (0.3 mL). 
The solution was stirred for 20 min at – 78 °C, then NEt3 (45 µL, 0.32 mmol, 7.25 equiv) was added into 
the reaction dropwise. The reaction was stirred for 5 min at the same temperature, then the cold bath was 
removed and the reaction stirred at room temperature for another 45 min. TLC showed complete 
conversion of the diol. The reaction was cooled to 0 °C in an ice/water bath. Dry MeNH2 gas was then 
passed above the reaction solution over 4 min via an inlet needle with an outlet needle, causing an 
increase in reaction volume and dissolution of the solids. The reaction was stirred for 4 h, gradually 
warming to room temperature in the ice/water bath. The flask was then opened to the Schlenk line, 
causing evaporation of the dissolved MeNH2. The solvent was removed under a stream of N2, giving a 
yellow oily solid. The rubber septum was quickly replaced with a new septum under positive N2 flow, and 
the residue was dried under high vacuum overnight. The flask was filled with N2. Dry AcOH (0.7 mL) 
was added to dissolve the brown residue. The solution was stirred at 80 °C (oil bath temperature) for 8.5 h. 
The reaction was cooled to room temperature and transferred to an Erlenmeyer flask equipped with a stir 
bar, rinsing with CH2Cl2 (10 mL). The solution was cooled to 0 °C in an ice/water bath. 3N NaOH was 
added dropwise with stirring until pH>10 (approx. 4.4 mL). The mixture was transferred to a separatory 
funnel, rinsing with CH2Cl2 (5 mL). After phase separation the pH was adjusted to 14 with 2 drops of 3N 
NaOH. The aqueous phase was then extracted with CH2Cl2 (2 × 3 mL). The combined organics were 
washed with saturated NaHCO3 (aq), dried over Na2SO4, filtered and concentrated in vacuo. The crude 
product was purified by silica gel column chromatography (20-40% EtOAc/pentane) to give the product 
as a colorless oil (6.0 mg, 47% yield). NMR data matches that of product from manual synthesis (Chapter 
3) 
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3. Synthesis of building blocks 
 
a. Synthesis of building blocks for 4.3 
 
 
Conditions: (a) 3-(trimethylsilyl)propiolaldehyde, Sn(OTf)2, NEt3, CH2Cl2, -78 oC, 2 h; (b) 
Me4NBH(OAc)3, MeCN/AcOH 2:1, -25 oC, 16 h; (c) Me3OBF4, proton sponge, CH2Cl2, 23 oC, 2.5 h; (d) 
(NH4)2Ce(NO3)6, MeCN/H2O, 10:1, 23 oC, 1 h; (e) Dess-Martin periodinane, CH2Cl2, 0 oC to 23 oC, 1.5 h; 
(f) CHI3, CrCl2, THF, 0 oC to 23 oC, 3 h. (g) n-BuLi, THF, B(OMe)3, -78 oC; 1N HCl; (h) N-
methyliminodiacetic acid, benzene/DMSO 10:1, 80 oC, 2 h; (i) AgNO3, 2,6-lutidine, acetone/H2O 1:1, 0 
oC, 2.5 h; (j) HSnBu3, Pd2dba3, RuPhos, CH2Cl2, 23 oC; (k) I2, CH2Cl2, 23 oC. 
 
 
To a 500-mL Schlenk flask charged with Sn(OTf)2 (112.5 mmol, 46.9 g) was added CH2Cl2 (500 mL) and 
triethylamine (120 mmol, 16.7 mL) dropwise. The resulting orange-brown suspension was cooled to -78 
°C. To the stirred mixture was added (S)-1-(p-methoxybenzyloxy)-2-methylpentan-3-one (4.31-1) (75.0 
mmol, 17.8 g, 2.00 mL) as a neat liquid over 15 minutes. The mixture was stirred for 2 hours at -78 °C. 
To the mixture was added 3-(trimethylsilyl)propiolaldehyde7 (43) (112.5 mmol, 14.2 g) as a neat liquid 
over 20 minutes. The mixture was stirred for an additional 3 hours at -78 °C. The reaction was quenched 
by pouring the mixture slowly into saturated aqueous NH4Cl (300 mL) cooled in an ice bath, rinsing with 
additional CH2Cl2. The mixture was stirred vigorously for 10 minutes, then filtered through Celite™ to 
remove the tin(II) salts. The filtrate was transferred to a 2-L separatory funnel and the phases separated. 
The organic phase was washed with saturated aqueous NH4Cl (200 mL). The combined aqueous phases 
were extracted with CH2Cl2 (200 mL). The combined organic phases were washed with H2O (200 mL), 
dried over anhydrous MgSO4, filtered and concentrated in vacuo to afford a yellow-brown oil. This 
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residue was subjected to flash chromatography on silica gel (EtOAc:hexanes 8:100 → 20:100) to afford 
3-2.2 as a colorless oil (36.71 g, 73% yield).  
 
TLC (20% EtOAc/hexanes) 
Rf = 0.22, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 8.5 (app d, J = 8.5 Hz, 2H), 6.87 (app d, J = 8.5 Hz, 2H), 4.78 (d, J = 3.5 Hz, 1H), 4.43 (d, J = 
11.5 Hz, 1H), 4.36 (d, J = 11.5 Hz, 1H), 3.79, (s, 3H), 3.58 (app t, J = 9 Hz, 1H), 3.41 (dd, J = 9, 5 Hz, 
1H), 3.14 (m, 1H), 2.92, (dq, J = 7.5, 3 Hz, 1H), 1.26 (d, J = 7.5 Hz, 3H), 1.01 (d, J = 7 Hz, 3H), 0.17 (s, 
9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 216.1, 159.3, 129.5, 129.3, 113.8, 104.0, 90.2, 73.1, 63.3, 55.2, 51.7, 44.7, 13.5, 10.5, -0.2 
 
HRMS (ESI+)  
Calculated for C20H30O4NaSi: 385.1811 
Found:    385.1808 
 
 
To a 1-L, 3-neck, round-bottom flask charged with tetramethylammonium triacetoxyborohydride (298 
mmol, 78.30 g) was added dry acetic acid (240 mL) and MeCN (400 mL). The resulting homogeneous 
solution was cooled to -30 °C and stirred for 30 minutes. To the stirred solution was added 4.31-2 (71.6 
mmol, 25.95 g), dropwise over 1 minute, as a solution in MeCN (50 mL + 50 mL rinse). The solution was 
stirred and allowed to slowly warm to 0 °C over 13 h. The reaction was then poured into aqueous dibasic 
sodium tartrate solution (0.5 M, 400 mL) and stirred for 1 hour. The solution was transferred into a 
separatory funnel, and Et2O was added. After mixing and phase separation, the aqueous layer was 
extracted with Et2O. The combined organic phase was washed with saturated aqueous NaHCO3 (2 × 200 
mL), then brine (20 mL). The organic phase was dried over anhydrous Na2SO4, filtered, and concentrated 
in vacuo. Toluene was added to azeotrope most of the remaining acetic acid prior to silica gel purification. 
The residue obtained after concentration was subjected to flash chromatography on silica gel 
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(EtOAc:hexanes:AcOH 10:90:2 → 20:80:2) to afford 4.31-3 as a pale yellow oil (18.51 g, 71% yield).  
Chromatographic purification was carried out again to obtain an analytically pure sample (colorless oil).  
 
TLC (30% EtOAc/hexanes) 
Rf = 0.39, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.22 (app d, J = 8.5 Hz, 2H), 6.87 (app d, J = 8.5 Hz, 2H), 4.65 (d, J = 2.5 Hz, 1H), 4.46 (d, J 
= 11 Hz, 1H), 4.45 (d, J = 11.5 Hz, 1H), 3.80, (s, 3H), 3.73-3.68 (m, 2H), 3.45 (dd, J = 9.5, 5.5 Hz, 1H), 
2.00-1.94, (m, 2H), 1.03 (t, J = 7 Hz, 6H), 0.17 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 159.4, 129.4, 129.3, 113.9, 105.6, 89.6, 80.1, 73.6, 73.4, 66.0, 55.2, 40.6, 34.9, 14.8, 12.8, -0.1. 
 
HRMS (ESI+) 
Calculated for C20H33O4Si: 365.2148 
Found:    365.2152 
 
 
To a 1-L Schlenk flask charged with 4.31-3 (25.8 mmol, 9.40 g) was added CH2Cl2 (450 mL). To the 
stirred solution was added Proton Sponge (141.9 mmol, 38.70 g) as a solid in one portion, then 
trimethyloxonium tetrafluoroborate (180.6 mmol, 38.70 g) as a solid in one portion. The mixture was 
stirred at 23 °C for 16 hours. The orange mixture was filtered and the solid was rinsed with additional 
CH2Cl2 (100 mL). The filtrate was concentrated in vacuo to ~50 mL, during which a solid precipitated. 
To this suspension was added Et2O (300 mL), mixed and filtered, rinsing with 150 mL Et2O. The filtrate 
was transferred to a 1-L separatory funnel and washed with 0.5 M HCl (2 × 250 mL). The aqueous phase 
was extracted with 100 mL Et2O. The combined organics were neutralized with saturated aqueous 
NaHCO3 (200 mL) and washed with brine, dried over anhydrous MgSO4, filtered and concentrated to 
give a yellow oil.  The oil was subjected to flash chromatography on silica gel (EtOAc:hexanes 1:20 → 
1:10) to afford 4.31-4 as a colorless oil (5.37 g, 53% yield).  
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TLC (10% EtOAc/hexanes) 
Rf = 0.33, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 7.25 (app d, J = 8.5 Hz, 2H), 6.89 (app d, J = 8.5 Hz, 2H), 4.44 (d, J = 11.5 Hz, 1H), 4.38 (d, J 
= 11.5 Hz, 1H), 4.21 (d, J = 3 Hz, 1H), 3.80, (s, 3H), 3.57 (dd, J = 9.5, 5 Hz, 1H), 3.41 (s, 3H), 3.39, (s, 
3H), 3.27 (dd, J = 9.0, 8.0 H, 1H), 3.13 (dd, J = 10.0, 2.5 Hz, 1H), 2.10 – 2.04, (m, 1H), 1.94 – 1.88 (m, 
1H), 1.09 (d, J = 7.0 Hz, 3H), 1.01 (d, J = 7.5 Hz, 3H), 0.18 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 160.0, 130.8, 129.0, 113.7, 104.7, 90.9, 85.1, 72.7, 72.0, 71.3, 61.2, 56.5 (2C), 55.2, 41.7, 35.7, 
16.4, 11.3, 0.0. 
 
HRMS (ESI+)  
Calculated for C22H36O4NaSi:  415.2281 
Found:    415.2272 
 
 
To a stirred solution of 4.31-4 in MeCN and H2O was added ceric ammonium nitrate (1.844 mmol, 1.011 
g) portion wise over 15 minutes under ambient atmosphere and temperature. The solution was stirred for 
60 min at 23 °C, then diluted with Et2O (100 mL) and washed H2O (150 mL) and saturated NaHSO3 (2 × 
150 mL). The combined aqueous layer was extracted with Et2O (100 mL). The organic phase was dried 
over anhydrous MgSO4, filtered and concentrated. The resulting oil was subjected to flash 
chromatography on silica gel (EtOAc:CH2Cl2 0:100 → 20:100) to afford 4.31-5 as a colorless oil (202 mg, 
77% yield).  
 
TLC (20% EtOAc/hexanes) 
Rf = 0.37, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
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δ 4.23 (d, J = 3 Hz, 1H), 3.86 (d, J = 11, 3 Hz, 1H), 3.53 (dd, J = 11.5, 4.5 Hz, 1H), 3.46, (s, 3H), 
3.40 (s, 3H), 3.24 (dd, J = 10, 2 Hz, 1H), 2.01-1.95 (m, 1H), 1.88-1.82, (m, 1H), 1.18 (d, J = 7.5 Hz, 3H), 
0.99 (d, J = 7 Hz, 3H), 0.18 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 104.3, 91.4, 87.7, 71.8, 64.4, 61.4, 56.4, 42.1, 35.6, 16.1, 11.2, -0.1 
 
HRMS (ESI+) 
Calculated for C14H28O3NaSi: 295.1705 
Found:    295.1708 
 
 
To a solution of 4.31-5 (15.15 mmol, 4.13 g) in CH2Cl2 (150 mL) in a 300-mL round-bottom flask cooled 
to 0 °C was added Dess-Martin Periodinane (30.3 mmol, 12.86 g) portionwise over 5 minutes, under 
ambient atmosphere. The reaction was stirred for 10 minutes after the addition was complete, then the 
ice/water bath was removed. The reaction was stirred for another 75 minutes, and then transferred to a 
separatory funnel. The mixture was extracted with 1:1 saturated NaHCO3/1.5 M Na2S2O3 (6 × 50 mL) 
until TLC indicated that all byproducts have been removed. The aqueous phase was then extracted with 
CH2Cl2 (100 mL), and the combined organic phases were washed with brine, dried over anhydrous 
Na2SO4, filtered and concentrated at 27 °C. The resulting oil (4.31-6) was dried briefly under high 
vacuum (~15 minutes), then used immediately for the next reaction. 
 
 
To a 500-mL Schlenk flask charged with anhydrous CrCl2 (242.4 mmol, 29.81 g) was added THF (250 
mL) and cooled to 10 °C in an ice/water bath. With the exclusion of light, to the stirred suspension was 
added slowly over 15 minutes via cannula a solution of 4.31-6 (assumed 15.15 mmol) and CHI3 (75.75 
mmol, 29.83 g) in THF (80 mL). The resulting red mixture was stirred at 23 °C for 2 hours. The mixture 
was filtered through Celite™ and washed with Et2O (300 mL). The dark-colored solution was transferred 
to a separatory funnel and washed with H2O (2 x 200 mL), brine, then dried over anhydrous MgSO4, 
filtered and concentrated to give a black residue. The residue was absorbed onto Celite™ in vacuo from 
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an acetone solution. The resulting powder was subjected to flash chromatography on silica gel 
(hexanes:EtOAc 100:0 → 20:100). The product obtained after chromatography was stirred with saturated 
Na2SO3 and passed through a pad of Darco® to remove residual iodine to afford 4.31-7 as a pale yellow 
oil (4.06 g, 68% yield over 2 steps). 
 
TLC (20% EtOAc/hexanes) 
Rf = 0.52, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.55 (dd, J = 15, 9.5 Hz, 1H), 6.02 (dd, J = 15, 1 Hz, 1H), 4.23 (d, J = 2 Hz, 1H), 3.43, (s, 3H), 
3.39 (s, 3H), 3.04 (dd, J = 10, 2 Hz, 1H), 2.49-2.43 (m, 1H), 1.72-1.65 (m, 1H), 1.13 (d, J = 6.5 Hz, 3H), 
0.94 (d, J = 7 Hz, 3H), 0.19 (s, 9H); 13C-NMR (125 MHz, CDCl3): δ 147.3, 104.3, 91.3, 85.1, 75.1, 71.8, 
61.3, 56.4, 43.2, 42.1, 18.1, 10.8, -0.0. 
 
HRMS (ESI+) 
Calculated for C15H27O2NaISi: 417.0723 
Found:    417.0741 
 
 
In an unoptimized procedure, a dry 200-mL Schlenk flask was charged with THF (46 mL) and 4.31-7 in 
10 mL THF. The solution was cooled to -78 °C and n-BuLi (1.6 M in hexanes, 12.3 mmol, 7.7 mL) was 
added dropwise via cannula over 15 minutes, during which the reaction turned yellow. The reaction was 
stirred at -78 °C for 25 minutes, then trimethylborate (13.45 mmol, 1.5 mL) was added neat in one portion. 
Stirring was continued at -78 °C for 20 minutes, then the cooling bath was removed. The reaction was 
slowly warmed to 23 °C over 2 hours. The reaction was poured into a 1 N HCl solution (200 mL) pre-
cooled to 0 °C and stirred for 15 minutes. The mixture was transferred to a separatory funnel, rinsing with 
100 mL Et2O. The mixture was shaken and the phases were separated. The aqueous phase was extracted 
with Et2O (2 × 50 mL). The combined organics were washed with H2O (50 mL), brine, dried over 
anhydrous MgSO4, filtered and concentrated to give a yellow oil (4.31-8), which was diluted with toluene 
(30 mL) and used directly in the next step. 
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To a solution of 4.31-8 in toluene (50 mL) and DMSO (5 mL) was added N-methyliminodiacetic acid 
(1.45 g, 9.84 mmol). The round-bottom flask was fitted with a Dean-Stark trap and a reflux condenser and 
refluxed for 4 hours. The reaction was cooled to 23 °C and transferred into 1:1 saturated NaCl/H2O (50 
mL). The organic phase was washed with another 50 mL 1:1 saturated NaCl/H2O. The combined aqueous 
phase was washed with Et2O (2 × 50 mL), and the organic layer was dried over anhydrous MgSO4, 
filtered, and concentrated. The residue was purified by flash column chromatography on silica gel 
(Et2O:acetone 100:0 → 1:2) to give 4.31-9 as a white solid (1.74 g, 50% yield over 2 steps).  
 
TLC (acetone/hexane 1:1) 
Rf = 0.47, stained by KMnO4. 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.24 (dd, J = 18, 8 Hz, 1H), 5.41 (dd, J = 18, 1 Hz, 1H), 4.21 (d, J = 3 Hz, 1H), 3.82 (d, J = 
16.5 Hz, 2H), 3.66 (dd, J = 16.5, 3 Hz, 2H), 3.40 (s, 3H), 3.38 (s, 3H), 3.08 (dd, J = 10, 2 Hz, 1H), 2.80, 
(s, 3H), 2.52-2.49 (m, 1H), 1.68-1.61 (m, 1H), 1.13 (d, J = 7 Hz, 3H), 0.95 (d, J = 7 Hz, 3H), 0.17 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 167.6, 167.5, 148.9, 104.8, 91.3, 85.6, 72.1, 61.6, 61.2, 56.8, 46.9, 42.8, 42.1, 18.2, 11.2, 0.2. 
 
HRMS (ESI+) 
Calculated for C20H35BNO6Si: 424.2327 
Found:    424.2329 
 
 
To a solution of 4.31-9 (1.69 g, 3.99 mmol) in acetone/H2O/lutidine (10:10:1, 84 mL) at 0 °C was added 
AgNO3 (3.39 g, 20.0 mmol) in one portion. The reaction was gradually allowed to warm to 23 °C over 2.5 
hours. The reaction was quenched by transferring the mixture into saturated aqueous NH4Cl (100 mL) and 
diluted with EtOAc (50 mL). The mixture was filtered to remove the insoluble salts. The filtrate was 
transferred to a separatory funnel and the phases were separated. The organic phase was washed with 0.5 
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M HCl (2 × 50 mL) and the aqueous phase extracted with EtOAc (50 mL). The organic layer was washed 
with brine, dried over anhydrous MgSO4, filtered and concentrated to afford a white foam. The foam was 
dissolved in Et2O (~10 mL), then 20% Et2O/hexane (30 mL) was added and the suspension was filtered, 
washing with additional 20% Et2O/hexane (20 mL). The filtrate was concentrated in vacuo to give 4.31-
10 as a white solid (1.22 g, 87% yield). 
 
TLC (acetone/hexane 1:1) 
Rf = 0.34, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.24 (dd, J = 17.5, 8 Hz, 1H), 5.41 (dd, J = 17.5, 1 Hz, 1H), 4.23 (t, J = 2 Hz, 1H), 3.79 (d, J = 
16 Hz, 2H), 3.66 (dd, J = 16, 1.5 Hz, 2H), 3.42 (s, 3H), 3.40 (s, 3H), 3.09 (dd, J = 10, 2.5 Hz, 1H), 2.81, 
(s, 3H), 2.55-2.47 (m, 1H), 2.40 (d, J = 2 Hz, 1H), 1.69-1.61 (m, 1H), 1.14 (d, J = 7 Hz, 3H), 0.96 (d, J = 
7 Hz, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 168.1, 168.0, 148.1, 85.3, 82.6, 74.3, 71.2, 61.4, 61.0, 56.6, 46.9, 42.5, 41.9, 18.0, 10.7 
 
HRMS (ESI+) 
Calculated for C17H27BNO6: 352.1931 
Found:    352.1933 
 
 
Preparation of catalyst stock solution. A dry 7-mL vial equipped with a PTFE-coated magnetic stir bar 
was charged with RuPhos (9.3 mg, 0.02 mmol). The vial was brought into the glovebox, and Pd2dba3 (4.6 
mg, 0.005 mmol) was added. CH2Cl2 (3 mL) was added, and the mixture was stirred at 23 °C for 25 
minutes. 
The freshly prepared catalyst stock solution was used immediately for the preparation of 4.31-11: A dry 
20-mL vial equipped with a PTFE-coated magnetic stir bar was charged with 4.31-10 (176 mg, 0.5 mmol). 
The vial was evacuated and filled with argon (x 3), then CH2Cl2 (5 mL) was then added, followed by the 
catalyst stock solution, rinsing with CH2Cl2 (2 mL). Tributyltin hydride (0.27 mL, 1.00 mmol) was added 
neat dropwise to the reaction under argon at 23 °C, over 1 hour 25 minutes. The reaction was stirred at 23 
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°C for 2 hours after the addition was complete. The reaction was concentrated in vacuo and purified by 
silica gel chromatography (10% to 50% acetone/hexanes). The yellow solid obtained after concentration 
was dissolved in 10% acetone/hexanes and passed through a pad of Darco® and Celite™ to give a 
colorless solution. The solution was concentrated in vacuo to give 4.31-11 as an off-white solid (255 mg, 
79% yield).  
 
TLC (acetone/hexane 1:1) 
Rf = 0.47, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.27 (dd, J = 18, 7.5 Hz, 1H), 6.12, (d, J = 19 Hz, 1H), 5.84, (dd, J = 19, 6 Hz, 1H), 5.38 (d, J 
= 18 Hz, 1H), 3.83-3.82 (m, 1H), 3.79 (dd, J = 16.5, 3 Hz, 2H), 3.65 (d, J = 16.5 Hz, 2H), 3.46-3.44 (m, 
1H), 3.44 (s, 3H), 3.26 (s, 3H), 3.11 (dd, J = 9.5, 2.5 Hz, 1H), 2.78, (s, 3H), 2.55-2.47 (m, 1H), 1.53-1.47 
(m, 6H), 1.31 (sext, J = 7.5 Hz, 6H), 1.13 (d, J = 6.5 Hz, 3H), 0.91-0.87 (m, 15H), 0.77 (d, J = 7.5 Hz, 
3H) 
 
13C-NMR (125 MHz, CDCl3 
δ 167.4, 149.1, 147.5, 130.4, 86.1, 84.0, 61.4, 60.8, 56.4, 46.6, 42.0, 41.7, 29.1, 27.2, 18.1, 13.7, 
9.8, 9.4 
 
LRMS (ESI+) 
Calculated for C29H55BNO6Sn: 644.3 
Found:    644.3 
 
 
To a solution of 4.31-11 (1.387 g, 2.16 mmol) in CH2Cl2 (20 mL) in a 50-mL round-bottom flask was 
added dropwise a solution of I2 (0.576 g, 2.27 mmol) in CH2Cl2 (30 mL) via a pressure-equalizing funnel 
at 0 °C under ambient atmosphere over 1 hour. The funnel was rinsed with CH2Cl2 (10 mL) and the 
solution added portion wise to the reaction. The ice bath was removed and the reaction was allowed to 
gradually warm to 23 °C over 1 hour. The reaction was transferred into a 250-mL separatory funnel, 
rinsing with additional CH2Cl2. The organic layer was washed with 2 × 30 mL 1 M Na2S2O5 solution, 
then with 2 × 25 mL 3 M KF solution. The combined aqueous layer was extracted with 25 mL CH2Cl2. 
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The organic phase was dried over anhydrous MgSO4, filtered and concentrated in vacuo. The crude 
product was purified by silica gel chromatography (1:6 to 2:3 acetone/hexanes) to give 4.31 as a white 
solid (0.827 g, 80%). 
 
TLC (acetone/hexane 1:1) 
Rf = 0.32, stained by KMnO4 
 
1H-NMR (500 MHz, CDCl3) 
δ 6.46 (dd, J = 14.5, 7 Hz, 1H), 6.26, (d, J = 14.5 Hz, 1H), 6.19, (dd, J = 17.5, 7.5 Hz, 1H), 5.39 
(d, J = 17.5 Hz, 1H), 3.94 (d, J = 16.5 Hz, 2H), 3.88-3.87 (m, 1H), 3.68 (dd, J = 16.5, 4.5 Hz, 2H), 3.42 
(s, 3H), 3.26 (s, 3H), 3.07 (dd, J = 9.5, 1.5 Hz, 1H), 2.80, (s, 3H), 2.55-2.47 (m, 1H), 1.12 (d, J = 7.0 Hz, 
3H), 1.50-1.45 (m, 1H), 0.76 (d, J = 7.0 Hz, 3H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 167.7, 167.6, 148.5, 145.8, 85.8, 82.8, 61.4, 61.0, 56.7, 46.8, 41.8, 41.6, 18.0, 9.8 
 
HRMS (ESI+): 
Calculated for C17H28BNO6I: 480.1054 
Found:    480.1053 
 
b. Synthesis of building blocks for the ratanhine library 
 
 
To a stirred solution of triphenylphosphine (1.10 g, 4.2 mmol, 1.2 equiv) in THF (10 mL) at 0 °C was 
added dropwise diisopropylazodicarboxylate (DIAD; 830 μL, 4.2 mmol, 1.2 equiv) to generate a yellow 
suspension. In one portion, 4-bromo-3-methoxyphenol (711 mg, 3.5 mmol, 1 equiv) and 2-(tert-
butyldiphenylsilyl)ethanol (1.19 g, 4.2 mmol, 1.2 equiv) were added. The mixture was stirred for 15 
minutes, after which the ice bath was then removed and the reaction warmed to ambient temperature. 
After stirring for 1 hour, the reaction was diluted with diethyl ether and adsorbed onto Celite™ in vacuo. 
The Celite™ pad was loaded onto a silica gel column and eluted with hexanes/DCM gradient (4:1 to 3:7).  
Fractions containing a minor impurity were re-adsorbed on Celite™ and eluted from a silica gel column 
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using a hexanes/DCM gradient (4:1 to 3:1).  Purified fractions were combined to afford 4.58 as a 
colorless amorphous solid (1.19g, 72% yield). 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.74 – 7.72 (m, 4H), 7.50 – 7.44 (m, 6H), 7.34 (d, J = 8.5 Hz, 1H), 6.43 (d, J = 2.5 Hz, 1H), 
6.27 (dd, J = 9.0, 3.0 Hz, 1H), 4.08 – 4.05 (m, 2H), 3.81 (s, 3H) 1.86 – 1.83 (m, 2H), 1.11 (s, 9H); 13C-
NMR (125 MHz, acetone-d6): δ 160.5, 157.5, 136.6, 134.7, 133.8, 130.3, 128.7, 107.7, 102.4, 101.3, 66.3, 
56.4, 28.1, 18.5, 12.5 
 
HRMS (EI+) 
Calculated for C25H29O2SiBr: 468.11202 
Found:    468.11118 
 
 
 
To a stirred solution of triphenylphosphine (765 mg, 3.0 mmol, 1.5 equiv) in THF (7.5 mL) at 0 °C was 
added dropwise diisopropylazodicarboxylate (DIAD; 570 μL, 3.0 mmol, 1.5 equiv) to generate a yellow 
suspension. In one portion, 4-bromo-3-(trifluoromethoxy)phenol (500 mg, 2.0 mmol, 1 equiv) and 2-(tert-
butyldiphenylsilyl)ethanol (830 mg, 3.0 mmol, 1.5 equiv) were added. The mixture was stirred for 15 
minutes, after which the ice bath was then removed and the reaction warmed to ambient temperature. 
After stirring for 16 hours, the reaction was diluted with diethyl ether and adsorbed onto Celite™ in 
vacuo. The Celite™ pad was loaded onto a silica gel column and eluted with 4:1 hexanes/DCM.  The 
colorless oil from this column was re-adsorbed onto Celite™, loaded onto silica gel, and eluted with a 
hexanes/DCM gradient (hexanes to 9:1 hexanes/DCM) to afford 4.59 as a colorless oil (785 mg, 77% 
yield). 
 
1H-NMR (500 MHz, acetone-d6) 
δ 7.71 – 7.69 (m, 4H), 7.55 (d, J = 8.5 Hz, 1H), 7.47 – 7.41 (m, 6H), 6.82 – 6.81 (m, 1H), 6.75 
(dd, J = 8.5, 2.5 Hz, 1H), 4.11 – 4.07 (m, 2H), 1.86 – 1.83 (m, 2H), 1.08 (s, 9H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 160.5, 157.5, 136.6, 134.7, 133.8, 130.3, 128.7, 107.7, 102.4, 101.3, 66.3, 56.4, 28.1, 18.5, 12.5. 
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Triphenylphosphine (PPh3, 7450 mg, 28.4 mmol, 1.8 equiv.) was charged in a 250-mL round-bottom 
flask equipped with a PTFE-coated magnetic stir bar and back-filled with N2. THF (70 mL) was added 
and the reaction mixture was cooled to 0 °C for 10 minutes. Diisopropyl azodicarboxylate (DIAD, 5.6 mL, 
28.4 mmol, 1.8 equiv.) was added dropwise to the reaction flask affording a white precipitate. This 
heterogeneous mixture was stirred at 0 °C for 10 minutes. 2-trimethylsilylethanol (4.1 mL, 28.4 mmol, 
1.8 equiv.) was added to the reaction flask and the resulting mixture was stirred at 0 °C for 10 minutes. 
Methyl p-hydroxybenzoate (2400 mg, 15.8 mmol, 1.0 equiv.) was added to the flask in one portion 
followed by THF (10 mL) and the resulting reaction mixture was and stirred at 0 °C for 10 minutes. After 
10 min, the reaction mixture was warmed to 23 °C with stirring for 16 hours. After 16 hours, the reaction 
mixture was concentrated in vacuo to afford a clear oil. This crude oil was dissolved in minimum amount 
of diethyl ether (5 mL). Hexanes (100 mL) were added and the solution was stirred at 23 °C for 5 minutes 
until white solid precipitated. The solid was filtered through a fritted filter funnel rinsing with hexanes. 
The filtrate was concentrated in vacuo to afford a clear oil, which was adsorbed onto Celite™ from an 
acetone solution and purified by SiO2 chromatography (20% DCM:hexanes → 50% DCM:hexanes) to 
afford 4.61-1 as a clear oil (434 mg, 11% yield). 
 
TLC (dichloromethane:hexanes 1:1) 
Rf = 0.28, shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
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δ 7.97 (d, J = 9.5 Hz, 2H), 6.88 (d, J = 9.0 Hz, 2H), 4.13 (t, J = 7.5 Hz, 2H), 3.88 (s, 3H), 1.15 (t, 
J = 8.0 Hz, 2H), 0.09 (s, 9H); 13C-NMR (125 MHz, CDCl3): δ 216.4, 172.1, 163.5, 132.3, 121.4, 114.2, 
65.8, 17.6, -1.35. 
 
HRMS (ESI+)  
Calculated for C13H20O3SiNa: 275.1079 
Found:    275.1084 
 
 
A 40-mL vial equipped with a PTFE-coated magnetic stir bar was charged with LiOH·H2O (722 mg, 17.2 
mmol, 10 equiv.) and H2O (4 mL). The vial was placed in a 60 °C aluminum heating block and stirred at 
that temperature for 5 minutes until a clear solution was afforded. The vial was removed from the heating 
block and a solution of 4.61-1 (434 mg, 1.72 mmol, 1.0 equiv.) in THF (9 mL, 0.2 M) was added to the 
reaction vial. The vial was sealed with a PTFE-lined cap and placed in a 60 °C aluminum heating block 
and stirred at that temperature for 14 hours. The reaction mixture was cooled to 23 °C, then to 0 °C for 10 
minutes. 6 N HCl was added dropwise to the crude reaction mixture with stirring until pH ≤ 1. The 
reaction mixture was transferred to a separatory funnel with H2O (20 mL) and EtOAc (40 mL). The 
phases were separated and the aqueous layer was extracted with EtOAc (40 mL x 2). The combined 
organic layers were washed with brine (50 mL), dried over anhydrous MgSO4, and concentrated in vacuo 
to afford a white solid. The crude solid was adsorbed onto Celite™ from an acetone solution and purified 
by SiO2 chromatography (1:4 EtOAc:hexanes → 2:1:7 EtOAc:EtOH:hexanes) to afford 4.61-2 as a white 
solid (361 mg, 88% yield).  
 
TLC (EtOAc:hexanes 1:4) 
Rf = 0.22, shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 8.03 (d, J = 9.0 Hz, 2H), 6.91 (d, J = 8.5 Hz, 2H), 4.15 (t, J = 7.5 Hz, 2H), 1.16 (t, J = 8.0 Hz, 
2H), 0.09 (s, 9H).  
 
13C-NMR (125 MHz, CDCl3) 
δ 172.2, 163.5, 132.3, 121.4, 114.2, 65.8, 17.6, -1.35 
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HRMS (ESI+) 
Calculated for C12H18O3SiNa: 261.0923 
Found:    261.0934 
 
 
A 100-mL flask equipped with a PTFE-coated magnetic stir bar was charged with 4.61-2 (361 mg, 1.51 
mmol, 1.0 equiv.) and back-filled with N2. 4.61-38 (447 mg, 1.82 mmol, 1.2 equiv.), DMAP (222 mg, 1.82 
mmol, 1.2 equiv.), and dichloromethane (20 mL, 0.08 M) were added to the reaction flask. The clear, 
colorless solution was cooled to 0 °C and stirred at that temperature for 10 minutes. DCC (375 mg, 1.82 
mmol, 1.2 equiv.) was added in one portion at 0 °C under N2 and stirred at that temperature for 10 
minutes. The ice bath was removed after 10 minutes and the reaction flask was allowed to warm to 23 °C 
with stirring over 15 hours. After 15 hours, the reaction mixture was concentrated in vacuo to afford a 
yellow sludge. The crude material was adsorbed onto Celite™ from an acetone solution and purified by 
SiO2 chromatography (30% DCM:hexanes → 40% DCM:hexanes) to afford 4.61-4 as a clear oil (575 mg, 
81% yield).  
 
TLC (30% DCM:hexanes) 
Rf = 0.21, shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 8.14 (d, J = 8.5 Hz, 2H), 7.92 (s, 1H), 7.61 (d, J = 8.5 Hz, 1H), 6.96 (d, J = 9.0 Hz, 2H), 6.92 
(d, J = 8.5 Hz, 1H), 6.70 (dd, J = 11.0 Hz, J = 14.5 Hz, 1H), 5.78 (s, 1H), 5.74 (s, 1H), 5.32 (d, J = 11.0 
Hz, 1H), 4.17 (t, J = 8.0 Hz, 2H), 1.18 (t, J = 7.5 Hz, 2H), 0.10 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 164.4, 163.6, 148.2, 137.5, 135.3, 132.8, 132.4, 129.2, 124.9, 120.8, 117.5, 114.4, 90.4, 65.9, 
17.5, -1.33. 
 
HRMS (ESI+) 
Calculated for C20H24O3SiI: 467.0540 
Found:    467.0534 
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A 50-mL flask equipped with a PTFE-coated magnetic stir bar was charged with 4.61-4 (575 mg, 1.23 
mmol, 1.0 equiv.), sealed with a septum, and back-filled with N2. Dichloromethane (12 mL, 0.1 M) was 
added to afford a clear, colorless solution. This solution was cooled to 0 °C and stirred at that temperature 
for 10 minutes. Bromine (0.14 mL, 2.71 mmol, 2.2 equiv.) was added dropwise to the reaction mixture at 
0 °C over the course of 20 minutes until a bright red color persisted. The crude reaction mixture was 
concentrated in vacuo in a 50-mL round-bottom flask and azeotroped with DCM (3 x 15 mL) to afford the 
dibromide as a yellow foamy solid (721 mg, 93% crude yield). The flask was charged with a PTFE-
coated magnetic stir bar, sealed with a septum, and back-filled with N2. Acetonitrile (11.5 mL, 0.1 M) 
was added and the reaction mixture was stirred at 23 °C for 5 minutes. DBU (0.2 mL, 1.34 mmol, 1.2 
equiv.) was added dropwise and the resulting mixture was stirred for 10 minutes. After 10 minutes, 
incomplete conversion was observed by TLC analysis, so another 0.3 mL of DBU was added dropwise. 
After 20 minutes of stirring at 23 °C, the reaction mixture was cooled to 0 °C and 1 N HCl (10 mL) was 
added. The reaction mixture was transferred to a separatory funnel with EtOAc (15 mL) and H2O (15 mL) 
and the layers were separated. The phases were separated and the aqueous layer was extracted with 
EtOAc (10 mL x 2). The combined organic layers were dried over anhydrous MgSO4 and concentrated in 
vacuo to afford a clear oil. The crude material was adsorbed onto Celite™ from an acetone solution and 
purified by SiO2 chromatography (40% DCM:hexanes) to afford 4.61-5 as a pale yellow oil (503 mg, 
75% yield over two steps).  
 
TLC (1:3 DCM:hexanes) 
Rf = 0.25, shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 8.13 (d, J = 9.0 Hz, 2H), 7.78 (s, 1H), 7.70 (d, J = 8.5 Hz, 1H), 6.98 (d, J = 8.5 Hz, 1H), 6.96 
(d, J = 9.0 Hz, 2H), 5.91 (d, J = 1.5 Hz, 1H), 5.84 (d, J = 2.0 Hz, 1H), 4.17 (t, J = 8.0 Hz, 2H), 1.17 (t, J 
= 8.0 Hz, 2H), 0.10 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 164.1, 163.6, 147.8, 138.9, 138.9, 135.4, 132.5, 125.3, 123.0, 122.7, 120.7, 114.4, 89.4, 
65.9,17.5, -1.34. 
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HRMS (ESI+) 
Calculated for C20H23O3SiBrI: 544.9645 
Found:    544.9646 
 
 
In a glove box, to a 7-mL vial equipped with a PTFE-coated magnetic stir bar and containing 4.61-5 (20 
mg, 0.037 mmol, 1.0 equiv.) and trans-propenyl boronic acid (4.73 mg, 0.055 mmol, 1.5 equiv.) was 
added ground potassium phosphate (23 mg, 0.11 mmol, 3.0 equiv.) and PdCl2dppf·CH2Cl2 (1.5 mg, 0.002 
mmol, 5 mol%) followed by THF (0.7 mL, 0.05 M). The vial was sealed with a cap and removed from the 
glove box. The vial was placed in a 45 °C aluminum heating block and stirred at that temperature for 24 
hours. After 24 hours, the reaction mixture was cooled to 23 °C, filtered through a pad of Celite™, and 
concentrated in vacuo. The crude material was adsorbed onto Celite™ from an acetone solution and 
purified by SiO2 chromatography (30% DCM:hexanes) to afford 4.61 as a pale yellow oil (13.5 mg, 80% 
yield).  
 
TLC (1:1 DCM:hexanes) 
Rf = 0.31, shortwave UV. 
  
1H-NMR (500 MHz, CDCl3) 
δ 8.15 (d, J = 8.5 Hz, 2H), 7.40 (s, 1H), 7.35 (d, J = 8.5 Hz, 1H), 7.13 (d, J = 8.5 Hz, 1H), 6.96 
(d, J = 9.0 Hz, 2H), 6.39 (d, J = 16.0 Hz, 1H), (dq, J = 15.5 Hz, J = 6.5 Hz, 1H),  5.89 (d, J = 1.5 Hz, 
1H), 5.82 (d, J = 1.5 Hz, 1H), 4.17 (t, J = 8.0 Hz, 2H), 1.90 (d, J = 7.0 Hz, 3H), 1.17 (t, J = 8.0 Hz, 2H), 
0.10 (s, 9H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 164.6, 163.4, 146.4, 135.8, 133.2, 132.4, 129.6, 127.6, 127.2, 126.8, 124.6, 123.2, 122.1, 121.2, 
114.3, 65.9, 18.5, 17.5, -1.33. 
 
HRMS (ESI+) 
Calculated for C23H28O3SiBr: 459.0991 
Found:     459.0987 
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A dry 25-mL Schlenk flask equipped with a PTFE-coated magnetic stir bar was charged with phenol 
4.61-3 (738 mg, 3 mmol) and DMAP (73.3 mg, 0.6 mmol) under N2. The flask was sealed with a rubber 
septum and CH2Cl2 (15 mL) was added via syringe. To this solution was added DIPEA (2.1 mL, 12.1 
mmol) in one portion. Benzoyl chloride (0.7 mL, 6.03 mmol) was then added neat dropwise over 5 
minutes. The reaction was stirred for another 19 hours at room temperature, then transferred into a 
separatory funnel containing 1 N HCl (10 mL). After mixing and phase separation, the organic layer was 
washed with another portion of 1 N HCl (10 mL) and then with H2O (20 mL). The combined aqueous 
layer was extracted with CH2Cl2 (20 mL). The organic phase was washed with brine (20 mL), dried over 
anhydrous MgSO4, filtered and concentrated. The crude product was purified by silica gel 
chromatography (30 - 35% CH2Cl2/hexanes) to afford 4.62-1 as a colorless viscous oil (643 mg, 61% 
yield). 
 
TLC (50% DCM/hexanes) 
Rf = 0.44, visualized by shortwave UV.  
 
1H-NMR (500 MHz, CDCl3) 
δ 8.21 (d, J = 7 Hz, 2H), 7.94 (d, J = 2 Hz, 1H), 7.66 (tt, J = 7.5, 1.5 Hz, 1H), 7.63 (dd, J = 8, 1.5 
Hz, 1H), 7.56 (t, J = 7.5 Hz, 2H), 6.94 (d, J = 8.5 Hz, 1H), 6.71 (dd, J = 17.5, 11 Hz, 1H), 5.77 (dd, J = 
18, 1 Hz, 1H), 5.34 (d, J = 11 Hz, 1H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 164.6, 148.0, 137.5, 135.4, 133.9, 132.7, 130.2, 129.0, 128.9, 128.7, 124.7, 117.7, 90.6. 
 
HRMS (ESI+) 
Calculated for C15H12O2I: 350.9882 
Found:    350.9890 
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A solution of 4.62-1 (3.37 g, 9.62 mmol) in CH2Cl2 (120 mL) in a 200-mL round-bottom flask was cooled 
to 0 °C under N2. Bromine (0.49 mL, 9.62 mmol) was added neat dropwise over 15 minutes. After the 
addition was complete, the reaction was stirred for a further 5 minutes. The reaction was concentrated in 
vacuo to give an orange solid. Residual bromine was removed by azeotroping the residue with CH2Cl2 (15 
mL × 2). The round bottom flask containing the crude product and equipped with a PTFE-coated 
magnetic stir bar was sealed with a rubber septum and back-filled with N2 twice. MeCN (120 mL) was 
added to dissolve most of the solid. DBU (1.4 mL, 9.5 mmol) was then added neat dropwise via syringe 
over 15 minutes. The reaction was stirred for 15 minutes before being charged with another portion of 
DBU (0.2 mL, 1.34 mmol) added neat dropwise into the reaction. After another 15 minutes, another 
portion of DBU (0.2 mL, 1.34 mmol) was added. The reaction was poured slowly into 2 N HCl solution 
(100 mL) cooled to 0 °C with vigorous stirring. EtOAc (50 mL) was added and the mixture stirred. After 
phase separation, the aqueous layer was extracted with EtOAc (50 mL). The combined organic phase was 
washed with brine (100 mL), then dried over anhydrous MgSO4, filtered and concentrated in vacuo. The 
crude product was purified by silica gel chromatography (30-35% CH2Cl2/hexanes) to afford 4.62-2 as an 
off-white solid (2.67g, 66% yield over 2 steps).  
 
TLC (40% CH2Cl2/hexanes) 
Rf = 0.47, visualized by shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 8.20 (d, J = 7.5 Hz, 2H), 7.79 (d, J = 2 Hz, 1H), 7.72 (dd, J = 8.5, 2 Hz, 1H), 7.66 (t, J = 7.5 
Hz, 1H), 7.52 (tt, J = 8, 1.5 Hz, 2H), 6.99 (d, J = 8.5 Hz, 1H), 5.92 (d, J = 2 Hz, 1H), 5.85 (d, J = 1.5 Hz, 
1H). 
 
13C-NMR (125 MHz, CDCl3) 
δ 164.4, 147.6, 138.9, 135.4, 133.9, 130.3, 128.8, 128.6, 125.1, 123.1, 122.5, 89.7. 
 
HRMS (ESI+) 
Calculated for C15H10O2BrINa: 450.8807 
Found:    450.8809 
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A dry 40-mL vial equipped with a PTFE-coated magnetic stir bar was charged with 4.62-2 (858 mg, 2.0 
mmol) and trans-propenyl boronic acid (223 mg, 2.6 mmol). The vial was brought into a glovebox and 
charged with K3PO4 (1.27 g, 3 equiv.), PdCl2dppf.CH2Cl2 (849 mg, 4 mmol) and THF (20 mL, 0.1 M). 
The vial was sealed with a Teflon-lined cap and stirred at 60 °C for 18 hours. The reaction was cooled to 
23 °C and filtered through a pad of Celite™ and concentrated in vacuo. The crude product was purified 
by silica gel chromatography (30-40% CH2Cl2/hexanes) to give 4.62 as an off-white solid (268 mg, 39% 
yield).  
 
TLC (40% CH2Cl2/hexanes) 
Rf = 0.43, visualized by shortwave UV. 
 
1H-NMR (500 MHz, CDCl3) 
δ 8.22 (dd, J = 8.0, 1.0 Hz, 2H), 7.65 (t, J = 7.5 Hz, 1H), 7.52 (app t, J = 8.0 Hz, 2H), 7.41 (d, J 
= 2.0 Hz, 1H), 7.36 (dd, J = 8.5, 2.0 Hz, 1H), 7.15 (d, J = 8.5 Hz, 1H), 6.40 (dd, J = 16.0, 1.5 Hz, 1H), 
6.26 (dq, J = 15.5, 6.5 Hz, 1H), 5.90 (d, J = 1.5 Hz, 1H), 5.83 (d, J = 2.0 Hz, 1H), 1.90 (dd, J = 7.0, 1.5 
Hz, 3H. 
 
13C-NMR (125 MHz, CDCl3) 
δ 164.8, 146.2, 136.0, 133.6, 133.3, 130.3, 129.5, 129.3, 128.6, 127.6, 127.2, 127.0, 124.5, 123.1, 
122.2, 18.5. 
 
HRMS (ESI+) 
Calculated for C18H16O2Br: 343.0334 
Found:    343.0336 
 
c. Synthesis of building blocks for 4.9 
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A mixture of p-nitrophenyl boronic acid (1.53 g, 9.17 mmol, 1 equiv), N-methyliminodiacetic acid (1.62 
g, 11.0 mmol, 1.2 equiv) in toluene (90 mL) and DMSO (9 mL) in a 200 mL rbf fitted with a Dean-Stark 
trap and a condenser was heated to reflux. The reflux was maintained for 1 h 50 min, emptying the Dean-
Stark trap once. The reaction was cooled to room temperature. Toluene was removed in vacuo and the 
residue was partitioned between 1:1 H2O/brine (100 mL) and 2:1 EtOAc/acetone (2:1). The aqueous layer 
was extracted with 2:1 EtOAc/acetone (90 mL). The combined organics were washed with brine (~ 50 
mL). The organic layer containing grey solids was filtered to separate the solids, rinsing with acetone. 
The grey solid was washed with H2O to remove any inorganic salts, then dried under air. The filtrate was 
dried over MgSO4 and Darco, then filtered through celite and concentrated in vacuo. To the solid residue 
was added ~ 10 mL of acetone. 100 mL Et2O was layered on top of the mixture and left to stand overnight. 
The crystals formed were isolated by vacuum filtration, rinsing with Et2O. The crystals were combined 
with the grey solids to give the desired product 16-1 (2.16 g, 85% yield).   
 
TLC (50% acetone/hexanes) 
Rf = 0.35, visualized by UV. 
 
1H-NMR (500 MHz, acetone-d6) 
δ 8.28-8.21 (m, 2H), 7.84 (app d, J = 8.5 Hz, 2H), 4.45 (d, J = 17.1 Hz, 2H), 4.25 (d, J = 17.1 Hz, 
2H), 2.83 (s, 3H). 
 
13C-NMR (125 MHz, acetone-d6) 
δ 169.0, 161.4, 151.4, 134.8, 123.2, 63.1, 48.5 
 
HRMS (EI+) 
Calculated for C11H11O6N2B:  278.07103 
Found:    278.07115 
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In an unoptimized procedure, a 100 mL recovery flask was charged with a stir bar, 16-1 (500 mg, 1.80 
mmol), THF (36 mL) and MeCN (12 mL). The solution was stirred to dissolve the solids. Pd/C (10 wt%, 
287 mg) was added. The flask was sealed with a rubber septum and N2 was bubbled through the mixture 
for 5 min. The N2 inlet was replaced with a H2 balloon. H2 was bubbled through the solution for 5 min. 
The outlet needle was removed and the reaction stirred under a H2 atmosphere at rt for 36 h. The flask 
was opened briefly to atmosphere and another portion of Pd/C (10 wt%, 63 mg) was added. The flask was 
re-sealed and H2 was bubbled through the mixture for 5 min. The outlet needle was removed and the 
reaction heated to 45 °C for 14 h to consume the remaining starting material. The reaction was cooled to 
rt, then purged with N2 for 10 min before filtering through celite, rinsing with MeCN (3 x 10 mL). The 
filtrate was concentrated in vacuo. The residue was taken up in MeCN (10 mL). Et2O (50 mL) was 
layered on top. The mixture was left to stand overnight. The crystals formed were isolated by vacuum 
filtration and dried under high vac to give 16 as a crystalline solid (341 mg, 76% yield).  
 
TLC (50% acetone/hexanes) 
Rf = 0.30, visualized by UV, stained by KMnO4 
 
1H-NMR (500 MHz, acetone-d6): δ 7.24-7.18 (m, 2H), 6.69-6.61 (m, 2H), 4.69 (br s, 2H), 4.25 (d, J = 
17.0 Hz, 2H), 4.04 (d, J = 2H), 2.69 (s, 3H). 
 
HRMS (ESI+) 
Calculated for C11H14N2O4B: 249.1047 
Found:    249.1048 
 
REFERENCES 
                                                     
1 Pangborn, A. B.; Giardello, M. A; Grubbs, R. H.; Rosen, R. K.; Timmers, F.J. Organometallics 1996, 15, 
1518-1520. 
2 Li, J.; Ballmer, S. G.; Gillis, E. P.; Fujii, S.; Schmidt, M. J.; Palazzolo, A. M. E.; Lehmann, J. W.; 
Morehouse, G. F.; Burke, M. D. Science 2015, 347, 1221-1226 
3 Bracher, F.; Schulte, B. Nat. Prod. Res. 2003, 17, 293-299. 
  
204 
 
                                                                                                                                                                           
4 Shing, T. K. M.; Yang, J. J. Org. Chem. 1995, 60, 5785-5789. 
5 Wilson, R. M.; Jen, W. S.; MacMillan, D. W. C. J. Am. Chem. Soc. 2005, 127, 11616-11617. 
6 Heathcock, C. H.; Piettre, S.; Ruggeri, R. B.; Ragan, J. A.; Kath, J. C. J. Org. Chem. 1992, 57, 2554-
2566. 
7 Hu, M.; Li, J.; Yao, S. Q. Org. Lett. 2008, 10, 5529-5531. 
8 Gillis, E. P.; Burke, M. D. J. Am. Chem. Soc. 2008, 130, 14084-14085. 
